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The Organic and Medicinal Chemistry Group at University Jaume I has 
developed several works during the last few years. These works defined a research 
line about organic chemistry goals and a different PhD studies for this years. 
 
As a result of this group research, some publications were available and 
determined the investigation road for last years. These group publications can be 
divided in cysteine proteases and asymmetric synthesis as follows.  
 
Cysteine proteases inhibitors publications:  
 
1. Dipeptidyl-α,β-epoxyesters as potent irreversible inhibitors of the cysteine 
proteases cruzain and rhodesain. 
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Asymmetric synthesis and derivatization: 
 
1. Stereoisomerization of β-Hydroxy-α-sulfenyl-γ-butyrolactones controlled 
by two concomitant 1,4-Type nonbonded sulfur-oxygen interactions as 
analyzed by X-ray crystallography. 
2. Highly stereoselective epoxidation of α-methyl-γ-hydroxy-α,β-unsaturated 
esters: rationalization and synthetic applications. 
3. Diastereoselective synthesis of γ-hydroxy-α,β-epoxyesters and their 
conversion into β-hydroxy α-sulfenyl γ-butyrolactones. 
4. Asymmetric epoxidation of poor-electron olefins. 
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According to these group experience and the interest fields of the group, 
this thesis was focused on all of these fields with new studies as summarized in the 
next chapter of objectives of the thesis. 
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English version 
 
This thesis was focused in all of the projects described above. During these 
studies, the main objective was to increase the experience and the skills in the 
organic chemistry laboratory. These fields are enough different to use very 
different kind of reactions, reagents, characterizations and techniques allowing to 
know more chemistry than working in a single field. The main objectives were 
divided in the following fields: 
 
Cysteine proteases inhibitors 
 
1. Design new cysteine proteases inhibitors against parasitic diseases and 
proteasome. 
2. Develop a quick and easy route to obtain the designed new inhibitors and 
control the modifications to make a wide scope for each family. 
3. Evaluate these new inhibitors against desired enzymes. 
4. Once evaluated the inhibition activity, redesign the structure inhibitors to 
increase the activity and make a new family of inhibitors. 
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Asymmetric synthesis and derivatization 
 
1. Explore compounds and reactions with new S-O interactions.  
2. Study new chiral poor-electron olefins compounds and the 
stereoselectivity in the epoxidation 
3. Study of mechanistic pathways of interesting transformations 
The progress of this investigation on these fields is explained in the following 
chapters and gave rise to new publications for our research group. 
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Versión española 
 
Teniendo en cuenta los campos de investigación descritos en la 
introducción general en los que tiene interés nuestro grupo de investigación, la 
tesis ha estado centrada en desarrollar todas y cada una de las líneas de 
investigación. Durante las investigaciones llevadas a cabo en esta tesis, el principal 
objetivo ha sido desarrollar la experiencia y la suficiencia investigadora, ampliando 
las aptitudes y conocimientos relacionados con la química orgánica. 
 
Los campos de investigación en los que se ha desarrollado la tesis son 
suficientemente diferentes, por la naturaleza de las reacciones, sustratos, reactivos 
y técnicas de caracterización que ha servido para ampliar más el conocimiento que 
habiéndose dedicado el tiempo a un solo campo. 
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Los principales objetivos quedan resumidos en los siguientes puntos: 
 
 
 
Inhibidores de cisteína proteasa: 
 
1. Diseñar nuevos inhibidores de cisteína proteasa contra enfermedades 
parásitas y proteasoma. 
2. Desarrollar rutas sintéticas rápidas y versátiles para obtener estos nuevos 
inhibidores, teniendo en cuenta la posibilidad de ampliar el número de 
compuestos por familia. 
3. Evaluar en primera persona estos nuevos inhibidores contra los enzimas 
deseados. 
4. Con los resultados de inhibición, plantear y rediseñar las estructuras de 
estos compuestos para obtener una nueva generación mejorada de 
inhibidores. 
 
 
 
 
Síntesis asimétrica y derivatizaciones 
 
1. Buscar nuevos compuestos con nuevas interacciones S-O. 
2. Llevar a cabo el estudio de la estereoselectividad de olefinas quirales 
deficientes en electrones.  
3. Hacer estudios exhaustivos de los mecanismos de reacción de 
transformaciones químicas interesantes. 
 
  
13 Objectives 
El progreso de estas investigaciones en cada uno de los campos mencionados va 
a ser explicados en los capítulos siguientes y ha dado lugar publicaciones.
  
 
 
Chapter 1: 
Study of the mechanism in the 
elimination of 2-arylsulfinyl 
esters 
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1.  Introduction 
During our previous study of the epoxidation of α-methyl-γ-hydroxy-α,β-
unsaturated esters,  two butyrolactones were obtained (syn-syn and syn-anti)1,2 as 
represented in scheme 1. 
 
 
Scheme 1. Previously obtained butyrolactones. 
 
                                                          
1 López, I.; Izquierdo, J.; Rodríguez, S.; González, F. V. J. Org. Chem. 2007, 72, 6614–6617 
2 González, F. V.; Jain, A.; Rodríguez, S.; Sáez, J.; Vicent, C.; Peris, G. J. Org. Chem. 2010, 75, 5888– 5894 
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As a further application of these compounds, synthesis of natural product 
1.3 was carried out. After sulfur oxidation of selected butyrolactone syn-anti to the 
corresponding sulfoxide, elimination reaction was carried out under refluxing 
toluene in open air. The spectroscopy data for compound 1.3 were identical to 
those described in the literature.3,4  
During this transformation, the attention was focused in the mechanism of 
elimination of 2-arylsulfinyl esters to form the alkene. Curiously, sulfone 1.5 was 
also obtained.  
 
Scheme 2: Formation of rearrangement product 1.5 
 
 The scheme 2 shows the elimination reaction of sulfoxide 1.2 to give 
exomethylenic compound 1.3 as the main reaction product and sulfone 1.5 as a 
minor product. Sulfone 1.5 results from an oxidative rearrangement of sulfoxide 
1.2 in a highly stereoselective fashion across the sulfoxide 1.4. The structure of 
sulfone 1.5 was determined by single crystal X-ray diffraction and it is shown in 
figure 1. Presumably, -oxo sulfoxide 1.2 rearranges to a -oxo sulfoxide 1.4 which 
upon oxidation furnishes -oxo sulfone 1.5. It has been reported the high tendency 
                                                          
3 Martínez, J. C. V.; Yoshida, M.; Gottlieb, O. R. Phytochemistry 1981, 20, 459-464 
4 Hanson, R. L.; Lardy, H. A.; Kupchan, S. M. Science 1970, 168, 376-380 
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of thioethers with neighboring hydroxyl groups to be oxidized to sulfones instead 
of sulfoxides.5 
 
Figure 1: ORTEP representations (50 % probability ellipsoids) of compound 1.5 
 
Since Cram and Kingsbury studied the mechanism of sulfoxides 
elimination and proposed an internal elimination mechanism (Ei),6 the elimination 
reactions of sulfoxides and sulfones are commonly applied in organic chemistry,7 
especially in the case of 2-arylsulfinyl esters with the aim of obtaining unsaturated 
carbonyl compounds.8,9,10,11 An example of eliminations to obtain alkenes can be 
observed in scheme 3. 
 
Scheme 3: Example of elimination of sulfoxides 
                                                          
5 Clennan, E. L.; Kang, Y. J. Org. Chem. 1992, 57, 4477– 4487 
6 Kingsbury, C. A.; Cram, D. J. J. Am. Chem. Soc. 1960, 82, 1810–1819 
7 Carreño, C. Chem. Rev. 1995, 95, 1717–1760 
8 Trost, B. M.; Salzmann, T. N.; Hiroi, K. J. Am. Chem. Soc. 1975, 97, 4887–4902 
9 Trost, B. M.; Leung, K. K. Tetrahedron Lett. 1975, 48, 4197–4200 
10 Trost, B. M.; Mao, M. K. T.; Balkovec, J. M.; Buhlmayer, P. J. Am. Chem. Soc. 1986, 108, 4965–4973 
11 Bänziger, M.; Kleina, S.; Rihs, G. Helv. Chim. Acta 2002, 85, 1399–1406 
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In the above mentioned work,6 authors studied the elimination of 1,2-
diphenyl-1-propyl phenyl sulfoxides and suggested also a competing homolytic 
mechanism. This mechanism would operate when the radicalary intermediate can 
be stabilized as for 1,2-diphenyl-1-propyl phenyl sulfoxides. They reached to this 
supposition based on the loss of stereospecificity in some products when the 
reaction was performed at high temperature (scheme 4).  
Although sulfoxide elimination reaction has been widely applied,12,13 no 
further evidence of this homolytic mechanism involving a sulfinyl group has been 
reported in the literature. 
 
Scheme 4: Theoretical pathways proposed in literature12 
Based upon the mechanistic pathways suggested in literature,12 two 
possible routes can be considered for the transformation of 2-arylsulfinyl esters 
into the unsaturated compound: the concerted elimination reaction and the radical 
process (scheme 5).  
 
 
                                                          
12 Cubagge, J. W.; Guo, Y.; McCulla, R. D.; Jenks, W. S. J. Org. Chem. 2001, 66, 8722-8736 
13 McCulla, R. D.; Jenks, W. S. J. Org. Chem. 2003, 68, 7871– 7879 
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Scheme 5: Mechanistic pathways for the elimination of 2-arylsulfinyl esters 
 
The main difference between two pathways is the existence of a radical 
intermediate, in the second one. Then, our efforts were focused in the 
confirmation of this intermediate in the reaction media by capturing the 
intermediate with a radical scavenger in the chemical reaction and by mass 
spectrometry techniques. 
 
 
 
 
 
 
Chapter 1 
 
22 
 
 
 
 
  
2.  Results and discussion  
For getting a wider scope in this study, a family of 2-arylsulfinyl esters 
with a range of alkyl and aryl groups (R) was prepared.  
2-Arylsulfinyl esters were prepared from 2-bromo esters in two steps. The 
treatment of commercially available 2-bromo esters with the corresponding 
thiolate, previously prepared by combining the corresponding thiol and sodium 
hydride in tetrahydrofuran as a solvent cold with an ice bath for 72 h, afforded the 
thioethers 1.6a-f in good yields, as it can be observed in table 1.  
  
Scheme 6: Preparation of thioethers 1.6a-f 
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Table 1. Preparation of thioethers 
Entry Product R R’ Ar Yield (%) 
1 1.6a H Et Ph 65 
2 1.6b H Et p-MeO-Ph 60 
3 1.6c H Et p-NO2-Ph 52 
4 1.6d Me Et Ph 93 
5 1.6e Et Et Ph 88 
6 1.6f H Bn Ph 70 
 
The thioethers were oxidized with m-CPBA in dichloromethane at -10 oC 
for 30 minutes, affording the corresponding sulfoxides 1.7a-f in good yields as 
shown in table 2. 
 
Scheme 7: Preparation of sulfoxides 1.7a-f 
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Table 2. Preparation of sulfoxides 
Entry Product R R’ Ar Yield (%) 
1 1.7a H Et Ph 83 
2 1.7b H Et p-MeO-Ph 51 
3 1.7c H Et p-NO2-Ph 62 
4 1.7d Me Et Ph 82 
5 1.7e Et Et Ph 92 
6 1.7f H Bn Ph 70 
 
The elimination reaction was done as shown in scheme 8, by heating at 
reflux in toluene for five hours. In all cases only trans isomer was isolated and any 
trace of cis isomer was observed by NMR, even when the reaction was carried out 
at 80 oC. 
 
Scheme 8: Elimination reaction 
Elimination compounds were characterized as the main reaction products 
and their data had fully consonance with the physical data from literature.14,15,16,17 
                                                          
14 Aldrich Library of 13C and 1H FT NMR spectra; Aldrich: Milwaukee; 1993, p 973C 
15 Nishizawa, M.; Hirakawa, H.; Nakagawa, Y.; Yamamoto, H.; Namba, K.; Imagawa., H. Org. Lett. 2007, 9, 5577–
5580 
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The crude reaction was complex as detected by NMR in all cases. Minor 
reaction products were phenylthiosulfonate 1.12 and sulfoxide 1.13 (scheme 9). 
Then a careful purification of the reaction mixture was carried out.  
 
 
Scheme 9: Elimination reaction products 
The sulfoxide 1.13 is a reaction product equivalent to the rearranged lactone 
1.4. This interesting transformation could be an alternative synthetic route to 
prepare 3-arylsulfinyl esters. 
 
2.1. Mechanism study  
In order to know in detail the mechanism in the elimination of 2-arylsulfinyl 
esters, a whole study was carried out. An important aspect of the study was to find 
out if the mechanism follows a homolytic pathway.  
 
2.1.1. Elimination of sulfonyl and sulfenyl esters 
The first point was to determine if sulfonyl esters and sulfenyl esters can 
also eliminate as sulfinyl esters do. Sulfonyl esters were prepared from previously 
                                                                                                                                                         
16 Kandula, S. R. V.; Kumar, P. Tetrahedron: Asymmetry 2005, 16, 3268– 3274 
17 Pittelkow, M.; Christensen, J. B. Org. Lett. 2005, 7, 1295– 1298 
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prepared thioethers. Sulfones were oxidized with m-CPBA in dichloromethane for 
1h, shown in scheme 10. The yields obtained are included in table 3.    
 
Scheme 10: Preparation of sulfonyl compounds  
 
Table 3. Preparation of sulfones 
Entry Product R R’ Ar Yield (%) 
1 1.14a H Et Ph 76 
2 1.14b H Et p-MeO-Ph 69 
3 1.14c H Et p-NO2-Ph 61 
4 1.14d Me Et Ph 89 
5 1.14e Et Et Ph 92 
6 1.14f H Bn Ph 83 
 
When those 2-arylsulfenyl esters and 2-arylsulfonyl esters were submitted 
to the elimination reaction under refluxing toluene for five hours, starting 
materials were recovered in all cases. The result (scheme 11), determined that only 
sulfinyl compounds can be converted to unsaturated carbonyl compounds by 
thermal treatment in toluene. 
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Scheme 11: Elimination reaction of sulfones and thioethers 
 
2.1.2. Crossover  
 
In order to determine if the formation of the rearranged 3-sulfinyl esters 
during the elimination of 2-arylsulfinyl esters results from an intramolecular 
process or it is intermolecular, a mixture of two different 2-arylsulfinyl esters (1.7b 
and 1.7f) was submitted to elimination conditions and the reaction products were 
identified. 
In the crossover experiment only two possibilities could be expected. The 
first one, illustrated in scheme 12, if the reaction was an intramolecular 
mechanism, only two sulfinyl compounds must be detected. 
 
 
Scheme 12: Theoretical products via intramolecular pathway 
 
On the other hand, if the reaction was an intermolecular mechanism four 
3-arylsulfinyl compounds can be obtained, as it is shown in scheme 13. 
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Scheme 13: Theoretical products via intermolecular pathway 
 
The mixture of compound 1.7b and 1.7f was refluxed in toluene for five 
hours and a complex crude reaction was obtained. All volatiles compounds were 
removed (ethyl acrylate 1.8 and benzyl acrylate 1.11) and a separation by 
chromatography led to two fractions, thiosulfonate esters and sulfoxides products. 
The fraction with all thiosulfonate compounds was analyzed by 1H-NMR and 13C-
NMR and very complex spectra were obtained. These fractions were also analyzed 
by electrospray ionization mass spectrometry, operating in positive mode (ESI +). 
The results obtained, unraveled a rapid and direct snapshot of three formed species 
for the thiosulfonate fraction (scheme 14), and four formed species for the 
sulfoxides (scheme 15). 
 
 
Scheme 14: Elimination reaction, thiosulfonate fraction 
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Figure 2: ESI-MS of the thiosulfonates fraction 
Scheme 15: Elimination reaction, sulfoxides fraction 
 
Figure 3: ESI-MS of the sulfoxides fraction 
m/z
250 255 260 265 270 275 280 285 290 295 300 305 310 315 320 325 330 335 340 345
%
0
100
298
273
268
264
257 261 266
289
281
277
295
303
319
305
311
328
321
333
(1.12+H)+
(1.12+Na)+
(1.12+K)+
(1.15+H)+
(1.15+Na)+
(1.15+K)+
(1.16+H)+
(1.16+Na)+
(1.12+NH4)
+
(1.15+NH4)
+
(1.16+NH4)
+
m/z
210 220 230 240 250 260 270 280 290 300 310 320 330 340 350
%
0
100
295
264
242
227
218
257
249
279
273
290
311
303
308
320
341333
328
349
(1.13+H)+
(1.13+Na)+
(1.17+H)+
(1.17+Na)+
(1.18+H)+
(1.18+Na)+
(1.19+H)+
(1.19+Na)+
(1.17+K)+
Chapter 1 
 
30 
The presence of these crossover products can only be explained by a 
scission of the C-S bond, demonstrating the process to be intermolecular. When 
same reaction was carried out at 80 oC same results were obtained.  
 
 
2.1.3. Reaction carried out in darkness 
 
It has been reported that a carbon-sulfur bond can be cleaved via 
photolysis.18 With the aim of confirming the role of light in the reaction, 2-
arylsulfinyl esters 1.7a-f were refluxed in toluene for five hours but in the absence 
of light, summarized in scheme 16.  
 
The results of the reactions were in all cases the same than in the presence 
of light, demonstrating that light is not the cause of the carbon-sulfur cleavage. 
 
 
Scheme 16: Elimination in the absence of light 
 
 
2.1.4. Trapping intermediates 
 
Although the crossover experiments indicates the participation of free 
radicals, it was convenient to confirm by a direct way the presence of free radicals 
in the reaction process. The strategy was based on the use of the tapping agents as 
the 2,2,6,6-tetramethyl-1-piperidinyloxy (tempo), which is a stable nitroxyl 
                                                          
18 Guo, Y.; Jenks, W. S. J. Org. Chem. 1997, 62, 857– 864 
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radical, and it could react with the radical intermediates to form new species in the 
reaction crude.19 The presence of these new species would provide a strong and 
clear evidence of the radical mechanism. The expected products are shown in 
scheme 17. 
 
 
Scheme 17: Theoretical expected products  
 
The typical elimination reaction was carried out with sulfoxides 1.7b, 1.7d 
and 1.7e in toluene for five hours in the presence of tempo at 80 oC. The reaction 
crude was carefully concentrated and investigated by ESI-MS. Compound 1.7b 
afforded adducts 1.20 and 1.24, compound 1.7d afforded adducts 1.21 and 1.23 and 
compound 1.7e afforded 1.22 and 1.23, as expected. The results can be seen in 
scheme 18.  
 
 
Scheme 18: Elimination reactions in the presence of tempo 
 
                                                          
19 Zhang, X.; Wang, H.; Guo, Y. Rapid Commun. Mass Spectrom. 2006, 20,1877– 1882 
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Only in the case of reaction of compound 1.7e was possible to do a full 
characterization of products 1.22 and 1.23. The complicated characterization of 
nitroxides as 1.20 are based on their reactivity as radical initiators,20 for this reason 
the trapping reaction at 110 oC were not useful for compounds 1.20 and 1.21. In 
that case, the reaction was performed at 80 oC; isolation and characterization were 
done to confirm the radical trapping product. 
 
With all these experiments and products, the radical mechanism for the 
elimination of aryl sulfinyl esters into enoates was demonstrated. The presence of 
ester which can stabilize the radical intermediate, allowed the radical pathway. 
The detection and characterization of tempo trap produces an organic evidence of 
the intermediates of the radical mechanism. 
 
The radical mechanism, complementing previous scheme 9, was proposed 
as depicted in scheme 19, according to the results and the reaction products. 
 
 
Scheme 19: Radical mechanism pathway 
 
Sulfoxides could give the sufinyl radical and the corresponding stabilized 
ester radical in a first step. Sulfinyl radicals combine to give vic-disulfoxides and 
                                                          
20 Braslau, R.; Burrill II,L.C.;  Siano, S.;  Naik, N.;  Howden, R.K.; Mahal, L.K.; Macromolecules, 1997, 30 (21), 
6445–6450 
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undergo to isomerization to form thiosulfonate. This product can partially be 
transformed into the diaryl sulfide and the sulfonic acid. 
 
These results demonstrated a radical mechanism for the elimination for this 
range of sulfoxides into enoates. Information of the intermediates in a multistep 
reaction is important to confirm the mechanism pathway.21 
 
 
 
2.2. Electrospray ionization tandem mass spectrometry 
 
2.2.1.  ESI mass spectrometry 
The electrospray ionization (ESI), operating in positive (+) or negative (-) 
mode, coupled to mass spectrometry is usually used in organic chemistry 
(sometimes coupled to liquid chromatography), to determine the masses of 
different compounds in a desired sample or reaction crude. 
A general scheme of the technique is illustrated in figure 4, the sample is 
ionized by an ESI source. This ionization is caused by a high voltage applied to a 
solvent containing the sample, to form an aerosol. After a nebulization and 
complete evaporation of solvent, sample analytes are charged and pushed by gas to 
the quadrupole. 
In the quadrupole, ions can be modulated and separated according to the 
m/z value because of the magnetic field generated.  
                                                          
21 Carey, F. A.; Sundberg, R. J. Advanced Organic Chemistry; Kluwer Academic/Plenum Publishers: New 
York, 2000; Part A, pp 226. 
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Finally these ions can be represented in a spectrum after the detector, 
giving important information about the masses of the molecules in the initial 
sample.  
 
 
Figure 4: ESI mass spectrometry 
Based on this technique, the study started by heating a solution of 1.7a at 
100 oC, different time aliquots were extracted, diluted with acetonitrile and 
analyzed by ESI(+) mass spectrometry. The spectrum of compound 1.7a in an 
initial solution is shown in upper panel of figure 5 and after 60 min in the lower 
panel of figure 5.  
Both spectra obtained were nearly identical, only the appearance of new 
signals corresponding to the PhSSO2Ph 1.12 product was detected.  This evidence 
was confirmed by the presence of the peaks assigned to (PhSSO2Ph+Na)+ (m/z 273) 
and (PhSSO2Ph+K)+ (m/z 289). 
Sample
Quadrupole DetectorESI
MS spectra
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Figure 5: ESI(+) mass spectra 
 
In ESI(-) mass spectrometry, only sulfonic acid (M-H)– was detected as 
expected. No evidence of diphenyldisulfide 1.25 was found as it was not easy to 
ionize in ESI (+ or -) conditions. 
On the other hand, the presence of these radical intermediates could not be 
identified by ESI mass spectrometry directly. Because of that, it was decided to 
perform experiments in tandem by working with ESI MS/MS and monitoring the 
conversion of 1.7a into ethyl acrylate 1.8. 
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2.2.2. Tandem ESI/MS 
The electrospray ionization tandem mass spectrometry (ESI-MS) is a 
technique which can be applied to determine intermediates in chemical reactions 
and biochemical processes.22,23,24  
It can be considered extended version of the ESI mass spectrometry since 
two more quadrupoles are operating for the same experiment. In the figure 6 is 
represented the scheme for this technique. It operates in the same way as before in 
the ESI mass spectrometry but a determinate m/z is selected (in Q1) to enter in the 
second quadrupole (q2). This q2 is usually working as a collision cell, collision 
induced dissociation (CID) takes place when a collision gas breaks the selected m/z 
ion in fragments. These new fragments ion are again modulated and separated 
according to the m/z values in the third quadrupole (Q3). Finally the detector can 
provide a spectrum of new compound present after the fragmentation. 
It is remarkable CID, in determinate cases, contribute with essential 
information about the structure and reactivity of a desired compound. 
 
                                                          
22 Santos, L. S.; Knaack, L.; Metzger, J. O. Int. J. Mass Spectrom. 2005, 246, 84–104 
23 Eberlin, M. N. Eur. J. Mass Spectrom. 2007, 13, 19– 28 
24 Santos, L. S. Eur. J. Org. Chem. 2008, 235– 253 
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Figure 6: Tandem ESI mass spectrometry 
Free radicals are difficult to detect due to instability and the fast 
transformation into other compounds. This technique was recently used to 
determine radical intermediates in some processes related with thermally driven 
homolytic reaction.25,26,27,28,29,30  
According to these results, attempts to intercept these radical intermediates 
were carried out based on the online tandem ESI-MS and MS/MS. MS/MS is an 
important technique because provide information about the structure of the 
compound for a selected m/z. 
In that tandem experiment, the selected m/z was 249, corresponding to 
(1.7a+Na)+ and (1.13+Na)+, displayed distinctive unimolecular dissociation upon 
collision-induced dissociation (CID) conditions. The m/z 249 (1.7a+Na)+ adduct 
was chosen to monitor the temporal reaction evolution. 
                                                          
25 Meyer, S.; Koch, R.; Metzger, J. O. Angew. Chem., Int. Ed. 2003, 42, 4700–4703 
26 Griep; Raming, J.; Metzger, J. O. Anal. Chem. 2000, 72, 5665– 5668 
27 Meyer, S.; Metzger, J. O. Anal. Bioanal. Chem. 2003, 377, 1108– 1114 
28 Fürmeier, S.; Metzger, J. O. J. Am. Chem. Soc. 2004, 126, 14485– 14492 
29 Zhang, X.; Liao, Y.; Qian, R.; Wang, H.; Guo, Y. Org. Lett. 2005, 7, 3877– 3880 
30 Schäfer, M.; Drayb, M.; Springer, A.; Zacharias, P.; Meerholz, K. Eur. J. Org. Chem. 2007, 5162– 5174 
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In the case of 1.7a m/z 249 (1.7a+Na)+, predominantly dissociated via C-S 
bond cleavage affording the radical (Int 1+Na)+ (m/z 124) represented in scheme 20 
and figure 7. On the other hand, compound 1.13 with m/z 249 (1.13+Na)+ 
dissociated via the formation of (1.8+Na)+ (m/z 123), as represented in scheme 21 
and figure 8. 
 
Scheme 20: Dissociation of compounds 1.7a 
 
Figure 7: Dissociation spectrum of compound 1.7a 
 
Scheme 21: Dissociation of compound 1.13 
(HSOPh + Na)+
(·SOPh + Na)+
  
39 Study of the mechanism in the elimination of 2-arylsulfinyl esters 
 
 
Figure 8: Dissociation spectrum of compound 1.13 
According to the collision energies, when the same energy was used (15eV) 
the intensity of the dissociated signal from (1.7a+Na)+ was greater than signals from 
(1.13+Na)+ demonstrating that species from 1.7a dissociated easier than from 1.13. 
The gas-phase behavior of 1.7a was reminiscent of that observed for heated 
solutions; then this compound was more prone to homolytically dissociate via C-S 
bond cleavage. 
Same results were obtained when compounds 1.7b-f were monitored in the 
evolution of the reaction. In all cases the homolytic cleavage of C-S bond was the 
detected by the radical intermediate Int 1-4 as in the previous case, illustrated in 
scheme 22 and figures 9-13. 
(HSOPh + Na)+
Chapter 1 
 
40 
 
Scheme 22: General compound obtained for compound 1.7b-f 
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Figure 9: Dissociation spectrum of compound 1.7b 
 
Figure 10: Dissociation spectrum of compound 1.7c 
(HSOPh + Na)+
(HSOPhOMe + Na)+
(·SOPhOMe + Na)+
(HSOPhNO2 + Na)
+
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Figure 11: Dissociation spectrum of compound 1.7d 
 
Figure 12: Dissociation spectrum of compound 1.7e 
 
(HSOPh + Na)+
(·SOPh + Na)+
(HSOPh + Na)+
(·SOPh + Na)+
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Figure 13: Dissociation spectrum of compound 1.7f 
 
To confirm the same results than in the solution assays, 2-aryl sulfide esters 
and 2-arylsulfonyl esters were submitted to the fragmentation studies. In the CID 
spectra of those compounds, no radical intermediates were detected. It is known 
that sulfones and thioethers do not eliminate as easily as sulfoxides do.31 
 
 
 
 
 
 
 
 
 
 
                                                          
31 Cubagge, J. W.; Vos, B. W.; Jenks, W. S. J. Am. Chem. Soc. 2000, 122, 4968– 4971 
(HSOPh + Na)+
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3.  Conclusions 
 
With these results, a complete reaction pathway was proposed (scheme 19) 
which explains the formation of all detected by-products. It was essential to have a 
complete view of all possible products before demonstrating the correct pathway. 
 
The presence of diphenyl disulfide 1.25 can be explained from the partially 
conversion from phenyl-thiosulfonate to diphenyl disulfide 1.25 and benzene 
sulfonic acid. The addition of sulfenic acids to unsaturated esters has been 
previously demonstrated,32,33,34 furthermore the low yield in the formation of 
rearrangement compounds as 1.13 is due to the high tendency of sulfinyl radicals 
or sulfenic acids to afford thiosulphonates. This final reaction pathway would 
depend on the subtle interplay between kinetics and thermodynamics of each 
elementary step.  
It was demonstrated the radical mechanism of dehydrosulfenylation of 2-
arylsulfinyl esters to afford enoates. The presence of radicalary intermediates in the 
mechanism was unequivocally confirmed by trapping them with tempo and by a 
                                                          
32 Shelton, J. R.; Davis, K. E. J. Am. Chem. Soc. 1967, 89, 718– 719 
33 Barton, D. H. R.; Comer, F.; Greig, D. G. T.; Lucente, G.; Sammes, P. G.; Underwood, W. G. J. Chem. Soc., 
Chem. Commun. 1970, 17, 1059-1060 
34 Barton, D. H. R.; Sammes, P. G.; Taylor, M. V.; Cooper, C. M.; Hewitt, G.; Looker, B. F.; Underwood, W. G. J. 
Chem. Soc., Chem. Commun. 1971, 18, 1137-1139 
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crossover experiment. The ESI-MS and tandem ESI-MS was an essential tool to 
detect these radical intermediates and their subsequent transformations in a 
monitored reaction, providing information of the mechanism.  
The radical mechanism pathway results to be complementary to the 
internal elimination (Ei) on literature. According to these previous results and this 
study, depending on the starting compound and thermodynamics and kinetics 
intermediate steps will determine the pathway to form the enoates. 
An unpreceded transformation of 2-arylsulfinyl esters to 3-arylsulfinyl 
esters as a side reaction was also observed based on radical mechanism. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
4.  Experimental information 
 
4.1. General methods 
 
All solvents used in reactions were freshly distilled from appropriate drying 
agents before use. 1H NMR spectra and 13C NMR spectra were measured in 
CDCl3 (1H, 7.24 ppm; 13C 77.0 ppm) solution at 30 °C on a 300 MHz or a 500 MHz 
NMR spectrometer. IR spectra were recorded as oil films or KBr discs or NaCl 
pellets on a FT-IR spectrometer. Silica gel 60 was used for column 
chromatography, while TLC was performed with precoated plates (Kieselgel 60, 
F254, 0.25 mm). Unless otherwise specified, all reactions were carried out under 
argon atmosphere with magnetic stirring. 
 
 
  
48 
Electrospray Ionization Mass Spectrometry (ESI–MS) and Electron Impact 
Mass Spectrometry (EI–MS) 
For the online reaction monitoring, ESI mass spectra were recorded using 
an ESI tandem mass spectrometer (quadrupole-hexapole-quadrupole). The drying 
gas was nitrogen. The temperature of the source block was set to 120 °C and the 
desolvation temperature to 150 °C. A capillary voltage of 3.5 kV was used in the 
positive scan mode, and the cone voltage (Uc) was set to 15 V to control the extent 
of fragmentation of the identified ions. Toluene solutions of 1.7a–f were heated at 
100 °C in an open vial, a drop of the solution was immediately extracted and 
diluted in hot CH3CN, and a positive-ion mass spectrum was collected. For CID 
experiments, the cations of interest were mass-selected using the first quadrupole 
(Q1) and interacted with argon in the hexapole collision cell at variable collision 
energies (typically in the Elaboratory = 3–10 eV range) while mass analyzing the 
products with the second analyzer. The isolation width was ca. 1 Da and argon was 
used as a collision gas to produce a pressure of 8 × 10–4 mbar. 
For accurate m/z determinations (for all the compounds except 
for diphenyl disulfide 1.25 and CID experiments, an ESI tandem mass spectrometer 
(quadrupole-Twave-time-of-flight) was used. The drying gas was nitrogen. The 
temperature of the source block was set to 120 °C and the desolvation temperature 
to 150 °C. A capillary voltage of 3.5 kV was used in the positive scan mode, and the 
cone voltage was set to a low value to control the extent of fragmentation 
(typically 15 V). Methanol sample solutions were infused via syringe pump directly 
connected to the ESI source at a flow rate of 10 μL/min. Mass calibration was 
performed using a mixture of NaOH 0.05 M/formic acid 10% (50:50) from m/z 50 
to 900. For accurate mass measurements, a solution of leucine enkephalin (m/z = 
556.2771) was introduced via the lock spray needle at a flow rate of 30 μL/min. 
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For an accurate m/z determination diphenyl disulfide 1.25, a GC–EIMS was 
used. The GC instrumentation used was equipped with an autosampler coupled to 
a TOF mass spectrometer operating in electron ionization (EI) mode. The GC 
separation was performed using a fused silica column (30 m × 0.25 mm i.d., 0.25 
mm film thickness). The oven temperature was programmed as follows: 90 °C 
(hold 1 min); 10 °C/min to 300 °C (hold 2 min). The total running time was 24 min. 
Splitless injections of 1 mL of sample extracts were carried out with an injector 
temperature of 300 °C and with a splitless time of 1 min. Helium 99.999% was used 
as carrier gas at a constant flow of 1 mL/min. The interface and ion source 
temperatures were set to 260 and 250 °C, respectively. A solvent delay of 3 min 
was used to prevent damage in the ion source filament. TOF MS was operated at an 
scan time of 0.95 s in the mass range m/z 60–300 and using a multichannel plate 
voltage of 2700 V. TOF MS resolution was about 8500 (fwhm) at m/z 614. Pure 
PFTBA (Perfluorotri-n-butylamine), used for the daily mass 
calibration/verification as well as for lock mass, was injected via syringe (∼ 1 mL) 
in the reference reservoir at 30 °C. The m/z monitored was 218.9856. 
 
X-ray Crystallography 
Crystals of compound 1.5 are air stable and were mounted on the tip of a 
glass fiber with the use of epoxi cement. X-ray diffraction experiments were 
carried out on a diffractometer using Mo Kα radiation (λ = 0.71073 Å) at room 
temperature. The data were collected with a frame width of 0.3° in ω and a 
counting time of 60 s per frame at a crystal to detector distance of 4 cm. The 
diffraction frames were integrated using the SAINT package and corrected for 
absorption with SADABS. The structures were solved by direct methods and 
refined by the full-matrix method based on F2 using the SHELXTL software 
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package. All non-hydrogen atoms were refined anisotropically. Hydrogen atoms 
were generated geometrically, assigned isotropic thermal parameters and allowed 
to ride on their respective parent carbon atoms. Crystal data and structure 
refinement for 1.5: empirical formula C12H14O5S; crystal system monoclinic; space 
group P2(1); unit cell dimensions a = 4.8321(7) Å, b = 21.157(3) Å, c = 6.4661(9) Å, 
β = 95.816(3)°; Z = 2; θ range for data collection 1.93–30.49°; reflections collected 
5373; independent reflections 3114 [R(int) = 0.0247]; goodness-of-fit on F2 = 1.030; 
final R indices [I > 2σ(I)] R1 = 0.0424, wR2 = 0.0928; R indices (all data) R1 = 
0.0685, wR2 = 0.1034; absolute structure parameter −0.03(8); largest diff peak and 
hole 0.268 and −0.180 e·Å–3. 
 
4.2. General experiment for compound preparation 
 
Preparation (4S,5S)-Dihydro-4-hydroxy-5-methyl-3-methylenefuran-
2(3H)-one (1.3) and (3R,4S,5S)-Dihydro-4-hydroxy-5-methyl-3-
((phenylsulfonyl)methyl)furan-2(3H)-one (1.5) 
An oxygen-flushed mixture of compound 1.2 (124 mg, 0.48 mmol) in 
toluene (8 mL) was heated at 110 °C for 5 h. Then the solvent was removed under 
vacuum and the resulting mixture was purified through chromatography (silica gel, 
hexanes/ethyl acetate (1:1), (1:2) and ethyl acetate) to afford 44 mg (71%) of 
compound 1.3 as a colorless oil and 16 mg (12%) of compound 1.5 as a white solid. 
Recrystallization from CHCl3/hexanes gave white needles (mp = 117–120 °C). 
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Spectroscopic data of 1.3:  
 
[α]D20 = −97.26 (c = 1.3, CHCl3); 1H NMR (300 MHz, CDCl3) δ 6.41 (1H, d, J = 2.1 
Hz), 5.97 (1H, d, J=1.5 Hz), 4.83 (1H, d, J = 5.7 Hz), 4.65 (1H, dq, J = 6.0, 6.6 Hz), 
1.34 (3H, d, J = 6.6 Hz); 13C NMR (75 MHz, CDCl3) δ 168.9, 138.8, 126.3, 78.4, 69.7, 
14.3; IR (NaCl) δ 3439, 3015, 2930, 1756, 1672, 1387, 1263, 1186, 1103, 1045, 958, 
910, 861, 821, 784 cm–1; HRMS m/z calcd for C6H8O3Na [M + Na+] 151.0371, found 
151.0354. 
Spectroscopic data of 1.5:  
 
 
[α]D26 = −33.94 (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.95 (2H, d, J = 7.2 Hz), 
7.72 (t, 1H, J = 7.5 Hz), 7.61 (t, 2H, J = 7.8 Hz), 4.72 (m, 1H), 4.63 (m, 1H), 3.56 (m, 
2H), 3.26 (m, 1H), 2.93 (d, 1H, J = 4.2 Hz), 1.49 (3H, d, J = 6.6 Hz); 13C NMR (75 
MHz, CDCl3) δ 174.6, 138.4, 134.5, 129.7, 127.8, 79.6, 70.1, 51.2, 42.7, 13.6 ppm; IR 
(NaCl) δ 3350, 2949, 2836, 1764, 1656, 1449, 1412, 1117, 1033 cm–1; 
HRMS m/z calcd for C12H14O5SNa [M + Na+] 293.0460, found 293.0429. 
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General Experimental Procedure for the Preparation of Thioethers 1.6a–f 
To an ice-bath solution of sodium hydride (1.85 g, 46.2 mmol) (60% in 
mineral oil) in tetrahydrofuran (110 mL) was added dropwise the corresponding 
thiophenol (92.4 mmol). The resulting mixture was stirred in an ice bath for 30 
min. The bromoester (92.4 mmol) was added, and the resulting mixture was stirred 
at room temperature for 72 h. The mixture was quenched with brine and extracted 
with ethyl ether (3 × 15 mL), and then the organic layers were washed with a 
saturated aqueous solution of sodium bicarbonate and water, dried (Na2SO4), and 
concentrated. The crude was purified through chromatography (silica gel, 
hexanes/ethyl acetate (95:5)) to afford the desired compound. 
Ethyl 2-(phenylthio)propanoate (1.6a): 
 
yield = 12.61 g, 65%; 1H NMR (300 MHz, CDCl3) δ 7.46–7.48 (2H, m), 7.26–7.32 
(3H, m), 4.11 (2H, q, J = 7.2 Hz), 3.78 (1H, q, J = 6.9 Hz), 1.48 (3H, d, J = 6.9 Hz), 
1.17 (3H, t, J = 7.2 Hz); 13C NMR (75 MHz, CDCl3) δ 173.0, 133.4, 129.2, 128.3, 
61.5, 45.6, 17.7, 14.3 ppm; IR (NaCl) δ 3060, 2981, 2933, 2872, 1955, 1883, 1732, 
1583, 1476, 1440, 1375, 1323, 1256, 1225, 1159, 1068, 1025, 897, 859, 776, 748, 691, 
596 cm–1; HRMS m/z calcd for C11H14O2SNa [M + Na+] 233.0612, found 233.0611. 
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Ethyl 2-((4-methoxyphenyl)thio)propanoate (1.6b): 
 
yield = 13.3 g, 60%; 1H NMR (500 MHz, CDCl3) δ 7.36 (2H, d, J = 8.0 Hz), 6.79 (2H, 
d, J = 8.5 Hz), 4.06 (2H, q, J = 7.0 Hz), 3.75 (3H, s), 3.57 (1H, q, J = 7.0 Hz), 1.37 
(3H, d, J = 7.0 Hz), 1.14 (3H, t, J = 7.5 Hz); 13C NMR (75 MHz, CDCl3) δ 172.9, 
160.5, 136.7, 123.4, 114.7, 61.2, 55.5, 46.2, 17.4, 14.3 ppm; IR (NaCl) δ 2927, 1727, 
1591, 1493, 1461, 1286, 1247, 1172, 1029, 827 cm–1; HRMS m/z calcd for 
C12H16O3SNa [M + Na+] 263.0718, found 263.0712. 
 
Ethyl 2-((4-nitrophenyl)thio)propanoate (1.6c): 
 
yield = 12.25 g, 52%; 1H NMR (500 MHz, CDCl3) δ 8.11 (2H, d, J = 8.5 Hz), 7.46 
(2H, d, J = 9.0 Hz), 4.15 (2H, m), 4.00 (2H, q, J = 7.0 Hz), 1.56 (3H, d, J = 7.5 Hz), 
1.19 (3H, t, J = 7.0 Hz); 13C NMR (125 MHz, CDCl3) δ 172.2, 144.9, 131.5, 129.3, 
124.3, 62.1, 44.1, 17.6, 14.4 ppm; IR (NaCl) δ 2925, 1732, 1596, 1578, 1515, 1477, 
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1341, 1259, 1174, 1076, 1013, 853, 742, 683 cm–1; HRMS m/z calcd for C11H14NO4S 
[M + H+] 256.0644, found 256.0647; calcd for C11H13NO4SNa [M + Na+] 278.0463, 
found 278.0464. 
Ethyl 2-(phenylthio)butanoate (1.6d): 
 
yield = 19.25 g, 93%; 1H NMR (300 MHz, CDCl3) δ 7.44 (2H, m), 7.25 (3H, m), 4.09 
(2H, dq, J = 1.2, 7.2 Hz), 3.56 (1H, dd, J = 6.6, 8.4 Hz), 1.70–1.95 (m, 2H), 1.15 (3H, 
t, J = 6.9 Hz), 1.09 (3H, t, J = 7.2 Hz); 13C NMR (75 MHz, CDCl3) δ 172.0, 133.7, 
132.7, 128.8, 127.7, 60.9, 52.4, 25.1, 14.0, 11.7 ppm; IR (oil) δ 3079, 2970, 2936, 
2877, 1959, 1884, 1735, 1583, 1480, 1443, 1368, 1343, 1300, 1234, 1209, 1160, 1091, 
1026, 941, 864, 811 cm–1; HRMS m/z calcd for C12H17O2S [M + H+] 225.0949, found 
225.0953; calcd for C12H16O2SNa [M + Na+] 247.0769, found 247.0772. 
 
Ethyl 2-(phenylthio)pentanoate (1.6e): 
 
yield = 19.35 g, 88%; 1H NMR (300 MHz, CDCl3) δ 7.43–7.47 (2H, m), 7.24–7.31 
(3H, m), 4.10 (2H, q, J = 7.2 Hz), 3.65 (1H, dd, J = 6.6, 8.1 Hz), 1.67–1.94 (m, 2H), 
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1.38–1.52 (m, 2H), 1.15 (3H, t, J = 6.6 Hz), 0.92 (3H, t, J = 7.2 Hz); 13C NMR (75 
MHz, CDCl3) δ 172.0, 133.7, 132.7, 128.7, 127.6, 60.7, 50.5, 33.7, 20.5, 14.0, 13.6 
ppm; IR (oil) δ 3066, 2968, 2936, 2876, 1958, 1884, 1733, 1585, 1483, 1444, 1374, 
1335, 1303, 1279, 1243, 1163, 1106, 1033, 934, 860, 808 cm–1; HRMS m/z calcd for 
C13H19O2S [M + H+] 239.1106, found 239.1115; calcd for C13H18O2SNa [M + Na+] 
261.0925, found 261.0923. 
 
Benzyl 2-(phenylthio)propanoate (1.6f): 
 
yield = 17.59 g, 70%; 1H NMR (300 MHz, CDCl3) δ 7.24–7.44 (10H, m), 5.11 (2H, 
s), 3.85 (1H, d, J = 7.2 Hz), 1.52 (3H, d, J = 7.2 Hz); 13C NMR (75 MHz, CDCl3) δ 
172.5, 135.5, 133.2, 133.0, 128.9, 128.5, 128.2, 128.0, 66.7, 45.3, 17.3 ppm; IR (oil) δ 
3061, 2986, 2936, 1959, 1888, 1735, 1586, 1480, 1443, 1380, 1324, 1268, 1162, 1063, 
1029, 1004, 954, 898, 780 cm–1; HRMS m/z calcd for C16H17O2S [M + H+] 273.0949, 
found 273.0946; calcd for C16H16O2SNa [M + Na+] 295.0769, found 295.0770. 
 
General Experimental Procedure for the Preparation of Sulfoxides 1.7a–f 
To a −10 °C cold solution of thioether (0.95 mmol) in CH2Cl2 (5 mL) was 
added a solution of m-CPBA (77% pure) (177 mg, 0.79 mmol) in CH2Cl2 (4 mL). 
The resulting mixture was stirred at −10 °C for 30 min, quenched with saturated 
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aqueous solution of sodium bicarbonate, and extracted with CH2Cl2 (3 × 15 mL), 
and then the organic layers were sequentially washed with brine and saturated 
aqueous solution of sodium bicarbonate and water, dried (Na2SO4), and 
concentrated. The crude was purified through chromatography (silica gel, 
hexanes/ethyl acetate (7:3)) to afford the desired sulfoxide. 
 
Ethyl 2-(phenylsulfinyl)propanoate (1.7a): 
 
yield = 178 mg, 83%); 1H NMR (500 MHz, CDCl3) δ 7.25–7.45 (5H, m) (major and 
minor), 4.12 (2H, m) (major and minor), 3.81 (1H, q, J = 6.5 Hz) (major), 3.49 (1H, 
q, J = 7.0 Hz) (minor), 1.49 (3H, d, J = 7.0 Hz) (major), 1.32 (3H, d, J = 7.5 Hz) 
(minor), 1.21 (3H, t, J = 6.5 Hz) (minor), 1.18 (3H, t, J = 7.0 Hz) (major); 13C NMR 
(125 MHz, CDCl3) δ 168.9, 168.1, 142.6, 140.9, 134.5, 132.1, 131.9, 129.7, 129.5, 
129.3, 125.5, 125.1, 66.2, 64.1, 62.1, 62.0, 14.3, 14.2, 10.0, 9.1 ppm; IR (NaCl) δ 
3051, 2988, 2926, 1968, 1895, 1724, 1577, 1472, 1445, 1371, 1316, 1254, 1215, 1165, 
1083, 1045, 1017, 920, 889, 858, 749, 691 cm–1; HRMS m/z calcd for C11H14O3SNa 
[M + Na+] 249.0556, found 249.0557. 
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Ethyl 2-((4-methoxyphenyl)sulfinyl)propanoate (1.7b): 
 
yield = 124 mg, 51%; 1H NMR (500 MHz, CDCl3) δ 7.56 (2H, d, J = 8.5 Hz) (major), 
7.52 (2H, d,J = 8.5 Hz) (minor), 7.00 (2H, d, J = 8.5 Hz) (major and minor), 4.04–
4.20 (2H, m) (major and minor), 3.85 (3H, s) (major and minor), 3.78 (1H, q, J = 7.0 
Hz) (major), 3.47 (1H, q, J = 8.0 Hz) (minor), 1.50 (3H, d, J = 7.0 Hz) (major), 1.27 
(3H, d, J = 7.0 Hz) (minor), 1.23 (3H, t, J = 7.0 Hz) (minor), 1.15 (3H, t, J = 7.0 Hz) 
(major); 13C NMR (125 MHz, CDCl3) δ 169.1, 168.3, 162.7, 133.2, 131.5, 127.3, 
126.9, 114.9, 114.8, 66.3, 64.3, 61.9, 55.8, 14.3, 14.3, 10.4, 8.9 ppm; IR (KBr) δ 3096, 
3069, 2981, 2940, 2842, 1727, 1598, 1500, 1459, 1306, 1258, 1173, 1092, 1024, 834, 
793, 626 cm–1; HRMS m/z calcd for C12H17O4S [M + H+] 257.0848, found 257.0849; 
calcd for C12H16O4SNa [M + Na+] 279.0667, found 279.0656. 
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Ethyl 2-((4-nitrophenyl)sulfinyl)propanoate (1.7c): 
 
yield = 160 mg, 62%; 1H NMR (500 MHz, CDCl3) δ 8.31 (2H, d, J = 8.5 Hz) (major), 
8.30 (2H, d,J = 9.0 Hz) (minor), 7.82 (2H, d, J = 9.0 Hz) (major), 7.77 (2H, d, J = 9.0 
Hz) (minor), 4.04–4.15 (2H, m) (major and minor), 3.84 (1H, q, J = 7.0 Hz) (major), 
3.48 (1H, q, J = 7.0 Hz) (minor), 1.41 (3H, d, J = 7.5 Hz) (major), 1.30 (3H, d, J = 7.0 
Hz) (minor), 1.17 (3H, t, J = 7.5 Hz) (minor), 1.15 (3H, t, J = 7.5 Hz) (major); 13C 
NMR (125 MHz, CDCl3) δ 169.6, 168.3, 149.7, 147.9, 126.6, 126.2, 127.3, 125.6, 
125.0, 65.6, 63.7, 62.5, 62.3, 14.2, 9.4, 9.0 ppm; IR (NaCl) δ 3101, 2985, 1732, 1603, 
1579, 1527, 1475, 1450, 1398, 1347, 1150, 1089, 1054, 1011, 1017, 853, 743, 723, 
684 cm–1; HRMS m/z calcd for C11H14NO5S [M + H+] 272.0593, found 272.0580; 
calcd for C11H13NO5SNa [M + Na+] 294.0412, found 294.0405. 
 
Ethyl 2-(phenylsulfinyl)butanoate (1.7d): 
 
yield = 187 mg, 82%; 1H NMR (500 MHz, CDCl3) δ 7.49–7.66 (5H, m) (major and 
minor), 3.95–4.10 (2H, m) (major and minor), 3.48 (1H, dd, J = 5.0, 10.0 Hz) 
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(major), 3.39 (1H, dd, J = 5.0, 9.5 Hz) (minor), 2.06–2.16 (1H, m) (major and 
minor), 1.76–1.90 (1H, m) (major and minor), 1.12 (3H, t, J = 7.5 Hz) (major), 1.06 
(3H, t, J = 7.5 Hz) (minor), 1.03 (3H, t, J = 7.0 Hz) (major), 1.00 (3H, t, J = 7.5 Hz) 
(minor); 13C NMR (125 MHz, CDCl3) δ 167.6, 166.7, 142.2, 141.1, 131.7, 131.4, 
129.9, 128.9, 124.8, 124.7, 73.5, 70.6, 61.3, 20.3, 18.7, 13.8, 11.5, 11.3 ppm; IR (oil) 
δ 3066, 2975, 2940, 2880, 2088, 1972, 1894, 1726, 1638, 1581, 1476, 1448, 1374, 
1335, 1258, 1202, 1163, 1089, 1039, 952, 860, 815 cm–1; HRMS m/z calcd for 
C12H17O3S [M + H+] 241.0898, found 241.0900; calcd for C12H16O3SNa [M + Na+] 
263.0718, found 263.0722. 
 
Ethyl 2-(phenylsulfinyl)pentanoate (1.7e): 
 
yield = 222 mg, 92%; 1H NMR (500 MHz, CDCl3) δ 7.46–7.65 (5H, m) (major and 
minor), 3.88–4.10 (2H, m) (major and minor), 3.53 (1H, dd, J = 5.5, 10.0 Hz) 
(major), 3.43 (1H, dd, J = 5.0, 9.0 Hz) (minor), 2.02–2.10 (1H, m) (major and 
minor), 1.73–1.84 (1H, m) (major and minor), 1.28–1.48 (2H, m) (major and 
minor), 1.09 (3H, t, J = 7.0 Hz) (major), 1.03 (3H, t, J = 7.5 Hz) (minor), 0.91 (3H, 
t, J = 7.0 Hz) (major), 0.88 (3H, t, J = 7.5 Hz) (minor); 13C NMR (125 MHz, CDCl3) δ 
167.9, 166.8, 142.3, 141.7, 131.7, 131.5, 129.0, 128.8, 124.8, 124.7, 72.1, 68.8, 61.2, 
28.7, 27.0, 20.3, 13.8, 13.5 ppm; IR (oil) δ 3062, 2968, 2940, 2879, 2095, 1972, 1891, 
1729, 1585, 1469, 1447, 1377, 1335, 1275, 1247, 1191, 1156, 1089, 1057, 941, 860, 
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825 cm–1; HRMS m/z calcd for C13H19O3S [M + H+] 255.1055, found 255.1053; calcd 
for C13H18O3SNa [M + Na+] 277.0874, found 277.0876. 
 
Benzyl 2-(phenylsulfinyl)propanoate (1.7f): 
 
yield = 192 mg, 70%; 1H NMR (300 MHz, CDCl3) δ 7.17–7.55 (10H, m) (major and 
minor), 5.10 (1H, d, J = 12.0 Hz) (major), 5.10 (1H, d, J = 12.0 Hz) (minor), 5.00 
(1H, d, J = 12.0 Hz) (major), 4.99 (1H, d, J = 12.0 Hz) (minor), 3.82 (1H, q, J = 7.2 
Hz) (major), 3.50 (1H, q, J = 7.2 Hz) (minor), 1.41 (3H, d, J = 6.9 Hz) (major), 1.26 
(3H, d, J = 7.2 Hz) (minor); 13C NMR (75 MHz, CDCl3) δ 168.4, 167.5, 142.0, 140.2, 
134.9, 131.7, 131.5, 129.1, 128.9, 128.6, 128.5, 128.4, 128.3, 125.0, 124.6, 67.4, 67.3, 
65.4, 63.5, 9.4, 8.6 ppm; IR (oil) δ 3067, 3036, 2939, 1965, 1894, 1732, 1583, 1499, 
1477, 1449, 1380, 1318, 1222, 1163, 1050, 998, 957, 920, 848, 820, 777 cm–1; 
HRMS m/z calcd for C16H17O3S [M + H+] 289.0898, found 289.0894; calcd for 
C16H16O3SNa [M + Na+] 311.0718, found 311.0713. 
 
Experimental Procedure for Elimination 
A mixture of sulfinyl compound 1.7 (1 mmol) in toluene (6 mL) was heated 
at 110 °C for 5 h (in the case of compounds 1.7a, 1.7b, 1.7c and 1.7f, the reaction 
was performed in a sealed flask to avoid acrylate loss). Then the resulting crude 
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mixture was purified through chromatography (silica gel, hexanes/ethyl acetate 
(1:1), (1:2) and ethyl acetate) to afford the corresponding enoate. 
 
S-phenyl benzenesulfonothioate (1.12): 
 
1H NMR (500 MHz, CDCl3) δ 7.13–7.51 (10H, m); 13C NMR (125 MHz, CDCl3) δ 
143.0, 136.6, 133.6, 131.4, 129.4, 129.0, 128.8, 127.9, 127.6, 127.2 ppm; IR (NaCl) δ 
3064, 1580, 1445, 1323, 1144, 1076, 1021, 748, 688 cm–1; HRMS m/z calcd for 
C12H10O2S2Na [M + Na+] 273.0020, found 273.0026. 
 
2-(Ethoxycarbonyl)ethyl benzenesulfenate (1.13): 
 
1H NMR (500 MHz, CDCl3) δ 7.61–7.62 (2H, m), 7.49–7.54 (3H, m), 4.11 (2H, q, J = 
7.5 Hz), 3.22 (1H, m), 2.97 (1H, m), 2.84 (1H, m), 2.54 (1H, m), 1.22 (3H, d, J = 7.5 
Hz); 13C NMR (125 MHz, CDCl3) δ 171.5, 143.4, 131.5, 129.6, 124.4, 61.4, 51.5, 
26.5, 14.4 ppm; IR (NaCl) δ 2963, 1733, 1445, 1373, 1260, 1087, 1045, 799, 750, 691 
cm–1; HRMS m/z calcd for C11H14O3SNa [M + Na+] 249.0561, found 249.0561. 
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Diphenyl disulfide (1.25): 
 
1H NMR (500 MHz, CDCl3) δ 7.13–7.17 (2H, m), 7.21–7.24 (4H, t, J = 8.5 Hz), 7.42 
(4H, d, J = 8.5 Hz); 13C NMR (125 MHz, CDCl3) δ 137.1, 129.0, 127.6, 127.2 ppm; IR 
(NaCl) δ 3064, 1946, 1864, 1800, 1735, 1574, 1470, 1432, 1379, 1298, 1068, 1017, 
896, 787, 735, 686, 605 cm–1; HRMS (EI) m/z calcd for C12H10S2 [M] 218.0224, 
found 218.0210. 
 
 
Experimental Procedure for Trapping the Radical 
A mixture of sulfinyl compound 1.7e (500 mg, 1.96 mmol) and 2,2,6,6-
Tetramethyl-1-piperidinyloxy (Tempo) (614 mg, 3.93 mmol) in toluene (10 mL) 
was heated at 80 °C for 2 h. The resulting crude mixture was carefully 
concentrated under vacuum and then purified through chromatography (silica gel, 
hexanes/ethyl acetate (95:5)) to afford compound 1.22 (17 mg, 3%) as an oil and 
compound 1.23 (60 mg, 11%) as a white solid. Recrystallization of 1.23 from 
CH2Cl2/hexanes gave white prismatic crystals (mp =128–130 °C). 
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Ethyl 2-((2,2,6,6-tetramethylpiperidin-1-yl)oxy)pentanoate (1.22): 
 
1H NMR (300 MHz, CDCl3) δ 4.21 (1H, dd, J = 6.6, 7.5 Hz), 4.15 (2H, q, J = 7.2 Hz), 
1.74–1.85 (2H, m), 1.01–1.48 (23H, m), 0.91 (3H, t, J = 7.2 Hz); 13C NMR (75 MHz, 
CDCl3) δ 173.6, 85.5, 60.1, 40.3, 34.2, 33.6, 33.0, 20.2, 17.9, 17.1, 14.2, 13.9 ppm; IR 
(KBr) δ 2974, 2933, 2876, 1748, 1466, 1381, 1366, 1269, 1245, 1184, 1133, 1105, 
1058, 1031, 993, 976, 963, 929, 881, 857, 793, 752, 722, 681, 650 cm–1; 
HRMS m/z calcd for C16H32NO3 [M + H+] 286.2382, found 286.2377. 
 
2,2,6,6-Tetramethylpiperidin-1-yl benzenesulfinate (1.23): 
 
1H NMR (300 MHz, CDCl3) δ 7.82–7.89 (2H, m), 7.39–7.47 (3H, m), 1.66 (6H, s), 
1.57 (12H, s);13C NMR (75 MHz, CDCl3) δ 147.2, 131.2, 128.5, 126.0, 60.8, 43.8, 
31.1, 16.7 ppm; IR (KBr) δ 3069, 3035, 2984, 2944, 2916, 2879, 1404, 1394, 1245, 
1204, 1184, 1139, 1095, 1071, 980, 922, 786, 766, 715, 701, 626, 613 cm–1; 
HRMS m/z calcd for C15H23NO2SNa [M + Na+] 304.1347, found 304.1348. 
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1. Introduction 
 
Intramolecular nonbonded S···X interactions have been extensively studied 
for some organic sulfur compounds in relation to the biological activities as well as 
the physical properties as advanced materials.35  
For example, it was reported thiazole nucleoside tiazofurin with antitumor 
activity to adopt an active conformation displaying a 1,4-type  S-O  interaction.36 
The interaction was postulated based on X-rays crystallographic (sulfur–oxygen 
distances were less than the sum of the Van der Waals radii (3.3 Å)) and 
computational studies (figure 1). 
 
                                                          
35 Iwaoka, M.; Isozuni, M. Molecules 2012, 17, 7266-7283 
36 Burling, F.T.; Goldstein, B.M. J. Am. Chem. Soc. 1992, 114, 2313–2320 
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Figure 1. Interaction proposed by Goldstein 
 
Nagao reported an 1,5-type S-O interaction in (acylimino)thiadiazoline 
derivatives, showed in figure 2, as angiotensin II receptor antagonists. It was 
demonstrated by X-ray crystallographic analysis and MO calculations.37 
 
 
Figure 2. Interaction proposed by Nagao 
 
Canadell synthetized an ethylenedithio-tetrathiafulvalene-thiomethyl-
oxazoline (EDT-TTF- (SMe)-OX, figure 3) derivatives and after theoretical 
calculations at DFT/B3LYP level and an X-ray crystallographic data analysis, the 
distance was significantly shorter than the sum of the van der Waals radii again.38  
 
                                                          
37 Nagao, Y.; Hirata, T.; Goto, S.; Sano, S.; Kakehi, A.; Iizuka, K.; Shiro, M. J. Am. Chem. Soc. 1998, 120, 3104–3110 
38 Réthoré, C.; Madalan, A.; Fourmigué, M.; Canadell, E.; Lopes, E.B.; Almeida, M,; Clérac, R.; Avarvari, N. New J. 
Chem. 2007, 31, 1468–1483 
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Figure 3. Interaction proposed by Canadell 
 
Omelchenko reported based on X-rays diffraction study and quantum-
chemical calculations, an intramolecular interaction S-O in thioindirubin (figure 
4).39 Again a special short distance between S and O denoted the interaction. 
 
 
Figure 4. Interaction proposed by Omelchenko 
In our group, we reported the stereoisomerization of β-hydroxy-α-
sulfenyl-γ-butyrolactones controlled by an 1,4-type of S-O interaction. Nine 
butyrolactones were prepared. It was observed that the syn-anti or syn-syn 
lactones (or any mixture of both) invariably isomerized into syn-anti/syn-syn 
lactones in a ratio of 6/4. The other two possible isomeric lactones (anti-syn or 
anti-anti) were never observed (figure 5).40 
                                                          
39 Shishkin, O.V.; Omelchenko, I.V.; Kalyuzhny, A.L.; Paponov, B.V. Struct. Chem. 2010, 21, 1005–1011 
40 González, F. V.; Jain, A.; Rodríguez, S.; Sáez, J.; Vicent, C.; Peris, G. J. Org. Chem. 2010, 75, 5888-5894 
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Figure 5. Stereoisomerization of β-hydroxy-α-sulfenyl-γ-butyrolactones through a 
retroaldol-aldol mechanism 
 
According to Parthasarathy,41 there are two recognizable types of sulfur-
oxygen interactions (defined by polar coordinates (polar θ and azimuthal φ 
angles)): nucleophilic oxygens tend to approach along the extension of one of the 
covalent bonds to sulfur (60o < θ < 90o) (110o < φ < 150o) and electrophilic oxygens 
tend to approach sulfur from the perpendicular direction to the plane through the 
C-S-C atoms (θ < 40o) (figure 6).  
 
 
 
 
 
 
 
                                                          
41 Rosenfield, R. E., Jr.; Partharasathy, R.; Dunitz, J. D. J. Am. Chem. Soc. 1977, 99, 4860-4862 
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Figure 6. Polar coordinates for S-O direction 
 
Crystal structures of syn–syn lactones were obtained, and it was observed 
that the sulfur–oxygen distances were less than the sum of the Van der Waals radii 
(3.3 Å), demonstrating an interaction. The angle formed by the hydroxyl oxygen, 
sulfur, and quaternary aromatic carbon being approximately 180° and the 
carboxylic oxygen–sulfur was directed <40° from the perpendicular to the C–S–C.  
 
It was concluded that two concomitant, attractive 1,4 intramolecular 
interactions of divalent sulfur with both the carbonyl and the hydroxyl oxygens as 
O
S
φ
Azimuthal angle
θ
Polar angle
Nucleophilic 
oxygen
Electrophilic 
oxygen
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the driving force to establish the stereochemical preference. It was also confirmed 
that a retroaldol-aldol mechanism operates. 
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2. Results and discussion 
 
The mechanism in the catalytic conversion of vitamin K 2,3-epoxy into 
vitamin K (figure 7), which is essential for blood coagulation, was studied by 
Silverman.42,43 Silverman’s study was done using 2,3-dimethyl-1,4-naphthoquinone 
2,3-epoxide as a model compound. 
 
 
Figure 7. Essential vitamin K structures 
 
                                                          
42
 Silverman, R. B. J. Am. Chem. Soc. 1981, 103, 5939-5941 
43
 Silverman, R. B. J. Org. Chem. 1981, 46, 4789-4791 
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When anti α-hydroxy-β-ethylsulfenyl-α,β-dimethyl naphthoquinone 
(anti-2.1) was treated with NaSEt a 8:2 mixture of syn / anti isomers was obtained 
(scheme 1). 
 
 
Scheme 1. Isomerization of Silverman model 
 
Two possible mechanims were proposed:  a retro-aldol/aldol mechanism or 
a redox mechanism (scheme 2).  
 
 
Scheme 2. Isomerization mechanisms proposed by Silverman 
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After this work the mechanism for the natural process of vitamin K was 
proposed based on the model. 
 
 
Figure 8. Natural process of vitamin K 
 
We decided to explore this reaction. The similarities between Silverman’s 
compounds and previous lactones studied by us (scheme 1) prompted us to confirm 
if sulfur-oxygen interaction might be also operating in this case.  
 
The preparation of the epoxyde model began with the preparation of the 
2,3-dimethylnaphthoquinone from menadione. It was prepared by two pathways 
as described in next schemes 3 and 4. 
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Scheme 3. Quinone preparation with first conditions 
 
 
Scheme 4. Quinone preparation with second conditions 
 
 
The epoxidation was carried out with hydrogen peroxide and Na2CO3 in 
MeOH affording the product in excellent yield (95%). 
 
 
Scheme 5. Epoxidation reaction of quinones 
 
Next step was the synthesis of α-hydroxy-β-ethylsulfenyl-α,β-dimethyl 
naphthoquinone anti-2.1 and anti-2.2 prepared from epoxide.44 The transformation 
                                                          
44 Fieser, L. F.; Campbell,W. P.; Fry, E. M.; Gates, M. D., Jr. J. Am. Chem. Soc. 1939, 61, 3216-3223 
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was performed as previously described in the literature using the corresponding 
thiol and triethylamine (scheme 6).8  
 
 
Scheme 6: Preparation of anti naphthoquinones 
 
Naphthoquinones syn-2.1, syn-2.2 and syn-2.3 were prepared from the 
epoxide with the adequate sodium thiolate as summarized in scheme 7.  
 
 
Scheme 7: Preparation of syn naphthoquinones 
 
Firstly we used Silverman’s conditions for the isomerization reaction 
(NaSEt as base) (table 1), treating compounds 2.1-2.3 with the corresponding 
sodium ethylthiolate or sodium phenylthiolate, same results as the ones reported 
by Silverman were obtained. When compound 2.3, not reported by Silverman, was 
submitted to same conditions then similar results were also obtained. In all cases 
syn isomers 2.1-2.3 were used as a single isomer. When anti 2.1-2.3 or any mixture 
of syn/anti isomers was used as starting materials under reported isomerization 
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conditions, syn isomer was obtained. Compounds 2.1-2.3 did not isomerize when 
triethylamine or N-methyl morpholine are used as bases. 
 
It was remarkable that in some cases (entries 1, 2, 3, 5, 6, 7 and 8) 2,3-
dimethylnaphthoquinone as an elimination product was also detected (scheme 4). 
The elimination would result from attack of thiolate to the sulfur atom, to form the 
corresponding naphthoquinone and the disulfide. 
Table 1. Isomerization reaction 
Entry Substrate Base anti / syn  
1 syn 2.1 NaSEt 14/65a 
2 anti 2.1 NaSEt 14/71a 
3 syn 2.1 NaSPh 5/83a 
4 syn 2.2 NaSEt 17/83 
5 syn 2.2 NaSPh 13/61a 
6 anti 2.2 NaSEt 27/68a 
7 anti 2.2 NaSPh 28/69a 
8 syn 2.3 NaSEt 8/82a 
9 syn 2.3 NaSPh 20/80 
10 syn 2.1 Et3N - 
11 anti 2.1 Et3N - 
12 syn 2.1 NMM - 
13 anti 2.1 NMM - 
a Elimination product was detected by NMR 
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Scheme 4: Competing retroaldol-aldol and elimination mechanisms. 
 
We hypothesized syn stereochemical preference during isomerization to be 
controlled by a S-O interaction (scheme 5).  
 
 
Scheme 5: Proposed S-O interaction 
 
Oxygenated compound 2.4-2.5 were prepared to determine the influence 
of the sulfur atom during isomerization and indirect probe of this interaction. The 
compounds were prepared starting from 2,3-dimethylnaphthoquinone epoxide 
using boron trifluoride as catalyst45 and the corresponding alcohol (ethanol and 
methanol) (scheme 6). This reaction did not work when using phenol. The opening 
reactions by using alcohols were much slower than when using thiols, curiously 
same happens in nature since vitamin K epoxide is opened very selectively by 
cysteine residue (reductase) but not by serine (coagulation factors).46 
 
                                                          
45 Izquierdo, J.; Rodríguez, S.; González, F. V. Org. Lett. 2011, 13, 3856-3859 
46 Furie, B.; Furie, B. C. Blood 1990, 75, 1753-1762 
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Scheme 6: Preparation of oxygenated anti compounds 2.4 and 2.5 
 
When compounds anti 2.4-2.5 were submitted to the isomerization 
conditions using NaSEt as base, a mixture of isomers was obtained. Results from 
oxygenated compounds 2.4-2.5 were analyzed and compared with sulfurated ones 
2.1-2.3. Compound anti-2.4 was treated with sodium phenylthiolate and sodium 
ethylthiolate (entries 1-2, table 2) affording a mixture of isomers in favor of anti-
isomer. This result was compared with sulfurated isomerization experiments 
(entries 1-3, table 1) and the opposite tendency was observed.  
 
When compound 2.5 was submitted to isomerization (entries 3-4, table 2) a 
quasi-equal ratio of syn/anti isomers was detected, while for the sulfur compounds 
(entries 8-9, table 1) syn isomer was the major one in all cases. 
 
Table 2: Isomerization reaction for compounds 2.4-2.5 
Entry Substrate Base anti/syn 
1 anti-2.4 NaSEt 70/30 
2 anti-2.4 NaSPh >95/5 
3 anti-2.5 NaSEt 58/42 
4 anti-2.5 NaSPh 38/62 
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According to the results, the observed general tendencies can be 
represented in the next scheme 7. 
 
 
Scheme 7: General isomerization tendency  
 
To conclude that S-O interactions are controlling the stereochemistry in 
sulfur compounds, (scheme 8). 
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Scheme 8: X-ray structure of syn-2.2 
 
According to the angles (azimuthal φ=113.7° and polar θ=99.4°) in the close 
contact between sulfur and oxygen of the hydroxyl, was quite similar than the case 
of the study of β-hydroxy-α-sulfenyl-γ-butyrolactones5 (azimuthal φ=107° and 
polar θ=93°). The distance between hydroxyl oxygen and al sulfur was 2.97 Å, less 
than Van der Waals radii (3.3 Å). The angles and distance confirm this interaction. 
 
The linear alignment of the C–S covalent bond and the coordinating 
hydroxyl oxygen should allow an effective orbital interaction between the oxygen 
lone electron pair and the σ* orbital of the S–C bond, which may elongate the S–C 
bond (1.77 Å for syn-2.2, 1.75 Å for the diphenyl disulfide). 
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This short distance between sulfur atoms and oxygen could be accepted as a 
nonbonded interaction stabilizing syn isomer in all cases. The phenyl group in the 
sulfur atom position was orientated away from hydroxyl group, maximizing the 
interaction. Type I S-O interactions usually approach along the extension of 
covalent bonds to sulfur, as this case. 
 
Other possible S-O interaction could occur between the carbonyl oxygen 
and sulfur atom, stabilizing with other nonbonded S-O interaction some isomers. 
In this case, the atomic distance was 3.55 Å and with values of angles (azimuthal 
φ=94.9° and polar θ=97.9°) quite different as expected for this kind of interactions. 
For this reason this parameters could not be attributed to S-O interaction. This 
might be due to the rigidity of the structure. The planar structure of the 
C
C
O
C-S-C plane
Elongated distance
1.77 Å 
(from 1.75 Å)
S
Short distance
2.97 Å
Sum VdW radii (3.3 Å)
σ* orbital
lone electron 
pair
Expected Sample
60o < θ < 90o θ = 99.4o
110o < φ < 150o φ = 113.7o
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naphthoquinones does not permit a free movement to get the correct distances and 
angles to contact sulfur and oxygen atoms. This might be the reason why β-
hydroxy-α-sulfenyl-γ-butyrolactones give syn isomer as a single isomer while for 
α-hydroxy-β-sulfenyl-α,β-dimethyl naphthoquinones some anti-isomer is also 
observed. 
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3. Conclusions 
 
It has been demonstrated that a 1,4 sulfur-oxygen intramolecular 
interaction of divalent sulfur and hydroxyl oxygen is the driving force for the syn 
stereochemical preference of α-hydroxy-β-sulfenyl-α,β-dimethyl 
naphthoquinones when submitted to basic isomerization. This has been 
demostrated by X-rays parameters of a single crystal structure and experimental 
isomerization reactions. When sulfur atom was replaced by oxygen atom, then the 
results were completely inverted, being anti isomers the major ones.   
 
This study complemented the understanding of the role played by this 
subtle noncovalent interaction in determining the biochemical processing of 
vitamin-K-epoxide during blood coagulation. 
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4. Experimental information 
 
All solvents used in reactions were freshly distilled from appropriate drying 
agents before use. 1H NMR spectra and 13C NMR spectra were measured in 
CDCl3 (1H, 7.24 ppm; 13C 77.0 ppm) solution at 30 °C on a 300 MHz or a 500 MHz 
NMR spectrometer. Mass spectra were measured in a hybrid quadrupole-t-TOF 
mass spectrometer operating at a resolution ca. 15000 FWHM (W-mode) with an 
orthogonal Z-spray-electrospray interface was used. The drying gas as well as 
nebulizing gas was nitrogen at a flow of 400 and 60 L/h, respectively. The 
temperature of the source block was set to 120 °C and the desolvation temperature 
to 150 °C. A capillary voltage of 3 kV was used in the positive scan mode, and the 
cone voltage was set to 15 V. Sample solutions were infused via syringe pump 
directly connected to the ESI source at a flow rate of 10 μL/min. ESI mass spectra 
were dominated by the presence of sodium adducts of the target compound. For 
the accurate mass measurements, a 2 mg/L standard solution of leucine enkephalin 
was introduced via the lock spray needle at a cone voltage set to 45 V and a flow 
rate of 30 μL/min. IR spectra were recorded as oil films or KBr discs or NaCl pellets 
on a FT-IR spectrometer. EM Science Silica Gel 60 was used for column 
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chromatography while TLC was performed with precoated plates (Kieselgel 60, 
F254, 0.25 mm). Unless otherwise specified, all reactions were carried out under 
nitrogen atmosphere with magnetic stirring. 
 
General experimental procedure for the preparation of thioethers anti-
2.1 and anti-2.2 
To an ice-bath cold solution of 2,3-dimethyl-1,4-napht-hoquinone-2,3-
epoxide (202 mg, 1.0 mmol) in dry acetonitrile (2.0 mL) was added drop wise the 
corresponding thiol (3.0 mmol) and then triethylamine (140 μL, 1.0 mmol). The 
resulting mixture was stirred cold with an ice-bath for 3.5 h. Then was quenched 
with dichloromethane (15 mL) and 5% Na2CO3 (15 mL). The organic layer was 
separated, the aqueous layer was extracted with dichloromethane (3×15 mL), and 
then the organic layers were dried (Na2SO4) and concentrated. The crude was 
purified through chromatography (silica-gel, hexanes/ethyl acetate (7:3)) to afford 
the desired compound. The resulting solid mixture was recrystallized from 
hexanes. 
 (2R,3S)-2-(Ethylthio)-3-hydroxy-2,3-dimethyl-2,3-dihydronaphthalene-1,4-
dione anti-2.1 
 
Recrystallized from hexanes gave white crystals, mp 91–92 °C (lit.2 93–93.5 °C) 
(Yield=251 mg, 95%). 1H NMR (500 MHz, CDCl3) δ 7.97 (1H, d, J=7.3 Hz), 7.85 
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(1H, d, J=7.2 Hz), 7.57–7.64 (2H, m), 3.84 (1H, br s), 2.44 (m, 1H), 2.16 (m, 1H), 
1.64 (3H, s), 1.55 (3H, s), 1.00 (3H, t, J=7.4 Hz). 13C NMR (125 MHz, CDCl3) δ195.2, 
192.8, 134.1, 133.8, 132.7, 132.2, 127.1, 126.8, 80.2, 60.9, 23.8, 18.5, 16.3, 13.8 ppm. 
IR (NaCl) δ3018, 2951, 2930, 1696, 1595, 1539, 1455, 1371, 1281, 1188, 1110, 1016, 
975, 937 cm−1. HRMS m/z calcd for C14H16O3SNa [M+Na+]: 287.0718, found: 
287.0720. 
 (2R,3S)-2-Hydroxy-2,3-dimethyl-3-(phenylthio)-2,3-dihydronaphthalene-1,4-
dione anti-2.2 
 
Recrystallized from hexanes gave white crystals, mp 109–112 °C (lit.2 115.5–
116.5 °C) (Yield=287 mg, 92%). 1H NMR (500 MHz, CDCl3) δ 7.87–7.98 (2H, m), 
7.62–7.67 (2H, m), 7.13–7.32 (2H, m), 3.64 (1H, s), 1.68 (3H, s), 1.58 (3H, s). 13C 
NMR (125 MHz, CDCl3) δ 194.9, 192.7, 137.0, 134.2, 133.8, 133.5, 132.2, 129.9, 
128.8, 127.2, 127.0, 80.2, 64.4, 18.5, 17.0 ppm. IR (NaCl) δ 3035, 2929, 1698, 1601, 
1507, 1370, 1113, 1047, 949, 888 cm−1. HRMS m/z calcd for C18H16O3SNa [M+Na+]: 
335.0718, found: 335.0719. 
 
General experimental procedure for the preparation of thioethers syn-
2.1, syn-2.2 and syn-2.3 
To an ice-bath cold solution of 2,3-dimethyl-1,4-naphtho-quinone-2,3-
epoxide (202 mg, 1.0 mmol) in dry tetrahydrofuran (5.0 mL) was added drop in one 
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portion the corresponding sodium thiolate (1.0 mmol). The resulting mixture was 
stirred cold with an ice-bath for 1 h. Then it was quenched with dichloromethane 
(15 mL) and water (15 mL). The organic layer was separated, the aqueous layer was 
extracted with dichloromethane (3×15 mL), and then the organic layers were dried 
(Na2SO4) and concentrated. The crude was purified through chromatography 
(silica-gel, hexanes/ethyl acetate (7:3)) to afford the desired compound. 
 
 (2S,3S)-2-(Ethylthio)-3-hydroxy-2,3-dimethyl-2,3-dihydronaphthalene-1,4-
dione syn-2.1 
 
Yield=243 mg, 92%. 1H NMR (300 MHz, CDCl3) δ 8.03–8.06 (1H, m), 7.96–7.99 
(1H, m), 7.64–7.74 (2H, m), 4.11 (1H, br s), 2.34 (m, 1H), 2.07 (m, 1H), 1.64 (3H, s), 
1.26 (3H, s), 0.94 (3H, t, J=7.5 Hz). 13C NMR (75 MHz, CDCl3) δ 198.8, 191.5, 134.8, 
134.1, 133.1, 131.1, 127.5, 126.7, 80.0, 62.5, 24.7, 23.7, 15.2, 13.7 ppm. IR 
(NaCl) δ 3040, 2930, 1730, 1600, 1442, 1332, 1225, 1159, 1068, 1025, 859, 777, 750, 
597 cm−1. HRMS m/z calcd for C14H16O3SNa [M+Na+]: 287.0718, found: 287.0715. 
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 (2S,3S)-2-Hydroxy-2,3-dimethyl-3-(phenylthio)-2,3-dihydronaphthalene-1,4-
dione syn-2.2 
 
Recrystallized from CH2Cl2–hexanes gave white crystals, mp 86–87 °C (lit.2 85.5–
89 °C) (Yield=281 mg, 90%). 1H NMR (500 MHz, CDCl3) δ 8.10 (1H, m), 7.92 (1H, 
m), 7.71–7.75 (2H, m), 7.27 (1H, t, J=7.4 Hz), 7.16 (2H, t, J=7.8 Hz), 7.06 (2H, 
d, J=7.3 Hz), 4.37 (1H, s), 1.66 (3H, s), 1.34 (3H, s). 13C NMR (125 MHz, 
CDCl3) δ 198.9, 191.3, 136.9, 135.0, 134.1, 134.0, 131.0, 129.9, 129.4, 128.8, 127.6, 
126.9, 80.1, 66.5, 25.2, 16.0 ppm. IR (NaCl) δ 3060, 2980, 2935, 1885, 1731, 1563, 
1442, 1330, 1253, 1160, 1075, 1025, 897, 859, 776, 691 cm−1. HRMS m/z calcd for 
C18H16O3SNa [M+Na+]: 335.0718, found: 335.0723. 
 
 (2S,3S)-2-Hydroxy-2,3-dimethyl-3-(methylthio)-2,3-dihydronaphthalene-1,4-
dione syn-2.3 
 
Recrystallized from CH2Cl2–hexanes gave orange solid, mp 81–83 °C 
(Yield=223 mg, 89%). 1H NMR (300 MHz, CDCl3) δ 8.01–8.04 (1H, m), 7.93–7.96 
(1H, m), 7.62–7.72 (2H, m), 4.15 (1H, br s), 1.70 (3H, s), 1.57 (3H, s), 1.26 (3H, 
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s). 13C NMR (75 MHz, CDCl3) δ 198.9, 190.1, 134.9, 134.1, 132.9, 131.0, 127.4, 
126.7, 80.0, 61.9, 25.0, 14.1, 12.4 ppm. IR (NaCl) δ 3019, 2987, 2937, 1680, 1592, 
1507, 1455, 1386, 1311, 1292, 1263, 1174, 1005, 885, 713 cm−1. HRMS m/z calcd for 
C13H14O3SNa [M+Na+]: 273.0561, found: 273.0562. 
 
 General experimental procedure for the preparation of ethers 2.4–2.5 
To an ice-bath cold solution of 2,3-dimethyl-1,4-naphtho-quinone-2,3-
epoxide (506 mg, 2.5 mmol) in dry dichloromethane (12.5 mL) and methanol 
(12.5 mL) was added drop wise boron trifluoride etherate (0.48 mL, 3.8 mmol). The 
resulting mixture was heated at 50 °C for 14 days. Then was quenched with 
saturated aqueous sodium bicarbonate (15 mL) and extracted with 
dichloromethane (3×15 mL), and then the organic layers were washed (brine), 
dried (Na2SO4) and concentrated. The crude was purified through chromatography 
(silica-gel, hexanes/ethyl acetate (7:3)) to afford the desired compound. 
 
 (2S,3S)-2-Ethoxy-3-hydroxy-2,3-dimethyl-2,3-dihydronaphthalene-1,4-
dione anti-2.4 
 
White needles, mp 67–70 °C (Yield=372 mg, 60%) (Quantitative yield based on 
recovered starting material).1H NMR (500 MHz, CDCl3) δ 7.90–7.93 (2H, m), 7.59–
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7.64 (2H, m), 4.01 (1H, br s), 3.47–3.53 (1H, m), 3.22–3.28 (1H, m), 1.38 (3H, s), 
1.34 (3H, s), 0.90 (3H, t, J=7.1 Hz). 13C NMR (125 MHz, CDCl3) δ 197.35, 197.14, 
134.3, 134.0, 133.3, 132.5, 126.9, 126.8, 85.0, 81.0, 60.1, 19.3, 15.5, 13.9 ppm. IR 
(NaCl) δ 3046, 2981, 1697, 1507, 1456, 1276, 1054, 984, 707, 667 cm−1. 
HRMS m/z calcd for C14H16O4Na [M+Na+]: 271.0946, found: 271.0948. 
 
(2S,3S)-2-Hydroxy-3-methoxy-2,3-dimethyl-2,3-dihydronaphthalene-1,4-
dione anti-2.5 
 
 
White needles, mp 97–99 °C (Yield=322 mg, 55%) (Quantitative yield based on 
recovered starting material).1H NMR (500 MHz, CDCl3) δ 7.94–7.99 (2H, m), 7.63–
7.69 (2H, m), 3.92 (1H, br s), 3.27 (3H, s), 1.37 (3H, s), 1.34 (3H, s). 13C NMR 
(125 MHz, CDCl3) δ 197.8, 196.8, 134.5, 134.1, 133.3, 132.2, 127.1, 127.0, 85.1, 
81.3, 52.5, 20.2, 13.9 ppm. IR (NaCl) δ 3019, 2958, 2938, 1698, 1596, 1539, 1455, 
1372, 1281, 1189, 1122, 1017, 938 cm−1. HRMS m/z calcd for C13H14O4Na [M+Na+]: 
257.0790, found: 257.0792. 
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Crystallographic data 
 
Single crystals of C18H16O3S were mounted on a MicroMount® polymer tip 
(MiteGen) in a random orientation. Data collection was performed on a SuperNova 
dual source equipped with a CCD Atlas detector diffractometer (Agilent 
Technologies). The crystal was kept at 293(2) K during data collection. Using 
Olex2,47 the structure was solved with the ShelXS48 structure solution program 
using Direct Methods and refined with the ShelXL49 refinement package using 
Least Squares minimisation. 
Syn-2.2: C18H16O3S, M =312.37, triclinic, a = 7.7667(5) Å, b = 10.1556(6) Å, c = 
10.4484(6) Å, α = 77.2900(10)°, β = 71.4970(10)°, γ = 80.5300(10)°, V = 
758.37(8) Å3, T = 298(2), space group P-1 (no. 2), Z = 2, μ(MoKα) = 0.223, 8857 
reflections measured, 3482 unique (Rint = 0.0164) which were used in all 
calculations. The final wR2 was 0.1110 (all data) and R1 was 0.0374 (>2sigma(I)). 
 
                                                          
47 O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. Puschmann, OLEX2: a complete structure 
solution, refinement and analysis program. J. Appl. Cryst. (2009). 42, 339-341. 
48 SHELXS-97 (Sheldrick, 1990). 
49 SHELXL, G.M. Sheldrick, Acta Cryst. 2008. A64, 112-122. 
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1. Introduction 
The α,β-epoxy esters are among the most interesting compounds due to the 
numerous transformations that can be performed with them. The opening of the 
oxirane ring can generate a large number of products which are interesting 
intermediates.50,51,52,53,54,55,56,57,58 
  
 
 
                                                          
50 Chong, J. M.; Sharpless, K. B. Tetrahedron Lett. 1985, 26, 4683-4686 
51 Meth-Cohn, O.; Moore, C.; Taljaard, H. C. J. Chem. Soc., Perkin Trans. 1 1988, 2663-2674 
52 Saito, S.; Takahashi, N.; Ishikawa, T.; Moriwake, T. Tetrahedron Lett. 1991, 32, 667-670 
53 Lanier, M.; Pastor, R. Tetrahedron Lett. 1995, 36, 2491-2492 
54 Righi, G.; Rumboldt, G.; Bonini, C. J. Org. Chem. 1996, 61, 3557-3560 
55 Concellón, J. M.; Bardales, E. Org. Lett. 2002, 4, 189-191. 
56 Concellón, J. M.; Bardales, E.; Llavona, R. J. Org. Chem. 2003, 68, 1585-1588 
57 Rodríguez, S.; Izquierdo, F.; Lopez, I.; Gonz alez, F. V. Tetrahedron 2006, 62, 11112-11123 
58 Lopez, I.; Izquierdo, J.; Rodríguez, S.; González, F. V. J. Org. Chem. 2007, 72, 6614-6617 
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Scheme 1. General α,β-epoxy esters applications 
Morita-Baylis-Hillman (MBH) is an important organic reaction forming a 
C-C bond between and activated alkene and a carbonylic compound. The reaction 
is performed in the presence of a tertiary amine or a phosphine. The reaction and 
mechanism is summarized in scheme 2. It has also been used in the total synthesis 
of interesting natural products.59,60 
 
 
Scheme 2. General reaction and mechanism of MBH reaction 
                                                          
59 Bailey, M.; Marko, I. E.; Ollis, W. D.; Rasmussen, P. R. Tetrahedron Lett. 1990, 31, 4509-4512 
60 Bailey, M.; Staton, I.; Ashton, P. R.; Mark_o, I. E.; Ollis, W. D. Tetrahedron: Asymmetry 1991, 2, 495-509 
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Some epoxidation reactions of MBH adducts have been previously 
reported. It is remarkable the importance of the hydroxyl group in this system due 
to the drastically effect on the diastereoselectivity depending on if it is protected or 
not. A. Meyers reported,61 as illustrated in scheme 3 the preparation of anti 
diastereoisomer epoxide in high selectivity when the hydroxyl group is silylated.  
 
 
Scheme 3. Epoxidation of O-silylated MBH adduct 
We previously reported, as it is shown in scheme 4, the diastereoselective 
nucleophilic epoxidation of γ-hydroxy-α,β-unsaturated esters using lithium tert-
butoxide as an oxidant. In this case syn isomer was obtained (dr> 70:30). 
 
 
Scheme 4. Epoxidation of γ-hydroxy-α,β-unsaturated esters 
We also observed that the reaction is more stereoselective if there is a 
substituent at the α-position, also again in favor if syn isomer (dr > 19:1). It can be 
observed in scheme 5. 
                                                          
61 Svenda, M.; Myers, A. G. Org. Lett. 2009, 11, 2437-2440 
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Scheme 5. Effect double bound substitution  
Due to the interesting scope of possibilities of the α,β-epoxy esters, the 
transformations of MBH adducts to prepare natural products and the lack of a deep 
study of the diastereoselectivity of the epoxidation reaction of MBH adducts, we 
decided to explore the stereoselectivity of the epoxidation of 3-hydroxy-2-
methylene esters. 
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2. Results and discussion 
 
The stereoselectivity of the epoxidation of 3-hydroxy-methylene 
carboxylate esters was studied. A large range of alkyl and aryl aldehydes was 
selected as representative electrophiles. 
 
 
Scheme 6: Preparation of MBH adducts 
 
For the preparation of the substrates, a whole study of different MBH 
reaction conditions was performed, due to the large number of conditions 
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described on literature and noting that the reaction conditions depends on the 
substrate. The results are summarized in table 1.  
  Table 1. MBH reaction results  
Entry Substrate Conditionsa Yield (%) 
1 3.1a dioxane/ H2O (1:1), 10 M, 48 h, r.t. 99 
2 3.1b dioxane/ H2O (1:1), 10 M, 48 h, r.t. 70 
3 3.1c dioxane/ H2O (1:1), 10 M, 48 h, r.t. 99 
4 3.1d dioxane/ H2O (1:1), 10 M, 48 h, r.t. 85 
5 3.1e dioxane/ H2O (1:1), 10 M, 48 h, r.t. 81 
6 3.1f dioxane/ H2O (1:1), 10 M, 48 h, r.t. 99 
7 3.1g dioxane/ H2O (1:1), 10 M, 48 h, r.t. 99 
8 3.1h dioxane/ H2O (1:1), 12 M, 48 h, r.t. 99 
9 3.1i solvent-free, 4 days, r.t. 82 
10 3.1j solvent-free, 5 weeks, r.t. 77 
11 3.1k dioxane/ H2O (1:1), 10 M, 36 h, r.t. 99 
12 3.1l solvent-free, 5 days, r.t. 94 
13 3.1m DMSO 7 M, 4 days, r.t. 99 
14 3.1n DMSO 7 M, 4 days, r.t. 99 
15 3.1o dioxane/ H2O (1:1), 10 M, 36 h, r.t. 89 
16 3.1p dioxane/ H2O (1:1), 10 M, 16 h, r.t. 95 
17 3.1q dioxane/ H2O (1:1), 10 M, 16 h, r.t. 87 
18 3.1r dioxane/ H2O (1:1), 10 M, 3 h, r.t. 83 
19 3.1s dioxane/ H2O (1:1), 10 M, 20 h, r.t. 85 
a Using DABCO as base 
 
Aldehydes were treated with acrylates using 1,4-Diazabicyclo[2.2.2]octane 
(DABCO) in all cases and the reactions were performed at room temperature. In 
Study of the stereoselectivity of the nucleophilic epoxidation of 3-hydroxy-2-methylene esters 
 
103 
most cases, a 1/1 mixture of dioxane/water was used as solvent as previously 
described.62 The reaction worked better if carried out at 10M concentration 
(respect to aldehyde), this is a higher concentration than the one reported.62 
Generally speaking, chemical yields were very good to excellent in all cases. The 
reaction times were between 3 hours to 5 weeks, depending on the substrate.  
 
Compounds 3.1m and 3.1n were prepared with dimethylsulfoxide as a 
solvent due to best results are obtained. It was remarkable that compounds 3.1i and 
3.1j were prepared under free solvent conditions and for longer time to get higher 
chemical yield.  
 
The epoxidation of MBH compounds 3.1a-s was carried out using lithium 
tert-butylperoxide (in situ prepared by adding 2 equivalents of tert-butyl hydrogen 
peroxide and 1.7 equivalents of methyl lithium) in tetrahydrofuran at -20 0C 
affording the desired epoxide in moderate to good yields.2,8,9 The nucleophilic 
epoxidation of MBH adducts generated a mixture of syn /anti epoxides in all cases, 
as described in scheme 7. The main results of the epoxidation reactions are 
illustrated in table 2.  
 
 
Scheme 7: Preparation of MBH adducts 
 
 
 
 
                                                          
62 Yu, C.; Liu, B.; Hu, L. J. Org. Chem. 2001, 66, 5413-5418 
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Table 2: Epoxidation reaction 
Entry R 3.2 : 3.3 ratio Yield (%) 
1 Me 67 : 33 72 
2 Et 76 : 24 70 
3 n-Pr 81 : 19 79 
4 i-Bu 81 : 19 71 
5 Chx 92 : 8 85 
6 PhCH2CH2 77 : 23 59 
7 PhCH=CH 53 : 47 47 
8 Ph 93 : 7 68 
9 p-Tol 89 : 11 82 
10 p-MeOPh 92 : 8 73 
11 p-FPh 90 : 10 65 
12 p-ClPh 84 : 16 52 
13 m-ClPh 92 : 8 38 
14 o-ClPh 92 : 8 52 
15 p-BrPh 90 : 10 68 
16 o-NO2Ph 83 : 17 43 
17 m-NO2Ph 80 : 20 60 
18 p-NO2Ph 91 : 9 65 
19 Furfuryl 93 : 7 69 
 
Results were analyzed according to the R substitution.  In all cases syn 
isomer was the major product for the epoxidation. Aliphatic products, entries 1-6, 
were obtained in good chemical yields (59% to 85%). For this series, the higher 
steric volume of R substituent the higher stereoselectivity is observed (67:33 to 
92:8). The alkenyl group, entry 7, is obtained in low chemical yield (47%) and poor 
diastereoselectivity (53:47).  In the aromatic series, in general, syn isomer was 
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obtained in good chemical yields (38% to 82%) and very good selectivity (80:20 to 
93:7).  
 
Next other oxidants were explored in order to increase the chemical yield 
and selectivity. Compound 3.1h was chosen as the substrate to assay new 
epoxidation conditions. New results can be seen in table 3. 
 
 
Scheme 8: Epoxidation reaction of compound 3.1h 
 
Table 3: Epoxidation of 3.1h using other oxidants 
Entry Conditions 3.2h : 3.3h ratio Yield (%) 
1a TBPLi 88:12 66 
2 CMPLi 91:9 72 
3 m-CPBA 90:10 28 
4 m-CPBA 88:12 80 
5 m-CPBA — NR 
6b TBPNa 85:15 41 
7c TBPNa 87:13 62 
8 TBPK 83:17 61 
a 0.8 equiv of MeLi + 1.5 equiv of TBHP 
b NaH + TBHP 
c NaOtBu + TBHP 
 
For entry 1, lithium tert-butyl peroxide was used but decreasing the 
amount of base (0.8 equivalents of methyl lithium and 1.5 equivalents of tert-butyl 
hydrogen peroxide in tetrahydrofuran at -20 oC for 20 h) but lower selectivity 
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(88:12) and chemical yield (66%) were observed. When lithium cumyl peroxide 
(1.5 eq cumyl hydrogen peroxide and 1.1 equivalents of methyl lithium) was used 
(entry 2), in the same condition as before, similar selectivity (91:9) and a sligh 
increase of chemical yield (72%) were observed. 
 
When sodium tert-butyl peroxide was used (readily prepared from 2 
equivalens of tert-butyl hydrogen peroxide and 1 equivalent of sodium tert-
butoxide) as an oxidant (entry 6) in tetrahydrofuran 0 oC for 3 hours, poor 
chemical yield (41%) and lower selectivity (85:15) were observed. Same conditions 
than entry 6 but a less amount of base were also tested as depicted in entry 7, (2 
equivalents of tert-butyl hydrogen peroxide and 0.25 equivalents of sodium tert-
butoxide) which increased the chemical yield (62%) and selectivity (87:13) respect 
to entry 6. When potassium tert-butyl peroxide (2 equivalents) was used (entry 8) 
in tetrahydrofuran at 0 oC for 3 hours, poor chemical yield (61%) and lower 
selectivity (83:17) were observed compared with lithium and sodium series. 
 
Finally an epoxidation using an electrophilic oxidant was also evaluated: 
2.1 equivalents of meta-chloroperbenzoic acid were used in dichloromethane for 
96 hours at room temperature (entry 3) and good selectivity (90:10) and poor 
chemical yield (28%) were oberved. These conditions but increasing temperature 
to 70 oC in a sealed tube (entry 4) led to the same selectivity (88:12) and an 
improvement of chemical yield (80%). When 2.5 equivalents of meta-
chloroperbenzoic acid were employed in the presence of 1.3 equivalents of 
potassium carbonate for 96 hours at room temperature (entry 5),63 starting material 
was recovered. It was remarkable that all chemical yields were calculated after 
chromatographic purification of the crude.  
                                                          
63 García-Ruano, J. L.; Fajardo, C.; Fraile, A.; Martí, M. R. J. Org. Chem. 2005, 70, 4300-4306 
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To confirm the stereochemistry, compounds 3.2b and 3.2h were compared with 
previous reported data,63,64 and epoxides 3.2d, 3.3d, 3.2e and 3.3e were derivatized 
into cyclic carbonates.  
 
 
Scheme 9. Preparation of cyclic compounds 
 
As it is illustrated in scheme 9, epoxides 3.2d, 3.3d, 3.2e and 3.3e were 
treated with sodium thiophenolate readily prepared by previously mixing 1.5 
equivalents of sodium hydride with 2 equivalents of thiophenol for 15 minutes 
cold with an ice-bath. Then the epoxide was added and reaction was carried out at 
0 oC for 15 min in THF at room temperature for 1,5 hours. The resulting diol was 
cyclized as carbonate by adding triphosgene and pyridine. 
 
                                                          
64 Adam, W.; Braun, M.; Griesbek, A.; Lucchini, V.; Staab, E.; Will, B. J. Am. Chem. Soc. 1989, 111, 203-212 
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The cyclic carbonates 3.4-3.7 were isolated in good chemical yields (70% - 
80%) and NOE experiments were carried out to make stereochemical assignments 
as illustrated in scheme 10. Both syn isomers 3.4 and 3.6 (from 3.2d and 3.2e, 
respectively) had a strong NOE effect between H-5 and the methyl ester group and 
other NOE effect between methylene bound to sulfur and H-alkyl chain in 5-
position. On the other hand, anti isomers 3.5 and 3.7 (from 3.3d and 3.3e, 
respectively) had a strong NOE effect between H-5 and the methylene bound to 
sulfur. 
 
Scheme 10: NOE experiments on carbonates 3.4-3.7 
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3. Conclusions 
 
A study of the diastereoselectivity of the epoxidation of 3-hydroxy-2-
methylene esters has been performed. An extensive experimental work was done 
for the optimization of MBH reaction as applied to a range of alkyl and aryl 
aldehydes. Most of MBH adducts were compared with previously published 
data.65,66,67,68,69 The study of epoxidation conditions of MBH adducts was reached. 
The diastereoselectivity preference of this nucleophilic epoxidation to syn isomer 
is confirmed in all of cases, complementing the other literature studies. Finally a 
ring opening transformation with thiophenol and triphosgene led to the formation 
of cyclic carbonates compounds for stereochemical assignments.   
 
 
                                                          
65 Lee, K.; Loh, T. Chem. Commun. 2006, 4209-4211 
66 Brzezinski, L. J.; Rafel, S.; Leahy, J. W. Tetrahedron 1997, 53, 16423-16434 
67 Mi, X.; Luo, S.; Cheng, J. J. Org. Chem. 2005, 70, 2338-2341 
68 Aggarwal, V. A.; Emme, I.; Fulford, S. Y. J. Org. Chem. 2003, 68, 692-700 
69 Guo, Y.; Shao, G.; Li, L.;Wu,W.; Li, R.; Li, J.; Song, J.; Qiu, L.; Prashad, M.; Kwong, F. Y. Adv. Synth. Catal. 
2010, 352, 1539-1553 
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4. Experimental information 
 
General experimental methods 
All solvents used in reactions were freshly distilled from appropriate drying 
agents before use. 1H NMR spectra and 13C NMR spectra were measured in 
CDCl3 (1H, 7.24 ppm; 13C 77.0 ppm) solution at 30 °C on a 300 MHz or a 500 MHz 
NMR spectrometer. IR spectra were recorded as oil films or KBr discs or NaCl 
pellets on a FT-IR spectrometer. EM Science Silica Gel 60 was used for column 
chromatography while TLC was performed with precoated plates (Kieselgel 60, 
F254, 0.25 mm). Unless otherwise specified, all reactions were carried out under 
argon atmosphere with magnetic stirring. 
 
General experimental procedure for the preparation of compounds 3.1a–s 
To a solution of aldehyde (1 mmol) in dioxane/water (1:1) (0.1 mL) was 
added methyl acrylate (3 mmol) and DABCO (1 mmol). The reaction was 
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monitored by TLC. Upon completion, water (70 mL) was added and poured onto a 
separatory funnel and extracted with ethyl ether or dichloromethane (3×30 mL), 
dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. 
The crude was purified through chromatography (silica-gel, hexanes/ethyl acetate 
(8:2), (6:4)) to afford the desired compound. 
Methyl 3-hydroxy-2-methylenebutanoate 3.1a16 
 
1H NMR (500 MHz, CDCl3) δ 6.19 (1H, s), 5.81 (1H, s), 4.59 (1H, q, J=6.5 Hz), 3.76 
(3H, s), 2.61 (1H, br s), 1.36 (3H, d, J=6.5 Hz).13C NMR (125 MHz, CDCl3) δ 167.1, 
143.6, 124.0, 67.2, 51.8, 22.1 ppm. 
 
Methyl 3-hydroxy-2-methylenepentanoate 3.1b17 
 
1H NMR (500 MHz, CDCl3) δ 6.22 (1H, s), 5.78 (s, 1H), 4.31 (1H, t, J=7.0 Hz), 3.76 
(3H, s), 2.43 (1H, br s), 1.73–1.61 (2H, m), 0.93 (3H, t, J=7.4 Hz).13C NMR 
(125 MHz, CDCl3) δ 167.0, 142.3, 124.7, 72.0, 51.5, 29.0, 10.0 ppm. 
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Methyl 3-hydroxy-2-methylenehexanoate 3.1c18 
 
1H NMR (500 MHz, CDCl3) δ 6.20 (1H, s), 5.78 (1H, s), 4.38 (1H, t, J=6.5 Hz), 3.76 
(3H, s), 2.41 (1H, br s), 1.63–1.58 (2H, m), 1.49–1.45 (1H, m), 1.31–1.38 (1H, m), 
0.90 (3H, t, J=6.7 Hz).13C NMR (125 MHz, CDCl3) δ 167.0, 142.5, 124.7, 71.3, 52.0, 
38.5, 19.0, 14.0 ppm. 
 
Methyl 3-hydroxy-5-methyl-2-methylenehexanoate 3.1d18 
 
1H NMR (500 MHz, CDCl3) δ 6.18 (1H, s), 5.78 (1H, s), 4.45 (1H, dd, J=8.5, 4.3 Hz), 
3.76 (3H, s), 2.40 (1H, br s), 1.80–1.75 (1H, m), 1.58–1.51 (1H, m), 1.44–1.38 (1H, 
m), 0.92 (6H, m).13C NMR (125 MHz, CDCl3) δ167.0, 142.8, 124.6, 71.3, 69.9, 51.9, 
45.5, 24.8, 23.3, 21.8 ppm. 
 
Methyl 2-(cyclohexyl(hydroxy)methyl)acrylate 3.1e19 
 
1H NMR (500 MHz, CDCl3) δ 6.23 (1H, s), 5.71 (1H, s), 4.06 (1H, d, J=7.2 Hz), 3.76 
(3H, s), 2.44 (1H, br s), 1.94 (1H, m), 1.50–1.76 (5H, m), 1.24–0.92 (5H, m).13C 
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NMR (125 MHz, CDCl3) δ 167.0, 141.2, 126.0, 53.4, 52.0, 42.4, 29.8, 28.1, 26.3, 
26.1, 25.9 ppm. 
 
Methyl 3-hydroxy-2-methylene-5-phenylpentanoate 3.1f20 
 
1H NMR (500 MHz, CDCl3) δ 7.30–7.17 (5H, m), 6.24 (1H, s), 5.81 (1H, s), 4.42 
(1H, dd, J=7.5, 5.7 Hz), 3.77 (3H, s), 2.85–2.79 (1H, m), 2.73–2.69 (1H, m), 2.42 
(1H, br s), 2.00–1.95 (1H, m).13C NMR (125 MHz, CDCl3) δ 167.0, 141.8, 128.5, 
125.9, 125.0, 70.1, 51.8, 38.0, 32.0 ppm. 
 
(E)-Methyl 3-hydroxy-2-methylene-5-phenylpent-4-enoate 3.1g19 
 
1H NMR (500 MHz, CDCl3) δ 7.39–7.22 (5H, m), 6.67 (1H, d, J=16.0 Hz), 6.29 (2H, 
m), 5.91 (1H, s), 5.13 (1H, m), 3.78 (3H, s), 2.97 (1H, br s).13C NMR (125 MHz, 
CDCl3) δ 166.7, 141.3, 136.5, 131.5, 129.2, 128.5, 127.8, 126.6, 125.8, 72.1, 
52.0 ppm. 
 
Methyl 2-(hydroxy(phenyl)methyl)acrylate 3.1h18 
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1H NMR (500 MHz, CDCl3) δ 7.38–7.26 (5H, m), 6.33 (1H, s), 5.83 (1H, s), 5.56 
(1H, s), 3.72 (3H, s).13C NMR (125 MHz, CDCl3) δ 166.7, 142.3, 141.6, 128.3, 127.7, 
126.8, 125.6, 72.7, 51.8 ppm. 
 
Methyl 2-(hydroxy(p-tolyl)methyl)acrylate 3.1i18 
 
1H NMR (300 MHz, CDCl3) δ 7.26 (2H, d, J=8.0 Hz), 7.15 (2H, d, J=8.0 Hz), 6.32 
(1H, s), 5.85 (1H, s), 5.53 (1H, s), 3.71 (3H, s), 2.34 (3H, s).13C NMR (125 MHz, 
CDCl3) δ 166.8, 142.1, 138.4, 137.5, 129.1, 126.5, 125.8, 73.1, 51.9, 21.1 ppm. 
 
Methyl 2-(hydroxy(4-methoxyphenyl)methyl)acrylate 3.1j20 
 
1H NMR (300 MHz, CDCl3) δ 7.28 (2H, d, J=8.8 Hz), 6.86 (2H, d, J=8.7 Hz), 6.31 
(1H, s), 5.84 (1H, s), 5.52 (1H, s), 3.79 (3H, s), 3.71 (3H, s).13C NMR (75 MHz, 
CDCl3) δ 166.8, 159.2, 142.2, 133.5, 127.9, 125.5, 113.8, 72.7, 55.2, 51.9 ppm. 
 
Methyl 2-((4-fluorophenyl)(hydroxy)methyl)acrylate 3.1k20 
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1H NMR (500 MHz, CDCl3) δ 7.33 (2H, dd, J=8.5, 5.5 Hz), 7.01 (2H, t, J=8.7 Hz), 
6.32 (1H, s), 5.82 (1H, s), 5.53 (1H, s), 3.73 (3H, s), 3.02 (1H, br s). 13C NMR 
(125 MHz, CDCl3) δ 166.6, 162.3 (d, J=245 Hz), 141.9, 137.0, 128.3 (dd, J=7.2, 
21.3 Hz), 126.0 (dd, J=15.0, 21.3 Hz), 115.2 (dd, J=12.5, 22.5 Hz), 72.6, 52.2 ppm. 
 
Methyl 2-((4-chlorophenyl)(hydroxy)methyl)acrylate 3.1l18 
 
1H NMR (500 MHz, CDCl3) δ 7.54 (1H, m), 7.34 (1H, m), 7.21–7.30 (2H, m), 6.32 
(1H, s), 5.97 (1H, s), 5.58 (1H, m), 3.76 (3H, s), 3.26 (1H, br s).13C NMR (125 MHz, 
CDCl3) δ 166.6, 141.6, 139.8, 133.6, 128.6, 127.9, 126.3, 72.7, 52.0 ppm. 
 
Methyl 2-((3-chlorophenyl)(hydroxy)methyl)acrylate 3.1m20 
 
1H NMR (500 MHz, CDCl3) δ 7.37 (1H, s), 7.26 (3H, m), 6.34 (1H, s), 5.83 (s, 1H), 
5.51 (1H, s), 3.72 (s, 3H), 3.03 (1H, br s).13C NMR (125 MHz, CDCl3) δ 166.5, 143.4, 
141.4, 134.4, 129.7, 127.9, 126.7, 126.6, 124.7, 72.7, 52.0 ppm. 
 
Methyl 2-((2-chlorophenyl)(hydroxy)methyl)acrylate 3.1n20 
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1H NMR (500 MHz, CDCl3) δ 7.54 (1H, m), 7.34 (1H, m), 7.21–7.30 (2H, m), 6.32 
(1H, s), 5.97 (1H, s), 5.58 (1H, m), 3.76 (3H, s), 3.25 (1H, br s).13C NMR (125 MHz, 
CDCl3) δ 166.9, 140.9, 134.5, 132.8, 128.9, 128.1, 127.0, 126.8, 68.9, 52.0 ppm. 
 
Methyl 2-((4-bromophenyl)(hydroxy)methyl)acrylate 3.1o20 
 
1H NMR (300 MHz, CDCl3) δ 7.47 (2H, m), 7.25 (2H, m), 6.33 (1H, s), 5.82 (1H, s), 
5.51 (1H, m), 3.73 (3H, s), 3.04 (1H, br s).13C NMR (75 MHz, CDCl3) δ 166.4, 141.9, 
140.6, 131.4, 128.6, 125.9, 121.6, 71.9, 51.9 ppm. 
 
Methyl 2-((2-nitrophenyl)(hydroxy)methyl)acrylate 3.1p18 
 
1H NMR (500 MHz, CDCl3) δ 7.95 (1H, dd, J=8.2, 1.3 Hz), 7.75 (1H, dd, J=7.9, 
1.3 Hz), 7.64 (1H, td, J=7.7, 1.3 Hz), 7.46 (1H, td, J=8.5, 1.4 Hz), 6.37 (1H, s), 6.20 
(1H, s), 5.73 (1H, s), 3.73 (3H, s), 3.35 (1H, br s). 13C NMR (75 MHz, 
CDCl3) δ 163.8, 145.6, 138.5, 133.7, 130.8, 126.3, 126.0, 123.7, 121.9, 64.7, 
49.5 ppm. 
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Methyl 2-((3-nitrophenyl)(hydroxy)methyl)acrylate 3.1q18 
 
1H NMR (500 MHz, CDCl3) δ 8.26 (1H, m), 8.14 (1H, ddd, J=8.2, 2.3, 1.2 Hz), 7.75 
(1H, m), 7.52 (1H, t,J=7.92 Hz), 6.41 (1H, s), 5.89 (1H, s), 5.63 (1H, s), 3.75 (3H, s), 
3.25 (1H, br s).13C NMR (125 MHz, CDCl3) δ 166.2, 148.3, 143.7, 141.0, 132.8, 
129.5, 126.9, 122.8, 121.7, 72.4, 52.3 ppm. 
 
Methyl 2-((4-nitrophenyl)(hydroxy)methyl)acrylate 3.1r18 
 
1H NMR (500 MHz, CDCl3) δ 8.18 (2H, d, J=10.9 Hz), 7.56 (2H, d, J=10.9 Hz), 6.38 
(1H, s), 5.86 (1H, s), 5.62 (1H, m), 3.73 (3H, s), 3.32 (1H, br s).13C NMR (125 MHz, 
CDCl3) δ 166.4, 148.6, 143.7, 141.0, 127.3, 127.2, 123.6, 72.7, 52.2 ppm. 
 
Methyl 2-(furan-2-yl(hydroxy)methyl)acrylate 3.1s18 
 
1H NMR (500 MHz, CDCl3) δ 7.35 (1H, s), 6.37 (1H, s), 6.31 (1H, m), 6.24 (1H, m), 
5.93 (1H, s), 5.57 (1H, s), 3.74 (3H, s), 3.21 (1H, br s).13C NMR (125 MHz, 
CDCl3) δ 166.4, 154.1, 142.3, 143.7, 139.5, 126.7, 110.4, 107.1, 67.2, 52.0 ppm. 
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General experimental procedure for the epoxidation of esters (3.2a–s) 
To a −78 °C cold THF (3.5 mL) was added TBHP (3.3 M in toluene) 
(2 mmol) and then methyllithium (1.6 M in hexanes) (1.7 mmol). The resulting 
mixture was stirred at −78 °C for 15 min and then a solution of compound 
3.1 (1 mmol) in THF (2 mL) was added drop wise and then the mixture was left at 
−20 °C (fridge) for 20 h. Then solid Na2SO3 (120 mg) was added in one portion and 
stirred for 15 min, then diluted with water and extracted with Et2O (3×30 mL), the 
organic layers were washed (brine), dried (Na2SO4), and concentrated. The crude 
oil was purified through chromatography (silica-gel, hexanes/EtOAc (7:3) and 
(1:1)). 
Methyl 2-(1-hydroxyethyl)oxirane-2-carboxylate 3.2a/3.3a 
 
 
(Yield=167 mg, 99%) (ratio of diastereomers 67/33). 1H NMR (500 MHz, 
CDCl3) δ 4.33 (1H, q, J=6.6 Hz) (minor), 4.16 (1H, q, J=6.4 Hz) (major), 3.71 (3H, s), 
3.10 (1H, d, J=5.9 Hz) (major), 4.64 (1H, d, J=6.1 Hz) (minor), 2.99 (1H, d, J=6.0 Hz) 
(minor), 2.96 (1H, d, J=5.8 Hz) (major), 2.08 (1H, br s), 1.31 (3H, d, J=6.4 Hz) 
(major), 1.29 (3H, d, J=6.6 Hz) (minor).13C NMR (125 MHz, CDCl3) δ 170.0 
(minor), 169.9 (major), 65.1 (major), 64.9 (minor), 59.6 (minor), 59.0 (major), 52.5 
(major), 52.4 (minor), 49.3 (minor), 49.2 (major), 18.6 (minor), 18.2 (major) ppm. 
IR (KBr) δ 3932, 3839, 2984, 2363, 1738, 1519, 1382, 1285, 1173, 1095, 971, 913, 
853 cm−1. HRMS m/z calcd for C6H10O4Na [M+Na+]: 169.0477, found: 169.0478. 
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Methyl 2-(1-hydroxypropyl)oxirane-2-carboxylate 3.2b/3.3b 
 
(Yield=128 mg, 70%) (ratio of diastereomers 76/24). 1H NMR (500 MHz, 
CDCl3) δ 3.75 (1H, m), 3.71 (3H, s), 3.12 (1H, d, J=6.0 Hz), 2.98 (1H, d, J=6.0 Hz), 
2.55 (1H, br s), 1.72 (1H, m), 1.48 (1H, m), 0.98 (3H, t,J=6.7 Hz). 13C NMR 
(125 MHz, CDCl3) δ 170.0, 71.0, 50.1, 52.5, 49.6, 26.0, 9.9 ppm. IR (KBr) δ 3770, 
3457, 2939, 2360, 1869, 1637, 1541, 1440, 1348, 1197, 1139, 1055, 950, 758 cm−1. 
HRMS m/z calcd for C7H12O4Na [M+Na+]: 183.0633, found: 183.0636 
(Yield 3.2c/3.3c=99%). 
 
syn-Methyl 2-(1-hydroxybutyl)oxirane-2-carboxylate 3.2c 
 
1H NMR (500 MHz, CDCl3) δ 3.84–3.87 (1H, m), 3.78 (3H, s), 3.12 (1H, 
d, J=5.9 Hz), 2.98 (1H, d,J=5.9 Hz), 1.69–1.40 (4H, m), 0.94 (3H, t, J=7.2 Hz).13C 
NMR (125 MHz, CDCl3) δ 170.0, 69.3, 58.3, 52.4, 49.6, 35.0, 18.7, 13.8 ppm. IR 
(KBr) δ 3649, 2960, 2361, 1740, 1560, 1457, 1382, 1197, 1139, 1077, 983, 760 cm−1. 
HRMS m/z calcd for C8H14O4Na [M+Na+]: 197.0790, found: 197.0786. 
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anti-Methyl 2-(1-hydroxybutyl)oxirane-2-carboxylate 3.3c 
 
1H NMR (500 MHz, CDCl3) δ 4.12–4.10 (1H, m), 3.78 (3H, s), 3.08 (1H, 
d, J=6.0 Hz), 2.98 (1H, d,J=6.0 Hz), 1.77 (1H, br s), 1.61–1.37 (4H, m), 0.94 (3H, 
t, J=7.1 Hz).13C NMR (125 MHz, CDCl3) δ 170.0, 69.0, 59.4, 52.5, 49.3, 35.1, 18.9, 
13.7 ppm. IR (KBr) δ 3466, 2960, 1739, 1639, 1567, 1441, 1356, 1287, 1212, 1197, 
1138, 1129, 1036, 982, 957 cm−1 (Yield 3.2d/3.3d=71%). 
 
syn-Methyl 2-(1-hydroxy-3-methylbutyl)oxirane-2-carboxylate 3.2d 
 
1H NMR (500 MHz, CDCl3) δ 3.92 (1H, dd, J=3.8, 9.2 Hz), 3.78 (3H, s), 3.12 (1H, 
d, J=5.9 Hz), 2.98 (1H, d,J=5.9 Hz), 1.93–1.86 (1H, m), 1.41–1.51 (2H, m), 0.95 (6H, 
t, J=6.5 Hz).13C NMR (125 MHz, CDCl3) δ170.0, 68.0, 58.5, 52.5, 49.6, 41.8, 24.4, 
23.5, 21.4 ppm. IR (KBr) δ 3743, 2956, 2361, 1738, 1438, 1368, 1171, 1116, 1078, 
994, 919, 864, 758 cm−1. HRMS m/z calcd for C9H16O4Na [M+Na+]: 211.0946, found: 
211.0942. 
 
anti-Methyl 2-(1-hydroxy-3-methylbutyl)oxirane-2-carboxylate 3.3d 
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1H NMR (500 MHz, CDCl3) δ 4.20 (1H, dd, J=3.8, 9.2 Hz), 3.77 (3H, s), 3.09 (1H, 
d, J=5.9 Hz), 2.98 (1H, d,J=5.9 Hz), 2.06–1.96 (1H, br s), 1.76–1.82 (1H, m), 1.48–
1.51 (1H, m), 1.27–1.35 (1H, m), 0.95 (6H, t,J=6.5 Hz).13C NMR (125 MHz, 
CDCl3) δ 170.0, 67.5, 59.6, 52.5, 49.3, 42.0, 24.4, 23.5, 21.3 ppm. IR (KBr)δ 3491, 
2957, 2393, 1738, 1440, 1368, 1184, 1115, 1094, 993, 919, 879 cm−1. 
 
syn-Methyl 2-(cyclohexyl(hydroxy)methyl)oxirane-2-carboxylate 3.2e 
 
1H NMR (500 MHz, CDCl3) δ 3.78 (3H, s), 3.39 (1H, d, J=6.7 Hz), 3.11 (1H, 
d, J=5.9 Hz), 2.96 (1H, d,J=5.9 Hz), 2.12 (1H, br s), 1.88 (1H, m), 1.75–1.63 (5H, m), 
1.26–1.03 (5H, m). 13C NMR (125 MHz, CDCl3)δ 170.1, 75.1, 57.3, 52.4, 49.7, 41.2, 
29.3, 28.2, 26.2, 26.0, 25.8 ppm. IR (KBr) δ 3799, 2930, 2669, 2342, 1741, 1377, 
1306, 1200, 1124, 1087, 1030, 932, 761 cm−1. HRMS m/z calcd for C11H18O4Na 
[M+Na+]: 237.1103, found: 237.1105. 
 
anti-Methyl 2-(cyclohexyl(hydroxy)methyl)oxirane-2-carboxylate 3.3e 
 
1H NMR (500 MHz, CDCl3) δ 3.77 (3H, s), 3.69 (1H, d, J=6.5 Hz), 3.02 (1H, 
d, J=5.9 Hz), 2.97 (1H, d,J=5.9 Hz), 1.94 (1H, m), 1.78–1.64 (5H, m), 1.30–0.94 (5H, 
m).13C NMR (125 MHz, CDCl3) δ 169.8, 74.5, 65.7, 58.7, 52.5, 49.6, 41.5, 29.6, 28.2, 
26.1, 25.8, 15.1 ppm. IR (KBr) δ 3752, 2936, 2668, 2341, 1740, 1422, 1232, 1153, 
1104, 1069, 1052, 974, 957 cm−1. 
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syn-Methyl 2-(1-hydroxy-3-phenylpropyl)oxirane-2-carboxylate 3.2f 
 
1H NMR (500 MHz, CDCl3) δ 7.33–7.20 (5H, m), 3.95 (1H, m), 3.77 (3H, s), 3.12 
(1H, d, J=6.0 Hz), 2.95 (1H, d, J=6.0 Hz), 2.93–2.88 (1H, m), 2.77–2.65 (1H, m), 
2.20–2.01 (1H, m), 1.82–1.93 (1H, m).13C NMR (125 MHz, CDCl3) δ 170.0, 141.5, 
128.4, 126.1, 68.9, 58.3, 52.6, 49.3, 34.8, 31.7 ppm. IR (KBr) δ 3873, 3063, 3003, 
2924, 2364, 1748, 1290, 1240, 1132, 1075, 754, 701 cm−1. 
 
anti-Methyl 2-(1-hydroxy-3-phenylpropyl)oxirane-2-carboxylate 3.3f 
 
1H NMR (500 MHz, CDCl3) δ 7.30–7.17 (5H, m), 4.11 (1H, d, J=9.3 Hz), 3.76 (3H, 
s), 3.05 (1H, d,J=6.0 Hz), 3.00 (1H, d, J=6.0 Hz), 2.93–2.87 (1H, m), 2.75–2.69 (1H, 
m), 1.99–1.93 (1H, m), 1.89–1.82 (1H, m), 1.54 (1H, br s).13C NMR (125 MHz, 
CDCl3) δ 170.0, 141.3, 128.4, 126.0, 68.9, 59.1, 52.3, 49.3, 34.5, 31.8 ppm. 
 
(E)-Methyl 2-(1-hydroxy-3-phenylallyl)oxirane-2-carboxylate 3.2g/3.3g 
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(Yield=103 mg, 47%) (ratio of diastereomers 53/47). 1H NMR (500 MHz, 
CDCl3) δ 7.40–7.24 (m, 5H), 6.74 (1H, d, J=16.0 Hz) (major and minor), 6.27 (1H, 
dd, J=6.3, 12.0 Hz) (major), 6.23 (1H, dd, J=5.8, 13.2 Hz) (minor), 4.85 (1H, 
dd, J=6.3, 1.3 Hz) (minor), 4.71 (1H, dd, J=6.5, 1.2 Hz) (major), 3.80 (3H, s) (major), 
3.79 (3H, s) (minor), 3.15 (1H, d, J=5.9 Hz) (major), 3.13 (1H, d, J=6.1 Hz) (minor), 
3.06 (1H, d, J=6.1 Hz) (minor), 3.00 (1H, d, J=5.9 Hz) (major). 13C NMR (125 MHz, 
CDCl3) δ 169.8 (minor), 169.7 (major), 136.2 (minor), 136.1 (major), 133.5 (major), 
133.1 (minor), 128.6, 128.1, 128.0, 126.7 (major and minor), 125.9 (minor), 125.6 
(major), 70.7 (major), 70.0 (minor), 59.0 (minor), 58.5 (major), 52.7, 52.6 (major 
and minor), 49.9 (major), 49.2 (minor) ppm. HRMS m/z calcd for C13H14O4Na 
[M+Na+]: 257.0790, found: 257.0792. 
 
syn-Methyl 2-(hydroxy(phenyl)methyl)oxirane-2-carboxylate 3.2h 10 
 
1H NMR (500 MHz, CDCl3) δ 7.43–7.30 (5H, m), 5.18 (1H, s), 3.73 (3H, s), 3.12 
(1H, d, J=5.9 Hz), 2.86 (1H, d, J=5.9 Hz).13C NMR (125 MHz, CDCl3) δ 169.7, 138.4, 
128.4, 127.0, 71.7, 59.0, 52.6, 49.7 ppm. IR (KBr) δ 3487, 3064, 2910, 2359, 1739, 
1269, 1160, 1082, 1027, 947, 757 cm−1. HRMS m/z calcd for C11H12O4Na [M+Na+]: 
231.0633, found: 231.0632. 
 
syn-Methyl 2-(hydroxy(p-tolyl)methyl)oxirane-2-carboxylate 3.2i 
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1H NMR (500 MHz, CDCl3) δ 7.29 (2H, d, J=8.0 Hz), 7.26 (2H, d, J=8.0 Hz), 5.15 
(1H, s), 3.72 (3H, s), 3.11 (1H, d, J=5.9 Hz), 2.86 (1H, d, J=5.9 Hz).13C NMR 
(125 MHz, CDCl3) δ 169.8, 137.9, 135.5, 128.9, 127.0, 71.4, 59.1, 52.6, 49.6, 
21.1 ppm. IR (KBr) δ 3502, 3005, 2923, 1743, 1197, 1125, 1020, 943, 837, 765, 
686 cm−1. HRMS m/z calcd for C12H14O4Na [M+Na+]: 245.0790, found: 245.0787. 
 
syn-Methyl 2-(hydroxy(4-methoxyphenyl)methyl)oxirane-2-carboxylate 3.2j 
 
1H NMR (500 MHz, CDCl3) δ 7.33 (2H, d, J=8.8 Hz), 6.87 (2H, d, J=8.8 Hz), 5.16 
(1H, s), 3.79 (3H, s), 3.67 (3H, s), 3.12 (1H, d, J=6.0 Hz), 2.85 (1H, d, J=6.0 Hz).13C 
NMR (125 MHz, CDCl3) δ 169.8, 159.5, 130.4, 128.5, 113.8, 71.2, 59.1, 55.2, 52.6, 
49.5 ppm. IR (KBr) δ 3493, 3003, 2910, 1742, 1197, 1124, 1031, 978, 917, 836, 
756 cm−1. HRMS m/z calcd for C12H14O5Na [M+Na+]: 261.0739, found: 261.0738. 
 
syn-Methyl 2-((4-fluorophenyl)(hydroxy)methyl)oxirane-2-carboxylate 3.2k 
 
1H NMR (500 MHz, CDCl3) δ 7.40 (2H, dd, J=8.5, 5.5 Hz), 7.03 (2H, t, J=8.7 Hz), 
5.15 (1H, s), 3.73 (3H, s), 3.13 (1H, d, J=6.0 Hz), 2.85 (1H, d, J=6.0 Hz). 13C NMR 
(125 MHz, CDCl3) δ 169.7, 162.2 (d, J=245 Hz), 134.2, 129.0 (dd, J=7.2, 21.3 Hz), 
115.2 (dd, J=12.5, 22.5 Hz), 71.1, 65.8, 52.7, 49.6 ppm. IR (KBr) δ 3477, 3070, 2958, 
2342, 1737, 1509, 1398, 1271, 1197, 1128, 1045, 980, 842, 756 cm−1. 
HRMS m/z calcd for C11H11FO4Na [M+Na+]: 249.0539, found: 249.0535. 
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syn-Methyl 2-((4-chlorophenyl)(hydroxy)methyl)oxirane-2-carboxylate 3.2l 
 
1H NMR (500 MHz, CDCl3) δ 7.37 (2H, d, J=8.0 Hz), 7.32 (2H, d, J=8.0 Hz), 5.29 
(1H, s), 3.73 (3H, s), 3.14 (1H, d, J=6.0 Hz), 2.88 (1H, d, J=6.0 Hz). 13C NMR 
(125 MHz, CDCl3) δ 169.6, 137.0, 134.1, 128.6, 128.5, 71.2, 58.7, 52.7, 49.7 ppm. IR 
(KBr) δ 3518, 3001, 2929, 1723, 1411, 1287, 1160, 1107, 1049, 982, 920, 756 cm−1. 
HRMS m/z calcd for C11H11ClO4Na [M+Na+]: 265.0244, found: 265.0245. 
 
syn-Methyl 2-((3-chlorophenyl)(hydroxy)methyl)oxirane-2-carboxylate 3.2m 
 
1H NMR (500 MHz, CDCl3) δ 7.44 (1H, s), 7.32 (3H, m), 5.10 (1H, s), 3.73 (3H, s), 
3.16 (1H, d, J=6.0 Hz), 2.90 (1H, d, J=6.0 Hz). 13C NMR (125 MHz, CDCl3) δ 169.6, 
140.6, 134.3, 129.6, 128.4, 127.1, 125.3, 71.3, 58.7, 52.8, 49.8 ppm. IR (KBr) δ 3466, 
3020, 2964, 1736, 1463, 1264, 1154, 1170, 1083, 962, 918, 877 cm−1. 
 
syn-Methyl 2-((2-chlorophenyl)(hydroxy)methyl)oxirane-2-carboxylate 3.2n 
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1H NMR (500 MHz, CDCl3) δ 7.54 (1H, m), 7.33 (1H, m), 7.24–7.29 (2H, m), 6.04 
(1H, s), 3.82 (3H, s), 3.06 (1H, d, J=6.0 Hz), 2.35 (1H, d, J=6.0 Hz). 13C NMR 
(125 MHz, CDCl3) δ 169.9, 135.0, 132.9, 129.5, 127.9, 126.9, 67.9, 58.6, 52.9, 
50.5 ppm. IR (KBr) δ 3741, 3019, 2938, 1734, 1472, 1390, 1297, 1195, 1064, 1028, 
1028, 758, 741 cm−1. 
 
syn-Methyl 2-((4-bromophenyl)(hydroxy)methyl)oxirane-2-carboxylate 3.2o 
 
1H NMR (500 MHz, CDCl3) δ 7.48 (2H, d, J=8.0 Hz), 7.32 (2H, d, J=8.0 Hz), 5.29 
(1H, s), 3.73 (3H, s), 3.14 (1H, d, J=6.0 Hz), 2.88 (1H, d, J=6.0 Hz). 13C NMR 
(125 MHz, CDCl3) δ 169.6, 137.5, 131.5, 129.0, 122.2, 71.2, 58.7, 52.7, 48.9 ppm. IR 
(KBr) δ 3711, 3077, 2957, 2360, 1923, 1592, 1728, 1460, 1333, 1286, 1196, 1127, 
1049, 935, 755 cm−1. HRMS m/z calcd for C11H11BrO4Na [M+Na+]: 308.9738, found: 
308.9735. 
 
syn-Methyl 2-((2-nitrophenyl)(hydroxy)methyl)oxirane-2-carboxylate 3.2p 
 
1H NMR (500 MHz, CDCl3) δ 7.96 (1H, dd, J=8.2, 1.3 Hz), 7.79 (1H, dd, J=7.9, 
1.3 Hz), 7.65 (1H, td, J=7.7, 1.3 Hz), 7.48 (1H, td, J=8.5, 1.4 Hz), 6.17 (1H, s), 3.82 
(3H, s), 3.13 (1H, d, J=6.0 Hz), 2.37 (1H, d,J=6.0 Hz). 13C NMR (125 MHz, 
CDCl3) δ 169.6, 148.3, 133.3, 129.8, 129.1, 124.6, 66.8, 58.1, 53.1, 51.0 ppm. IR 
(KBr) δ 3648, 3093, 2957, 1725, 1440, 1357, 1267, 1200, 1156, 1053, 947, 747 cm−1. 
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syn-Methyl 2-((3-nitrophenyl)(hydroxy)methyl)oxirane-2-carboxylate 3.2q 
 
1H NMR (500 MHz, CDCl3) δ 8.33 (1H, m), 8.17 (1H, ddd, J=8.2, 2.3, 1.2 Hz), 7.81 
(1H, m), 7.52 (1H, t,J=7.92 Hz), 5.19 (1H, s), 3.74 (3H, s), 3.22 (1H, d, J=6.0 Hz), 
2.95 (1H, d, J=6.0 Hz). 13C NMR (125 MHz, CDCl3) δ 169.4, 148.2, 133.3, 129.2, 
123.2, 122.1, 71.0, 65.7, 52.8, 49.7 ppm. IR (KBr) δ 3712, 3092, 3006, 2957, 2876, 
1735, 1441, 1353, 1289, 1163, 1096, 976, 935, 866, 758 cm−1. 
 
syn-Methyl 2-((4-nitrophenyl)(hydroxy)methyl)oxirane-2-carboxylate 3.2r 
 
1H NMR (500 MHz, CDCl3) δ 8.22 (2H, d, J=8.0 Hz), 7.65 (2H, d, J=8.0 Hz), 5.13 
(1H, s), 3.73 (3H, s), 3.48 (1H, d, J=6.0 Hz), 2.94 (1H, d, J=6.0 Hz). 13C NMR 
(125 MHz, CDCl3) δ 169.5, 146.0, 128.1, 127.8, 123.4, 71.4, 58.4, 53.0, 49.9 ppm. IR 
(KBr) δ 3902, 3087, 2958, 2342, 1925, 1715, 1517, 1442, 1221, 1096, 1053, 946, 
777 cm−1. HRMS m/z calcd for C11H11NO6Na [M+Na+]: 276.0484, found: 276.0482. 
 
syn-Methyl 2-(furan-2-yl(hydroxy)methyl)oxirane-2-carboxylate 3.2s 
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1H NMR (500 MHz, CDCl3) δ 7.38 (1H, s), 7.26 (1H, s), 6.39 (1H, m), 6.33 (1H, m), 
5.29 (1H, s), 3.75 (3H, s), 3.23 (1H, d, J=6.0 Hz), 3.05 (1H, d, J=6.0 Hz). 13C NMR 
(125 MHz, CDCl3) δ 169.3, 125.6, 142.5, 110.4, 107.7, 64.5, 52.6, 49.0 ppm. IR 
(KBr) δ 3932, 3153, 3004, 2957, 1734, 1633, 1359, 1231, 1048, 975, 753 cm−1. 
 
General experimental procedure for the preparation of cyclic carbonates 
(3.4-3.7) 
An ice-bath cold suspension of sodium hydride (60% in mineral oil) 
(1.12 mmol) in THF (1 mL) was treated with thiophenol (2.25 mmol). The mixture 
was stirred at rt for 15 min and then a solution of the epoxyester 3.2 (0.75 mmol) 
in THF (1 mL) was added drop wise and the mixture was stirred at rt for 1.5 h. 
Then it was treated with pyridine (0.22 mmol) and triphosgene (0.48 mmol). The 
mixture was refluxed for 15 h. Then brine was added and extracted with Et2O 
(3×20 mL), the organic layers were washed (brine), dried (Na2SO4), and 
concentrated. The crude oil was purified through chromatography (silica-gel, 
hexanes/EtOAc (8:2) and (7:3)). 
 
syn-Methyl-5-isobutyl-2-oxo-4-((phenylthio)methyl)-1,3-dioxolane-4-
arboxylate 3.4 
 
1H NMR (500 MHz, CDCl3) δ 7.46 (2H, m), 7.25–7.33 (3H, m), 4.73 (1H, m), 3.81 
(3H, s), 3.58 (1H, d,J=15.0 Hz), 3.47 (1H, d, J=15.0 Hz), 1.77 (1H, m), 1.44 (1H, m), 
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1.35 (1H, m), 0.92 (3H, d, J=6.5 Hz), 0.84 (3H, d, J=6.5 Hz). 13C NMR (125 MHz, 
CDCl3) δ 167.7, 152.7, 134.7, 131.3, 129.3, 127.7, 86.6, 80.4, 53.2, 39.6, 38.6, 25.1, 
23.0, 21.2 ppm. IR (KBr) δ 3059, 2959, 1811, 1743, 1626, 1540, 1470, 1387, 1306, 
1200, 1116, 1025, 968, 746 cm−1. HRMS m/z calcd for C16H20O5SNa [M+Na+]: 
347.0929, found: 347.0929. 
 
anti-Methyl-5-isobutyl-2-oxo-4-((phenylthio)methyl)-1,3-dioxolane-4-
carboxylate 3.5 
 
1H NMR (500 MHz, CDCl3) δ 7.46 (2H, m), 7.25–7.33 (3H, m), 4.76 (1H, m), 3.70 
(3H, s), 3.42 (2H, s), 1.71 (1H, m), 1.49 (1H, m), 1.47 (1H, m), 0.98 (3H, 
d, J=6.5 Hz), 0.95 (3H, d, J=6.5 Hz). 13C NMR (125 MHz, CDCl3) δ 168.6, 152.2, 
134.4, 131.9, 129.2, 127.8, 85.6, 80.4, 53.4, 37.9, 37.5, 24.9, 23.2, 21.2 ppm. IR 
(KBr) δ 3059, 2959, 1806, 1749, 1582, 1439, 1360, 1257, 1132, 1048, 963, 744 cm−1. 
 
syn-Methyl-5-cyclohexyl-2-oxo-4-((phenylthio)methyl)-1,3-dioxolane-4-
carboxylate 3.6 
 
1H NMR (500 MHz, CDCl3) δ 7.39 (2H, m), 7.25–7.17 (3H, m), 4.37 (1H, m), 3.73 
(3H, s), 3.57 (1H, d,J=15.0 Hz), 3.35 (1H, d, J=15.0 Hz), 1.80 (1H, m), 1.40–1.77 
(5H, m), 1.24–0.79 (5H, m). 13C NMR (125 MHz, CDCl3) δ 168.9, 152.4, 134.8, 
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131.9, 129.2, 127.8, 86.0, 85.7, 53.5, 37.7, 37.3, 29.5, 28.1, 25.7, 25.4, 25.1 ppm. IR 
(KBr) δ 3060, 2929, 2857, 1741, 1582, 1402, 1195, 1024, 927, 845, 713, 629 cm−1. 
HRMS m/z calcd for C18H22O5SNa [M+Na+]: 373.1086, found: 373.1089. 
 
anti-Methyl-5-cyclohexyl-2-oxo-4-((phenylthio)methyl)-1,3-dioxolane-4-
carboxylate 3.7 
 
1H NMR (500 MHz, CDCl3) δ 7.47 (2H, m), 7.24–7.33 (3H, m), 4.43 (1H, m), 3.76 
(3H, s), 3.56 (1H, d,J=15.0 Hz), 3.48 (1H, d, J=15.0 Hz), 1.77 (1H, m), 1.68–1.76 
(5H, m), 1.10–1.25 (5H, m). 13C NMR (125 MHz, CDCl3) δ 167.9, 152.6, 134.7, 
131.7, 129.2, 127.7, 86.6, 85.8, 53.3, 40.8, 38.6, 28.6, 28.5, 25.7, 25.2, 25.0 ppm. IR 
(KBr) δ 2934, 2854, 1747, 1584, 1584, 1440, 1178, 1052, 930, 634 cm−1. 
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1.  Introduction 
 
1.1. Proteases 
 
Proteases are a big family of enzymes with proteolytic activity, catalyzing 
the hydrolysis of peptides bonds. Proteases are involved in numerous important 
physiological processes including protein turnover, digestion, blood coagulation 
and wound healing, fertilization, cell differentiation and growth, cell signaling, the 
immune response, and apoptosis. The loss of the control in this activity causes 
some diseases such as Alzheimer’s disease, stroke, cancer, emphysema, 
inflammation, viral infections and cataracts.  
 
For better understanding of subsequent parts of the chapter a scheme has 
been represented in scheme 1. 
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Scheme 1. General proteases scheme 
 
 
1.2. Cysteine proteases  
 
Cysteine proteases are a big group of proteases, all having a cysteine residue 
in the active site causing the proteolysis. General mechanism is depicted in scheme 
2. In the first step a deprotonation of the sulfhydryl group by histidine residue 
takes place, forming a dyad (other cysteine proteases form a triad with an extra 
amino acid). Next step involves a nucleophilic attack of the thiolate anion to the 
carbonyl carbon of the peptide bond. A tetrahedral intermediate is formed and 
oxyanion is stabilized by hydrogen bond forming backbones with other amides.  
Then, the acylation of the enzyme occurs releasing the amino group of the C-
terminal part of the peptide. A hydrolysis of the thioester leads to other tetrahedral 
Cysteine serine, threonine, aspartic, glutamic, asparagine, 
mixed, metallo-proteases and unknown
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intermediate, collapsing to release the acid group of the N-terminal part of the 
peptide, regenerating the free enzyme.  
 
 
 
Scheme 2. Cysteine protease general mechanism 
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1.2.1. Classification of cysteine proteases 
 
Cysteine proteases are classified into 14 clans members based on the 
catalytic site composition, mechanism and evolution. The most important family is 
the CA or papain like, so called for the isolation and characterization of papain 
from papaya (Carica papaya) in 1879. Papain was also the first cysteine protease 
structure to be solved.  
 
Figure 1. Papain structure 
 
On the other hand, cysteine proteases are present in other organisms such 
as in bacteria, fungi, protozoa (cruzain in Trypanosoma cruzi, rhodesain in 
Trypanosoma brucei, amoebopain in Entamoeba histolytica), plants and mammals 
(calpains and cathepsins). 
 
 
1.3. Human proteases 
Proteases can mainly develop the proteins degradation in two places of the 
cell, in cytoplasm/nuclear (pH aprox 7.4) called proteasome or in lysosomes (pH 4 - 
5.5) generally cathepsins families. 
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1.3.1. Proteasome: active site, process and diseases 
Proteasome recycles the unneeded or damage proteins, with previously 
mentioned proteases mechanism. The protein, to be degraded, must be tagged to 
small molecules called ubiquitin. Then the degradation process takes places in a 
hidden active site of a cylindrical core, illustrated in figure 2.  
 
 
Figure 2. Protein degradation process 
The proteasome components are referred to Svedberg sedimentation 
coefficient (S) being the most exclusively in mammals the 26S proteasome. This 
26S proteasome contains one 20S protein subunit and two 19S subunits. Figure 3 
shows the scheme of the described distribution and a real lateral and top view of 
the proteasome. 
20S is formed by four heptameric rings, with two different subunits α and 
β. The main catalytic activity is located in the β-subunits. In eukaryotic 
proteasomes, containing seven subunits and in the case of mammals only β1, β2 and 
β5 are catalytic (constitutive proteasome, in brain).  On the other hand, the altered 
proteasome (immunoproteasome, in spleen) with more active sites are described by 
β1i, β2i and β5i. 
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Figure 3. Proteasome components 
The degradation involved several proteases, depending of the type of the 
cell, the nature of the process, the place or the unit and other factors but the most 
important residue is threonine.  
The most common diseases related with the non-natural function of these 
proteasomic enzymes are related to cardiac dysfunctions, cataracts formation, 
neurodegenerative disorders (Parkinson, Alzheimer, Huttington…), viral 
infections (HIV…), autoimmune diseases and cancer.   
 
1.3.2. Human cathepsins  
In the lysosomal system, the degradation of proteins is normally carried out 
by a combination of several proteases, amylases, lipases and nucleases. The most 
important known proteases are aspartic, serine and cysteine protease. Cysteine 
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cathepsins are essential in most lysosomal proteases and these cathepsins belong to 
the papain family of cysteine proteases. 
Most of cathepsins are from lysosomal cysteine proteases (B, C, F, H, K, L, 
O, S, V, X and W) and the rest are from aspartic proteases (D and E) or serine (A 
and G).  
Disorder or abnormal function, figure 4, of these cathepsins 
(overexpression or modified activity) caused several diseases in the organism as 
atherosclerosis, cancer and metastasis, metabolic syndrome, obesity and type II 
diabetes, Lung diseases, immune defects, rheumatoid arthritis, osteoarthritis. 
 
Figure 4. Cellular location of cathepsins  
 
1.4. Parasitic diseases 
The presence of these proteases in viruses and other organisms denotes the 
importance of these enzymes in the cycle life of the some parasites. For this reason 
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the study of these enzymes and their inhibition could be a good strategy to 
compete and to cure the diseases provoked. 
 
1.4.1. American trypanosomiasis (Chagas’ disease) 
Chagas’ disease is caused by the protozoan parasite Trypanosoma cruzi (T. 
cruzi). It is located in Latin American in areas from 21 countries. According to the 
last WHO study in 2014, is calculated over 7-8 million people are infected. 
T. cruzi parasites are mainly transmitted by contact with the faeces of 
infected blood-sucking triatomine bugs. These bugs, vectors that carry the 
parasites, typically live in the cracks of poorly-constructed homes in rural or 
suburban areas. Normally they are hidden during the day and become active at 
night, when they feed on human blood. They usually bite an exposed area of skin 
such as the face, and the bug defecates close to the bite. The parasites enter into 
the body when the person instinctively scrubs the bug faeces into the bite, the 
eyes, the mouth, or into any skin break. 
Vector Parasite 
 
 
Triatominae 
 
 
 
Trypanosoma cruzi 
 
Figure 5. Vector and parasite for Chagas’ disease 
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Chagas’ disease can be treated with Benznidazole and also Nifurtimox. Both 
medicines are almost 100 % effective in curing the disease if given soon after 
infection at the onset of the acute phase. However, the efficacy of both diminishes 
the longer a person has been infected. Treatment is also indicated for those in 
whom the infection has been reactivated (for example due to immunosuppression), 
for infants with congenital infection and for patients during the early chronic 
phase. To the infected adults, especially those with no symptoms should be offered 
the treatment. The potential benefits of medication in preventing or delaying the 
development of Chagas’ disease should be weighed against the long duration of 
treatment (up to 2 months) and possible adverse reactions (occurring in up to 40 % 
of treated patients). 
The structure of Benznidazole and Nifurtimox is shown in figure 6. They 
should not be taken by pregnant women or by people with kidney or liver failure. 
Nifurtimox is also contraindicated for people with a background of neurological or 
psychiatric disorders. 
              
Figure 6. Structure of Chagas’ disease pharmaceuticals  
 
1.4.2. African trypanosomiasis (sleeping sickness) 
Sleeping sickness is a vector-borne parasitic disease. It is caused by 
infection with protozoan parasites belonging to the genus Trypanosoma 
(Trypanosoma brucei gambiense is found in 24 countries in west and central Africa 
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and Trypanosoma brucei rhodesiense is found in 13 countries eastern and southern 
Africa). They are transmitted to humans by tse-tse fly (Glossina genus) which have 
acquired their infection from human beings or from animals harbouring the 
human pathogenic parasites. 
Tse-tse flies are found just in sub-Saharan Africa though only certain 
species transmit the disease. For reasons that are so far unexplained, there are 
many regions where tse-tse flies are found, but sleeping sickness is not. Rural 
populations living in regions where transmission occurs and which depend on 
agriculture, fishing, animal husbandry or hunting are the most exposed to the 
tsetse fly and therefore to the disease. The disease develops in areas ranging from a 
single village to an entire region. Within an infected area, the intensity of the 
disease can vary from one village to the next. 
Vector Parasite 
 
 
Tse-tse fly 
 
 
 
Trypanosoma 
  
Figure 7. Vector and parasite for sleeping sickness 
The type of treatment depends on the stage of the disease. The drugs used 
in the first stage of the disease are of lower toxicity and easier to administer. The 
earlier the disease is identified, the better the prospect of a cure. In the first stage 
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Pentamidine and Suramin are used, and in the second stage Melarsoprol, 
Eflornithine and a combination treatment of Nifurtimox and Eflornithine were 
usually used, illustrated in figure 8. 
 
 
Figure 8. Structure of sleeping sickness pharmaceuticals  
 
1.4.3. Malaria 
Malaria is a mosquito-borne infectious disease; the disease is transmitted by 
the bite of an infected female Anopheles mosquito. This bite introduces the 
parasites from the mosquito's saliva into a person's blood. Five species 
of Plasmodium can infect and be spread by humans. Most deaths are caused by 
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P. falciparum because P. vivax, P. ovale, and P. malariae generally cause a milder 
form of malaria. 
 
 
Vector Parasite 
 
 
Anopheles stephensi 
 
 
Plasmodium falciparum 
  
 Figure 9. Vector and parasite for malaria 
 
Globally, an estimated 3.2 billion people are at risk of being infected with 
malaria and developing disease, and 1.2 billion are at high risk. According to the 
latest estimates for WHO in 2014, 198 million cases of malaria occurred globally in 
2013 (uncertainty range 124–283 million) and the disease led to 584000 deaths 
(uncertainty range 367000–755000). The burden is heaviest in the WHO African 
Region, where an estimated 90% of all malaria deaths occur, and in children aged 
less than 5 years, who account for 78 % of all deaths. Several campaigns have been 
made for many years for these diseases do not been neglected.  
Design, synthesis and evaluation of new inhibitors of cysteine proteases and proteasome  
 
145 
  
 Figure 10. Neglected diseases campaigns 
 
There are a number of drugs that can help prevent malaria such as 
Chloroquine and Mefloquine, but cause side effects and there is not one that 
assures the total protection. 
 
 Figure 11. Structure of malaria pharmaceuticals 
 
1.5.  Cysteine protease inhibitors 
 
An inhibitor is a compound that decreases the activity of an enzyme. As 
previously demonstrated, cysteine proteases are important therapeutic targets in a 
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large number of diseases; a strategy to remove or decrease the effect of these 
diseases is based on the design and synthesis of new cysteine proteases inhibitors.  
 
Depending of the nature of the bonding of inhibitor to enzyme in the 
active site, the inhibition could be reversible or irreversible. In the inhibitors 
designed in this thesis we focused in the interaction of the inhibitor and the thiol 
of the cysteine 25 of the active site represented in figure 12. 
 
 
  
Figure 12: Representative active site of cysteine protease 
 
 
1.6. Classification of cysteine protease inhibitors 
Completing the previous classification based on the kinetics (reversible or 
irreversible), further classifications can be done, represented in scheme 3. The 
non-active side directed inhibitors are commonly allosteric effectors, interacting in 
other place of the enzyme. The active side directed inhibitors, can be divided based 
on the covalent or non-covalent bonding. The non-covalent bounded are usually 
substrate analogues or transition state analogues (depending on the similarity to 
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the catalytic intermediates). The covalent bonding inhibitors are subdivided in 
transition state analogues (e.g. aldehydes), enzyme activated inhibitors 
(intermediate goes through a non-catalytic pathway e.g. esters or amides), dead 
end inhibitors (form irreversible enzyme-inhibitor complex e.g. nitriles) and 
affinity labels (the irreversible reaction forms permanent enzyme-inhibitor 
complex e.g. epoxide) 
     
 
Scheme 3. Inhibitor classification 
 
 
 
Active side-directed Non-active side-directed
Covalently bounded Non-Covalently boundedReversible or irreversible
Inhibitor binding
Substrate analogues Tight binding analoguesMechanism basedAffinity labels
Transition state analoguesTransition state analogues Enzyme activated
Dead end inhibitors
Epoxy, halo 
ketones
Aldehydes Esters and 
amides
Nitriles
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1.7. Types of inhibitors70 
 
A literature background of the types of inhibitors was done in order to 
design new compounds with high activity. The attention was focused on epoxides, 
halomethyl ketones, aziridines and Michael acceptors as the main inhibitors to be 
analyzed.  
 
1.7.1. Epoxides 
One of the first cysteine proteases inhibitors was E-64, figure 13, an 
irreversible compound isolated in 1978 from the funghi Aspergillius japonicus by 
Hanada.71  
 
 
                                                          
70 Based on: Powers, J. C.; Asgian, J. L.; Ekici, Ö. D.; James, K. E. Chem. Rev. 2002, 102, 4639–4750 
71 Hanada K, Tamai M, Yamagishi M, Ohmura S, Sawada J, Tanaka I. Agric. Biol. Chem 1978, 42, 523–528 
Design, synthesis and evaluation of new inhibitors of cysteine proteases and proteasome  
 
149 
 
Figure 13. E-64c structure and interactions in active site 
E-64 inhibits papain, ficin, bromelain, cathepsins B,72,73 cathepsins H,74 
cathepsins F,75 cathepsins K,76,77 cathepsins L,78,79 cathepsins O,80 cathepsins S,81 
cathepsins V,82 and cathepsins X,83 calpain,84,85 calpain II,86 cruzain,87 and their 
                                                          
72 Inaba, T.; Hirayama, Y.; Fujinaga, N. Agric. Biol. Chem. 1979, 43, 655 
73 Hashida, S.; Towatari, T.; Kominami, E.; Katunuma, N. J. Biochem. 1980, 88, 1805 
74 Barret, J.; Kembhavi,A.; Brown, M.; Kirschke, H.; Knight, C.; Tamai, M.; Hanada, K. Biochem.  J. 1982, 201, 189-
198 
75 Wang, B.; Shi, G. P.; Yao, P. M.; Li, Z.; Chapman, H. A.; Bromme, D. J. Biol. Chem. 1998, 273, 32000 
76 Bossard, M. J.; Tomaszek, T. A.; Thompson, S. K.; Amegadzie, B. Y.; Hanning, C. R.; Jones, C.; Kurdyla, J. T.; 
McNulty, D. E.; Drake, F. H.; Gowen, M.; Levy, M. A. J. Biol. Chem. 1996, 271, 12517 
77 Aibe, K.; Yazawa, H.; Abe, K.; Teramura, K.; Kumegawa, M.; Kawashima, H.; Honda, K. Biol. Pharm. Bull. 1996, 
19, 1026 
78 Towatari, T.; Tanaka, K.; Yoshikawa, D.; Katunuma, N. J. Biochem. 1978, 84, 659 
79 Katunuma, N.; Towatari, T.; Kominami, E.; Hashida, S.; Takio, K.; Titani, K. Acta Biol. Med. Ger. 1981, 40, 1419 
80 Santamaria, I.; Velasco, G.; Pendas, A. M.; Paz, A.; Lopez-Otin, C. J. Biol. Chem. 1999, 274, 13800 
81 Goursalin, B. J.; Lachance, P.; Bonneau, P. R.; Storer, A. C.; Kirschke, H.; Bro¨mme, D. Bioorganic Chem. 1994, 
22, 227 
82 Bro¨mme, D.; Li, Z.; Barnes, M.; Mehler, E. Biochemistry 1999, 38, 2377 
83 Therrien, C.; Lachance, P.; Sulea, T.; Purisima, E. O.; Qi, H. T.; Ziomek, E.; Alvarez-Hernandez, A.; Roush, W. 
R.; Menard, R. Biochemistry 2001, 40, 2702 
84 Sugita, H.; Ishiura, S.; Suzuki, K.; Imahori, K. J. Biochem. (Tokyo), 1980, 87, 339. 
85 Suzuki, K. J. Biochem. (Tokyo) 1983, 93, 1305 
86 Parkes, C.; Kembhavi, A. A.; Barrett, A. J. Biochem. J. 1985, 230, 509 
87 Roush, W. R.; Hernandez, A. A.; McKerrow, J. H.; Selzer, P. M.; Hansell, E.; Engel, J. C. Tetrahedron 2000, 56, 
9747 
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crystal structure in papain.88 Several research groups have synthetized modified 
analogs to increase the inhibition results. 
In our research group, we explored new dipeptidyl epoxide compounds as a 
new warheads based on previously reported epoxyketones.89 This new generation 
was called α,β-epoxyesters (figure 14) and they were very potent irreversible 
inhibitors of cysteine proteases, as it is shown in table 1 with E-64c.90 
 
 
 
Figure 14. Dipeptidyl epoxy-compounds 
Table 1: Inhibition result kinact/Ki (s-1M-1) 
Compound cruzain rhodesain cathepsin B 
INH 1 128.200 - - 
INH 2 330.000 - - 
INH 3 82.900 92.090 120 
INH 4 25.200 23.500 84.5 
E-64c 70600 - - 
                                                          
88 Varughese K, Ahmed F, Carey P, Hasnain S, Huber C, Storer A. Biochemistry 1970, 28, 1332–2 
89 Roush, W. R.; González, F. V.; Hanssell, E.; McKerrow, J. H. Bioorg. Med. Chem. Lett. 1998, 8, 2809-2812 
90 González, F. V.; Izquierdo, J.; Rodríguez, S.; McKerrow, J. H.; Hanssell, E. Bioorg. Med. Chem. Lett 2007, 6697-
6600 
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The first peptidyl α,β-epoxyketones described in the literature are the 
natural microbial products epoxomicin and eponemycin (figure 15).91,92  
 
Epoxomicin, an α,β-epoxyketone, is a natural microbial metabolite, which 
was first isolated from Actinomyces due to its in vivo antitumor activity against 
murine B16 melanoma tumors. Despite this potent activity, the mechanism of 
biological action has not been definitely elucidated. 
 
 
 
Figure 15. Epoxomicin and Eponemycin compounds 
 
 
Spaltenstein and co-workers, in search of a selective proteasome inhibitor, 
were the first to report in 1996 enzyme inhibitors that inhibited the proteasome. 
The tripeptide α,β-epoxyketone Cbz-Ile-Ile-Phe-(2R)-EP inhibits the 
chymotrypsin-like activity of the 20S proteasome at low nanomolar concentrations 
(IC50 = 5 nM).93 Shortly after the discovery of this new class of compounds that 
inhibited the proteasome, the search began to identify other inhibitors of the 
proteasome that incorporated the α,β-epoxyketones pharmacophore. This 
                                                          
91 Sugawara, K.; Hatori, M.; Nishiyama, Y.; Tomita, K.; Kamei, H.; Konishi, M.; Oki, T. J. Antibiot. 1990, 43, 8 
92 Hanada, M.; Sugawara, K.; Kaneta, K.; Toda, S.; Nishiyama, Y.; Tomita, K.; Yamamoto, H.; Konishi, M.; Oki, T. J. 
Antibiot. 1992, 45, 1746 
93 Spaltenstein, A.; Leban, J. J.; Huang, J. J.; Reinhardt, K. R.; Viveros, O. H.; Sigafoos, J.; Crouch, R. Tetrahedron 
Lett. 1996, 37, 1343-1346 
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inhibition results suggested that other α,β-epoxyketones, such as Epoxomicin and 
its derivatives, could target and inactivate the proteasome and could be used as 
molecular probes and therapeutic agents. 
A mechanism has been recently suggested for the inhibition of subunit 5 
of proteasome by epoxomycin,94 figure 16. 
 
 
Figure 16. Inhibition mechanism of Epoxomycin  
 
 
1.7.2. Halomethyl ketones 
As an extension of previous work in serine protease inhibitors, these halo 
methyl ketones (HMK) demonstrated to be one of the most interesting inhibitors. 
Since Rasnik95 and Shaw96 developed fluoromethyl ketones (FMK), several new 
                                                          
94 Groll, M.; Kim, K. B.; Kairies, N.; Huber, R.; Crews, C. M. J. Am. Chem. Soc. 2000, 122, 1237– 1238 
95 Rasnick, D. Anal. Biochem. 1985, 149, 461-465 
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inhibitors emerged with different leaving groups like chloromethyl ketones (CMK, 
figure 17) which are irreversible inhibitors. 
 
 
Figure 17. General structure of a CMK inhibitor 
Peptidyl halomethyl ketones also inhibit a variety of cysteine proteases 
such as papain, cathepsins B, H, and L, calpains, and caspases. 
 
1.7.3. Aziridines 
Aziridines contain a reactive aziridine-2,3-dicarboxylic acid or aziridine-2-
carboxylic acid moiety attached to a peptide or amino acid residue. Three types of 
aziridine inhibitors of cysteine proteases have been described97 according to the 
moieties surrounding the aziridine group, illustrated in figure 18. 
 
                                                                                                                                                         
96 Rauber, P.; Angliker, H.; Walker, B.; Shaw, E. Biochem. J. 1986, 239, 633 
97 Schirmeister, T. J. Med. Chem. 1999, 42, 560 
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Figure 18. Aziridine inhibitors types 
These compounds are irreversible inhibitors of the cysteine proteases 
papain, cathepsins B, L, and H. The proposed mechanism of inhibition of cysteine 
proteases by aziridines is similar to that proposed for epoxysuccinyl derivatives. 
However, it is known that aziridines inhibit most effectively at low pH values.98 
This increased inhibitory reactivity is due to the protonation of the aziridine 
nitrogen possibly by the active site histidine residue. The protonated aziridine can 
also interact with the oxyanion hole of cysteine proteases with energetically 
favorable hydrogen bonding.99 Although both the aziridine and the epoxysuccinyl 
may have similar chemical reactivities, differences exist between the two classes of 
inhibitors.  
Ready protonation of the nitrogen of type II aziridines is one difference 
between aziridines and their epoxysuccinyl analogues. A second difference is the 
hydrogenbonding abilities of the two classes of inhibitors. Aziridines are H-bond 
donors, whereas the epoxysuccinyl inhibitors are H-bond acceptors. These 
differences suggest that the two classes of inhibitors may have different binding 
                                                          
98 Martichonok, V.; Plouffe, C.; Storer, A. C.; Menard, R.; Jones, J. B. J. Med. Chem. 1995, 38,  3078 
99 Schirmeister, T. Biopolymers 1999, 51, 87 
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modes and possibly variable interactions with cysteine proteases. Last, unlike most 
epoxysuccinyl inhibitors, the R,R-configuration of the aziridine ring is preferred 
for inhibition in both types II and III aziridine inhibitors, whereas the type I 
aziridine inhibitors with the S,S-configuration are better inhibitors. 
A natural product, Miraziridine (figure 19) is an aziridinesuccinyl 
derivative isolated from the marine sponge Theonella mirabilis.100The IC50 value for 
cathepsin B is 1.4 g/mL and was the first reported vinyl arginine residue  
 
Figure 19. Structure of Miraziridine 
 
1.7.4. Michael acceptors inhibitors 
One of the first Michael acceptors described in the literature is the 
fumarate derivative of E-64c, figure 20. This inhibitor contains an α,β-unsaturated 
carboxyl moiety and was found to be an irreversible inhibitor of cathepsin B (kapp = 
625 M-1 s-1), cathepsin H (kapp = 11 M-1 s-1), and cathepsin L (kapp = 2272 M-1 s-1).101 
                                                          
100 Nakao, Y.; Fujita, M.; Warabi, K.; Matsunaga, S.; Fusetani, N. J. Am. Chem. Soc. 2000, 122, 10462 
101 Barrett, A. J.; Kembhavi, A. A.; Brown, M. A.; Kirschke, H.; Knight, C. G.; Tamai, M.; Hanada, K. Biochem. 
J. 1982, 201, 189-198 
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Figure 20. E-64c derivative 
Hanzlik and co-workers were the first group to design a series of amino 
acid derived Michael acceptor inhibitors for cysteine proteases. They showed that 
various vinyl sulfone and α,β-unsaturated carbonyl derivatives of phenylalanine 
are inhibitors of papain and dipeptidyl peptidase I (DPPI).102,103 Hanzlik and co-
workers then incorporated a range of Michael acceptor electrophiles into dipeptide 
analogues and studied their effects on papain.104The most reactive derivatives with 
papain were an unsaturated ester and a simple vinyl sulfone as figure 21 shows. 
 
Figure 21. Vinyl sulfone and α,β-unsaturated carbonyl compounds 
These vinyl sulfone cysteine protease inhibitors were later developed into a 
class of inhibitors for a variety of other cysteine proteases by Palmer and co-
workers. They designed potent inhibitors against disease-associated cysteine 
proteases, such as cathepsins B, L, S, and K (also called cathepsin O2), calpains, and 
cruzain.105 This class of irreversible inhibitors, which contain a double bond 
                                                          
102 Hanzlik, R. P.; Thompson, S. A. J. Med. Chem. 1984, 27, 711-712 
103 Thompson, S. A.; Andrews, P. R.; Hanzlik, R. P. J. Med. Chem. 1986, 29, 104-111 
104 Liu, S.; Hanzlik, R. P. J. Med. Chem. 1992, 35, 1067-1075 
105 Palmer, J. T.; Rasnick, D.; Klaus, J. L.; Brömme, D. J. Med. Chem. 1995, 38, 3193-3196 
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activated by an electron-withdrawing sulfone functional group, was subsequently 
shown also to inhibit the rhinovirus 3C protease and cathepsin V.106,107 
Peptidyl vinyl sulfones and other Michael acceptors are stable, unreactive 
toward nucleophiles, and need the catalytic machinery of the cysteine proteases 
for activation. Vinyl sulfones are less reactive toward nucleophiles than vinyl 
ketones or vinyl esters (summarized in table 2), which is an advantage for in vivo 
studies. In addition, vinyl sulfones can be manipulated on both the P and P´site of 
the molecule, allowing for greater selectivity and reactivity toward target enzymes 
(illustrated in figure 22). Thus, most of the Michael acceptors, which have been 
studied, are vinyl sulfones.  
Table 2: Inhibition of Papain 
by Ac-Phe-NH-CH2-CH=CH-R 
with different EWG 
R k2/Ki (M-1 s-1) 
COOCH3 26.1 
SO2CH3 18.7 
COOH 5.0 
CN 1.7 
CONH2 1.1 
PhNO2 - 
                                                          
106 Dragovich, P. S.; Webber, S. E.; Babine, R. E.; Fuhrman, S. A.; Patick, A. K.; Matthews, D. A.; Lee, C. A.; Reich, 
S. H.; Prins, T. J.; Marakovits, J. T.; Littlefield, E. S.; Zhou, R.; Tikhe, J.; Ford, C. E.; Wallace, M. B.; Meador, J. W., 
3rd; Ferre, R. A.; Brown, E. L.; Binford, S. L.; Harr, J. E.; DeLisle, D. M.; Worland, S. T. J. Med. Chem. 1998, 41, 
2806-2818 
107 Somoza, J. R.; Zhan, H.; Bowman, K. K.; Yu, L.; Mortara, K. D.; Palmer, J. T.; Clark, J. M.; McGrath, M. E. 
 Biochemistry 2000, 39, 12543-12551 
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Figure 22. Proposed vinyl sulfone inhibition mechanism 
 
Roush and co-workers have carried out extensive structure activity 
relationship (SAR) studies with vinyl sulfone inhibitors of cruzain to develop new 
therapies for Chagas' disease. Cruzain is the major cysteine protease of T. cruzi, the 
causative agent of Chagas' disease. Initially, Roush et al. expanded on Palmer's 
work with Mu-Phe-Hph-VS-Ph (kinact/Ki = 203000 M-1 s-1) and made a number of 
structural variants to design potent and selective inhibitors of cruzain.108 The 
crystal structure of cathepsin K with the vinyl sulfone APC3328 revealed that the 
phenyl residue of the vinyl sulfone unit did not make optimal interactions with 
prime site residues represented in figure 23.109  
 
                                                          
108
 Roush, W. R.; Gwaltney, S. L., II; Cheng, J.; Scheidt, K. A.; McKerrow, J. H.; Hansell, E. J. Am. Chem. 
Soc. 1998, 120, 10994-10995 
109 McGrath, M. E.; Klaus, J. L.; Barnes, M. G.; Brömme, D. Nat. Struct. Biol. 1997, 4, 105-109 
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Figure 23. Complex cathepsin K with APC3328 
 
Roush et al. synthesized vinyl sulfonamides and vinyl sulfonate esters to 
enhance the prime site interactions. These inhibitors have the structure Cbz-Phe-
Hph-VS-R, where R = Ph, CH2Ph, CH2CH2Ph, NHPh, and OPh, and were found to 
be time-dependent inhibitors of cruzain, papain, and cathepsin B. Vinyl 
sulfonamides are designated peptidyl-VS-NH-R, where R = alkyl or aryl, whereas 
vinyl sulfonate esters are designated peptidyl-VS-O-R, where R = aryl. Roush 
discovered the most potent cruzain inhibitor reported to date shown in figure 24, 
Cbz-Phe-Hph-VS-OPh (kassoc = 16800000 M-1 s-1), which has the preferred one-
atom oxygen spacer between the sulfonyl unit and phenyl ring.110  
 
Figure 24. Roush’ vinyl sulfonate inhibitor for cruzain 
                                                          
110 Roush, W. R.; Cheng, J.; Knapp-Reed, B.; Alvarez-Hernandez, A.; McKerrow, J. H.; Hansell, E.; Engel, J. 
C. Bioorg. Med. Chem. Lett. 2001, 11, 2759-2762 
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1.8. Activity based probe (ABP) and affinity based 
protein profiling (ABPP) 
 
Recently one of the most studied fields is the research of proteins especially 
in the active mode. Proteomics focus the attention in the study of these proteins 
and their interactions, functions… and finally the understanding of the function of 
one protein in a physiological process. ABP provides a direct chemical probe of the 
activity and mechanism in the active site of an enzyme only for catalytically-
activated species.  
A typical ABP are formed by 3 essential elements: First one is the reactive 
part, normally consist in a warhead that can form a covalent union with the target 
protein and an amino sequence to increase the affinity and specificity in the active 
site. Second one is the linker, which provides the necessary space between the 
reactive part and the tag, element used for identification or location. The last part 
is the tag allowing an easy and quick detection and simple purification. Normally 
an affinity tag (biotin) is used for isolation proteins and fluorescent tag (BODIPY) 
for quantification and monitoring, illustrated in figure 25. 
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Warhead Linker Tag 
Epoxides, phophonates, 
sulfonates, vinyl… 
Alkyl, peptide, glycol… Biotin, Bodipy, 
radioactive… 
 
Figure 25. General ABP structures 
Linker TagWarhead
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One of the most important tools in the proteomic studies is ABPP, an 
analytical technique which is useful in complex proteins. The identification of 
proteomes (normal and diseased state, in separately assays) with ABPP as 
biomarkers is a powerful application. It can be separated and identified the active 
enzymes after this ABPP incubation application by SDS-PAGE. A final 
identification using a mass spectrometry analysis allows identifying the interest 
enzymes. It is summarized in figure 26, the ABPP process of the diseased state and 
normal state (done in separate assays) in a same picture.  
 
Figure 26. ABPP application process 
This same methodology can be applied in cancer field to in vivo profiling 
cathepsins activity. The monitoring is due to BODIPY presence using ABPP in 
mice. A simple comparison of located signal in normal islets, in tumors and with 
the corresponding inhibitor can illustrated the decrement in the number of the 
tumor islets (figure 27).111 
                                                          
111 Joyce, J. A., Baruch, A., Chehade, K., Meyer-Morse, N., Giraudo, E., Tsai, F. Y., Greenbaum, D. C., Hager, J. H., 
Bogyo, M., Hanahan, D. Cancer Cell, 2004, 5, 443-453 
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Identification
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Figure 27. ABPP application on tumor cells 
Finally, according to the methodology used during this PhD, ABPP was 
used as a strong tool to carry out competitive assays between different small 
molecules as inhibitor to check as a routine procedure the inhibition capacity 
compared with a well-known inhibitor.  
Treatment of different new inhibitors with proteasome and subsequent 
ABPP protocol and SDS-PAGE, can contribute to rewarding information about the 
new inhibitors. New inhibitors should be easily evaluated (separately way), the 
more potent inhibitor the more decrease in the intensity in the gel analysis seen in 
figure 28. 
Cathepsin Z
Cathepsin B/L
Cathepsin C
Normal Tumor Tumor + 
inhibitor
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Figure 28. ABPP competitive assay 
It also works with a new inhibitor confirming the low level of 
concentration of inhibitor not detecting the enzyme activity.  This concentration 
(figure 29) could be compared with other literature inhibitors and extract 
interesting conclusions.   
 
Figure 29. ABPP assay for minimum concentration 
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2.  Synthesis and results 
The aim of this work is to develop new families of inhibitors against 
parasitic cysteine proteases and proteasome enzyme. Initially, in our group only 
developed cysteine proteases inhibitors for parasitic diseases, but since my research 
stay in the Prof. Dr. Overkleeft, theses new inhibitors families were tested against 
proteasome too.  
 New warheads could be designed and synthetized based on previously 
described inhibitors, then taking in account best amino acid sequence and making 
a new warhead a wide range of new inhibitors could be made. The general 
structure is represented in figure 30. 
 
 
Figure 30. General structure of designed new compounds 
War HeadRecognition 
Aminoacid sequence
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2.1. New nitro compounds as inhibitors 
 
The synthesis of this family of new inhibitors was based on the structure of 
already known dipeptidyl vinyl sulfones. It was presumed that the substitution of a 
sulfone by a nitro group could afford a new type of reversible inhibitors. Based on 
the mechanism since nitroalkanes are more acidics than imidazole (pKa in DMSO 
for nitroalkane= 17.2; sulfone= 29; imidazole= 23) the intermediate anion resulting 
from the Michael addition of enzyme thiolate to the double bond of nitroalkene 
would not be protonated by imidazolium Histidine. Reversely, sulfones are less 
acidic than imidazoles and vinyl sulfones inhibitors are irreversible inhibitors of 
cysteine proteases. 
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Figure 31. Comparison of nitro and sulfones inhibitors 
 
Also the synthetic versatility of nitroalkenes could lead to other type of 
inhibitors through epoxidation, cyclopropanation… (figure 32).           
 
Figure 32. Structure comparison of nitro and sulfone compounds 
 
This family of new inhibitors based on the presence of a nitro group is 
showed below in figure 33 and big ranges of transformation are based on other 
previously described inhibitors such as epoxides, aziridines or ciclopropanes. 
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Figure 33. Structure designed for new nitro compounds 
The retrosynthetic analysis for this nitrocompounds is represented in the 
next figure 34 affording the nitroalkenes and other modified nitrocyclopropanes. 
 
Figure 34. Retrosynthetic analysis for new nitro compounds 
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2.1.1. Dipeptidyl/tripeptidyl nitroalkenes 
 
The work started on the preparation of the nitroalkene moiety as the most 
similar with vinyl sulfones. According to previously retrosynthetic analysis, N-
protected amino aldehydes were obtained from commercially available amino acid 
with Weinreb methodology or by using diisobutyl aluminum hydride as illustrated 
in figure 35. 
 
 
Figure 35. Preparation of amino aldehyde precursor 
 
Aldehydes were submitted to a nitroaldol reaction (scheme 4) using an 
excess of nitromethane or nitroethane (usually 6 equivalents) in dichloromethane 
and a catalytic amount of triethylamine. Nitroaldols were obtained in excellent 
chemical yields as inseparable mixtures of two diastereoisomers (around 50/50 
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ratio) in the case of nitromethane or four diastereoisomers (about 25% de each 
diastereoisomer) in the case of nitroethane, summarized in table 3. 
 
Scheme 4. Nitroaldol reaction 
  
Table 3. Nitroaldol reaction results 
Entry R1 R2 Yield (%)a 
1 CH3 H 95 
2 i-Butyl H 90 
3 Bn H 85 
4 (CH2)2Ph H 93 
5 CH3 Me 88 
6 i-Butyl Me 77 
7 Bn Me 86 
8 (CH2)2Ph Me 87 
a Yield for the diastereoisomeric mixture 
 
The mixture of nitroaldols was submitted to amino deprotection conditions 
with trifluoroacetic acid in dichloromethane and subsequent amino coupling with 
the desired amino acid affording dipeptidyl nitro aldols as diastereoisomeric 
mixture in good chemical yields as can be seen in scheme 5,table 4. 
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Scheme 5. Deprotection and coupling reactions  
Table 4. Deprotection and coupling results 
Entry R1 R2 R3 Yield (%) 
1 CH3 H Bn 78 
2 CH3 H i-Butyl 86 
3 i-Butyl H Bn 85 
4 i-Butyl H i-Butyl 69 
5 Bn H Bn 74 
6 Bn H i-Butyl 71 
7 (CH2)2Ph H Bn 86 
8 (CH2)2Ph H i-Butyl 81 
9 CH3 Me Bn 71 
10 CH3 Me i-Butyl 73 
 
Finally these nitroaldols mixtures were treated with mesyl chloride in 
dichloromethane with triethylamine as a base affording the desired elimination 
product (scheme 6) in good yields as a single isomer for R2= H and as an E/Z 
mixture of compounds for R2= Me (table 5). 
 
Scheme 6. Elimination reaction  
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Table 5. Elimination results 
Product Entry R1 R2 R3 Yield (%) 
4.1 1 CH3 H Bn 93 
4.2 2 CH3 H i-Butyl 88 
4.3 3 i-Butyl H Bn 81 
4.4 4 i-Butyl H i-Butyl 74 
4.5 5 Bn H Bn 89 
4.6 6 Bn H i-Butyl 75 
4.7 7 (CH2)2Ph H Bn 92 
4.8 8 (CH2)2Ph H i-Butyl 82 
4.9 9 CH3 Me Bn 71 
4.10 10 CH3 Me i-Butyl 64 
 
For the preparation of α-methylated nitroalkenes (scheme 7), same 
reactions sequences were employed but elimination step needed longer time and 
more equivalents for reaction go to completion. 
 
 
Scheme 7. Elimination reaction of α-methylated nitroalkenes 
 
In vitro testing against cysteine proteases of prepared dipeptidyl 
nitroalkenes represented in figure36 are currently carried out.   
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Figure 36. Dipeptidyl nitroalkenes prepared 
Dipeptidyl nitroalkenes have been recently patented (EP14382307) and we 
expected be published in a medicinal chemistry journal in the next few months. 
 
On the other hand the structural analogy of nitroalkenes with vinyl 
sulfones can be seen in a docking study. It was compared the known K11777 vinyl 
sulfone (orange) with one nitroalkene 4.1(green) in the active site. It was 
illustrated in figure 37. 
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Figure 37. Docking study of nitroalkenes 4.1 
 
As it can be seen, the orientation of two amino sequences are the same, 
maximizing the interactions in the pockets and reducing the energy in both cases. 
In the warhead part, the double bond is in the same position and the orientation. 
Furthermore, two oxygens of the nitro group in exactly the same position as the 
two oxygens of the sulfone. 
 
A tripeptidyl nitroalkene inhibitor having three L-leucine aminoacids was 
also prepared. The preparation of this compound started from Boc-nitroaldol 
derived from leucine which was deprotected with trifluoroacetic acid  in 
dichloromethane and coupled with Boc-Leucine under standard conditions to give 
the desired dipeptidylnitroaldol,  (yield = 79%) scheme 8. 
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Scheme 8. Deprotection and coupling reactions 
 
Same sequence was applied to resulting modified dipeptide but using Cbz-
Leucine giving rise to corresponding tripeptidyl nitroaldol (yield = 69%), scheme 9. 
 
 
Scheme 9. Deprotection and coupling reactions 
 
Finally, the nitroaldol was submitted to elimination, scheme 10, by 
activation of alcohol group into mesylate which eliminates to afford the desired 
tripeptidyl nitroalkene 4.12 (yield = 67%). 
 
 
Scheme 10. Elimination reaction 
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2.1.2. Inhibition testing 
In vitro testing against cysteine proteases are currently carried out.   
Biological test in Hela cell lysate  
 
The standard protocol was carried out with 1h of incubation, 1h labelling 
of residual activity with LWA-300 (green bodipy-epoxomicin) and resolve on 12.5 
SDS-PAGE. The inhibition results are illustrated for inhibitor 4.12 in figure 38. 
 
 
 
 
 
Figure 38. SDS-PAGE for inhibitor 4.12 
 
As it can be seen in the figure, the inhibitor needs high concentrations to 
observe the inhibition effect on the intensity of the signal in all the targets. This 
concentration is too much high to consider compound 4.12 as a good inhibitor. On 
cinh (μM) 0 1 3 10 30 100 300 1000
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the other hand, the same intensity decrease in all targets suggests that inhibitor is 
not specific for any target. 
 
These results might be due to the expected reversibility of nitroakenes. 
Proteasome inhibitors needs to be irreversible as is the case for epoxomicin to 
achieve good inhibition results.  
 
 
 
2.1.3. Dipeptidyl nitro cyclopropanes 
Nitroaldol mixtures were submitted to elimination conditions, scheme 11, 
with mesylchloride in dichloromethane with triethylamine to obtain the 
corresponding nitroalkenes in excellent yields as it can be seen in table 6.  
 
 
Scheme 11. Elimination reaction 
Table 6. Elimination results 
Compound Entry R1 R2 Yield (%) 
4.13 1 CH3 H 95 
4.14 2 i-Butyl H 90 
4.15 3 Bn H 85 
4.16 4 (CH2)2Ph H 93 
4.17 5 CH3 Me 88 
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The obtained nitroalkenes were treated with sulfur ylide derived from 
trimethyl sulfoxonium iodine treated with sodium hydride or potassium terc-
butoxide in dimethylsulfoxide affording a 50/50 mixture of trans cyclopropanes as 
shown in table 7 and scheme 12. Simmons-Smith cyclopropanation conditions 
using diethyl zinc and diiodomethane in dichloromethane were not successful. 
 
Scheme 12. Cyclopropanation reaction 
 
Table 7. Cyclopropanation assay 
Entry R1 Base Yield (%) 
1 CH3 NaH 27.7 
2 i-Butyl t-BuOK 53.6 
3 Bn t-BuOK 34.8 
4 (CH2)2Ph t-BuOK 37.2 
 
After deprotecting Boc group with trifluoroacetic acid in dichloromethane, 
the resulting amine was coupled, scheme 13, with the desired Cbz-aminoacid with 
common coupling reagents (HOBT, EDC and DIPEA) in dichloromethane to form 
the dipeptidyl structure summarized in table 8. 
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Scheme 13. Deprotection and coupling reactions 
Table 8. Coupling results 
Compound Entry R1 R2 Yield (%) 
4.18 1 CH3 Bn 74 
4.19 3 i-Butyl Bn 81 
4.20 5 Bn Bn 71 
4.21 7 (CH2)2Ph Bn 79 
 
In vitro testing against cysteine proteases of prepared dipeptidyl 
nitrocyclopropanes are currently carried out and it will be publish. 
 
 
Figure 39. Dipeptidyl nitrocyclopropanes prepared 
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2.1.4. Nitroepoxides 
Once dipeptidyl nitroalkenes were prepared, then we planned about the 
synthesis dipeptidyl nitroepoxides starting from already obtained nitroalkenes. 
Some epoxidation conditions (n-BuLi/t-BOOH, m-CPBA, H2O2/NaOH) were 
unsuccessful but when α-substituted nitroalkene 4.17 was treated with hydrogen 
peroxide and sodium hydroxide in methanol at -78 oC for 1h, a 6/4 mixture of 
isomeric epoxides was obtained, represented in scheme 14. 
 
 
Scheme 14. Epoxidation reaction 
 
Unfortunately resulting epoxides could not be purified by standard 
chromatography. The exploitation of these nitroepoxides is currently undergoing 
in our research group. 
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2.2. Amidation trough carbamates 
 
As previously mentioned, dipeptidyl epoxiesters are potent cysteine 
proteases inhibitors synthesized in our group.112 In order to prepare several grams 
of these compounds for in vivo testing, an improvement of previous synthetic 
route was required. The new route considered an asymmetric nitroaldol reaction 
between epoxialdehyde and nitroalkane as described in the scheme 15. 
 
 
 
Scheme 15. New synthesis for dipeptidyl epoxyesteres 
                                                          
112 González, F. V.; Izquierdo, J.;  Rodriguez, S.; McKerrow, J. H.; Hansell, E. Bioorg. Med. Chem. Lett. 
2006, 17, 6697–6700 
Chapter 4 
 
182 
 
In order to prepare required epoxyaldehyde in an asymmetric fashion, our 
attention was focused on the asymmetric epoxidation of ethyl fumaraldehyde as 
previously reported.113 
 
 
For the preparation of diphenyl-L-prolinol, Corey conditions were 
followed.114 L-proline was N-protected as benzyl carbamate and then esterified as a 
methyl ester. Then resulting ester was treated with phenyl magnesium bromide, 
but unexpectedly prolinol 4.22 was obtained (scheme 16). 
 
 
Scheme 16. Synthesis of diphenyl-L-prolinol 
 
This result evoked us to study the reactivity of these carbamates due to 
carbamates and amides are widely used as protecting groups for amines.115 Some 
reports described the conversion of carbamates to amides,116,117,118 but a more 
convenient and general methods to accomplish this transformation was needed.   
                                                          
113 Sundén, H.; Ibrahem, I.; Córdova, A.; Tetrahedron Lett. 2006, 47, 99-103 
114 Corey, E. J.; Shibata, S.; Bakshi, R. K. J. Org. Chem. 1988, 53, 2861-2863 
115 Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 4th ed.; Wiley: New York, 2006 
116 Li, W.-R.; Yo, Y.-C.; Lin, Y.-S. Tetrahedron  2000, 56, 8867–8875 
117 White, J.D.; Blakemore, P. R.; Milicevic, S.; Choudhry, S. C.; Cupano, J.; Serico, L. Org. Lett. 2001, 4, 1803–
1806 
118 El Kaim, L.; Grimaud, L.; Lee, A.; Perroux, Y.; Tirla, C. Org. Lett. 2004, 6, 381–383 
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2.2.1. Results and discussion 
 
The idea was to set up a general and convenient procedure to transform 
carbamates of primary amines into a wide range of amides by treatment with 
available Grignard reagents. 
Several amines (benzylamine, allylamine and 3-phenylpropylamine) were 
protected as carbamates (methyl, benzyl and terc-butyl) trough reaction with the 
corresponding alkoxy carbonyl chloride in the presence of sodium hydroxide.3 The 
resulting carbamate was treated with a Grignard reagent for 24h in 
tetrahydrofuran giving in all cases amides, scheme 17, in high chemical yields as 
indicated in table 9. 
 
 
Scheme 17: General protected amines reaction  
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Table 9: Amides preparation 
Entry R1 R2 Grignard (R3MgX) Yield (%) 
1 Bn Bn MeMgBr 66 
2 Bn Bn EtMgBr 70 
3 Bn Bn PhMgBr 73 
4 Bn Bn t-BuMgCl 74 
5 Bn Ph(CH2)3 MeMgBr 77 
6 Bn Ph(CH2)3 EtMgBr 72 
7 Bn Ph(CH2)3 t-BuMgCl 89 
8 Bn Ph(CH2)3 i-PrMgCl 62 
9 Bn CH2=CHCH2 MeMgBr 43 
10 Bn CH2=CHCH2 EtMgBr 43 
11 Bn CH2=CHCH2 t-BuMgCl 69 
12 Bn CH2=CHCH2 i-PrMgCl 99 
13 Me Ph(CH2)3 MeMgBr 95 
14 Me Ph(CH2)3 EtMgBr 71 
15 Me Ph(CH2)3 t-BuMgCl 79 
16 Me Ph(CH2)3 i-PrMgCl 83 
17 t-Bu Ph(CH2)3 EtMgBr 85 
   
As shown in the table the methodology resulted to be versatile by 
combining three amines and five Grignard reagents. 
A one-pot procedure starting from amines was also optimized (scheme 18). 
The desired amine was treated with an alkoxy carbonyl chloride in the presence of 
triethylamine, after that the corresponding Grignard reagent was added and the 
amide was obtained in high chemical yield illustrated in table 10. 
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Scheme 18: One-pot conversion 
Table 10: One-pot procedure 
Entry R1 R2 R3 Yield (%) 
1 Ph(CH2)3 Me Et 87 
2 Ph(CH2)3 Bn Et 92 
3 Ph(CH2)3 Bn Me 66 
4 CH2=CHCH2 Bn Me 70 
5 CH2=CHCH2 Bn t-Bu 47 
6 CH2=CHCH2 Bn i-Pr 58 
7 CH2=CHCH2 Bn Et 36 
8 CH2=CHCH2 Me Et 41 
9 CH2=CHCH2 Me Me 83 
10 Ph(CH2)3 t-Bu Et 90 
 
When carbamates of secondary amines are used as a starting material 
instead of primary ones then corresponding ketone and secondary amine are 
obtained. It was conveniently reasoned an N,O-magnesium chelate intermediate is 
formed when primary amines are used (scheme 19). 
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Scheme 19: Mechanisms of the reactions 
In the case of N-protected-diphenyl-L-prolinol a chelate can also be 
formed due to the presence of tertiary alcohol (scheme 20), following the primary 
amines behavior across a chelate intermediate.  
 
 
Scheme 20: Chelation intermediate for N-protected-diphenyl-L-prolinol 
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2.2.2. Conclusion 
 
A new robust, versatile and cheap procedure was developed to transform 
carbamates into amides. Furthermore a one-pot procedure was optimized for the 
transformation of amines into amides using carbamates as intermediates. The wide 
range of amines and Grignard reagent showed the large number of products that 
could be obtained.  
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2.3. Epoxysulfones derived from amino acids as 
eletrophilic traps 
 
As mentioned before, epoxides are present in the structure of potent 
inhibitors of cysteine proteases such as E-64 and dipeptidyl epoxyesters. In the 
other hand, vinyl sulfones such as K11777 are also potent cysteine protease 
inhibitors. By combining both moieties, an epoxysulfone results as shown in 
scheme 21. 
 
 
Scheme 21. Design of new inhibitors 
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We planned to synthesize epoxysulfones as potential cysteine proteases 
inhibitors. The retrosynthetic route was designed considering two possible 
pathways; the Darzens route in scheme 22 or the vinyl sulfone epoxidation in 
scheme 23. 
 
Darzens route: 
 
 
Scheme 22. Darzens route 
 
Vinyl sulfone epoxidation: 
 
 
Scheme 23. Vinyl sulfone epoxidation route 
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2.3.1. Darzens route 
After a literature search, it was found that Darzens reactions to prepare 
epoxysulfones had been reported using aromatic aldehydes only.119 The reactions 
were performed using aromatic aldehydes, chloromethyl phenyl sulfone and a base 
(KOH, t-BuONa…). Usually the reaction product was the epoxysulfone, only if the 
reaction is performed at -78 oC halohydrins can be isolated. 
 
Scheme 24. Reported Darzens conditions 
The work was started by applying these previous reported conditions using 
carbobenzyloxy alaninal (1 equivalent) and commercially available 
bromomethylphenylsulfone (1 equivalent) as starting materials in the presence of a 
base (1 equivalent), shown in scheme 25. A range of bases and conditions were 
assayed in order to find optimal conditions are summarized in table 11.  
 
Scheme 25. Reported Darzens conditions 
                                                          
119 Voght, P.; Tavares, D. Can. J. Chem. 1969, 47, 2875-2881 
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Table 11. First Darzens condition test 
Entry Base Conditions Result 
1 NaOH / TBABr DCM/r.t. SM 
2 t-BuONa t-BuOH/Et2O/r.t. SM 
3 LDA (0.7eq) THF/-78oC SM 
4 LDA (1eq) THF/-78oC SM 
SM = starting material recovered 
In all cases starting material was recovered as indicated in the table 11. 
Then it was reasoned that the NH group might be consuming base and the reaction 
did not work. For this reason it was decided to diprotect the amine group as a 
dibenzyl amine (scheme 26). Diprotection and esterification of alanine was carried 
out using an excess of benzyl bromide and potassium carbonate in 
dimethylformamide.  A reduction of ester to a primary alcohol was carried out 
using lithiumaluminum hydride in tetrahydrofuran and a final Swern oxidation 
was done to afford to the desired diprotected aminoaldehyde. 
 
 
Scheme 26. Preparation of N,N-protected aldehyde 
Over this diprotected aldehyde several Darzens conditions were tested 
(scheme 27). Using kinetic bases (LDA and n-BuLi), four bromohydrins were 
detected in low yields (<20%) in about 25% for each diastereoisomer. Other bases 
as potassium hydroxide and sodium terc-butoxide did not afford to the desired 
epoxide, as it is shown in table 12. 
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Scheme 27. Darzens of diprotected aldehyde 
Table 12. Darzens condition using diprotected alaninal 
Entry Base (1eq) Conditions Result 
1 LDA THF / -78oC to r.t. bromohydrins 
2 KOH / TBABr Tol / r.t. SM 
3 t-BuONa t-BuOH / Et2O / r.t. SM 
4 n-BuLi THF / -78oC to r.t. bromohydrins 
SM = starting material recovered 
 Although epoxides were not isolated, they were detected by NMR and then 
it was decided to isolate the halohydrins which could be used as intermediates to 
be further converted into desired epoxides. 
It was decided to assay the reaction using chloromethyl phenyl sulfone 
instead of bromomethyl phenyl sulfone. Chloromethyl phenyl sulfone was 
prepared in 92% yield from commercially available thioanisol with sulfuryl 
chloride in a first step and subsequent oxidation to sulfone with Oxone represented 
in scheme 28.120 
 
Scheme 28. Preparation of chloromethyl phenyl sulfone 
                                                          
120 Trost, B. M.; Grese, T. A. J. Org. Chem. 1991, 56, 3189-3192  
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Darzens reactions were performed using carbobenzyloxy alaninal, 
chloromethyl phenyl sulfone and n-butyl lithium as a base, as shown in scheme 29. 
When one equivalent of base and chloromethyl phenyl sulfone were used starting 
material was recovered, then some reactions were performed with increasing 
number of equivalents of these two reagents. A satisfactory result was observed 
(entry 4) when 2.5 equivalents of chloromethyl phenyl sulfone and 2.5 equivalents 
of n-butyl lithium were added affording chlorohydrins in a 75 % chemical yield as 
a mixture of 4 diastereoisomers (about 30/26/23/21).  
 
Scheme 29. Preparation of chloromethyl phenyl sulfone 
 
Table 13. Darzens condition using Cbz- alaninal 
Entry Base eq Sulfone eq Yield (%) 
1 1 1 0 
2 1.5 1.5 <15 
3 2 2 65 
4 2.5 2.5 75 
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The reaction crude was purified by chromatography, affording 
chlorohydrins as inseparable mixtures. The mixture of chlorohydrins was 
submitted to epoxidation conditions with different bases and solvents to obtain the 
epoxides, represented in scheme 30. 
 
Scheme 30. Preparation of epoxides 
 
Table 14. Epoxidation of chlorohydrins 
Entry Basea Solvent Conditions Result 
1 K2CO3 MeOH 30 min / 0oC epoxides 
2 NaH THF 30 min / 0oC retroDarzens 
3 t-BuONa THF 30 min / 0oC retroDarzens 
a 1 equivalent 
 
As can be observed in the table 14, potassium carbonate in methanol (entry 
1) afforded the epoxides as 1H-NMR and MS denoted but they could not be isolated 
by chromatography. When other bases were used (entries 2-3), retroDarzens 
mechanism took place, explained in scheme 31. 
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Scheme 31. RetroDarzens mechanism  
The obtained epoxysulfones were used in the next step as a crude mixture 
to prepare desired dipeptidyl epoxysulfones. The deprotection of the amine and 
peptide coupling is shown in scheme 32. Deprotection of carbamate was assayed by 
hydrogenation reaction using palladium over charcoal as a catalyst under hydrogen 
atmosphere. After an extensive experimental work, no hydrogenation reaction 
assay afforded desired amine. Analysis of the reaction crude by NMR and MS 
denoted a complex reaction mixture of compounds. It was then decided to change 
the amine protecting group. 
 
Scheme 32. Deprotection and coupling steps. 
 
Due to the difficult to work with complex mixtures of chlorohydrins, the 
reaction crude without purification and the difficult to remove de protecting group 
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with the presence of the epoxide, it was decided to change to Boc group and try to 
isolate the chlorohydrins of Darzens reaction and study their configuration. 
tert-Butoxycarbonyl alaninal was prepared by reduction of the ester or the 
Weinreb amide. Aldehyde was purified by chromatography before submitting it to 
Darzens reaction. This resulted to be critical in order to get a clean reaction 
mixture from the Darzens reaction, scheme 33. An extensive experimental work 
was performed to optimize Darzens reaction. Several Darzens conditions were 
tested and different results were obtained. A mixture of four chlorohydrins was 
obtained in all cases. Chromatographic separation of four isomeric chlorohydrins 
resulted to be a difficult task in some cases.  
 
 
  
Scheme 33. Darzens reaction using Boc-alaninal 
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Table 15. Darzens results 
Entry Basea Conditions Proportionc Yield (%) 
1 n-BuLi THF, -78oC, 30min 33:27:24:16 75 
2 n-BuLi THF, -78oC, 5h 35:26:25:14 77 
3 n-BuLi THF, -90oC, 2h 33:24:24:19 71 
4 n-BuLi THF/DMF, -78oC, 30min 27:15:46:12 66 
5 LDA THF, -78oC, 30min 36:29:21:13 70 
6 t-BuOK THF, 0oC, 30min degradation - 
7 t-BuOK THF, -78oC, 30min 17:8:42:33 55 
8 KHMDS THF, -78oC, 30min 40:13:29:17 63 
9 LiHMDS THF, -78oC, 30min 35:25:25:15 67 
10 t-BuOK DMF, -78oC, 30min Epoxidesb (1/1.7) 45 
a 2.5 eq and 2.5 eq of chloromethyl phenyl sulfone 
b cis (4.29 + 4.30) /trans ( 4.27 + 4.28) 
c of chlorohydrins (4.23 : 4.24 : 4.25 : 4.26) 
 
Previous assays demonstrated that the reaction does not work if using less 
than 2 equivalents of base and 2 equivalents of sulfone. A satisfactory chemical 
yield was obtained when 2.5 equivalents of n-butyl lithium and 2.5 equivalents of 
chloromethyl sulfone were used affording a 33:27:24:16 mixture of chlorohydrins 
(entry 1). In this case the reaction was done in 30 minutes, tetrahydrofuran was 
used as a solvent and the temperature was -78 oC. 
When reaction time and temperature were changed (entries 2-3) no 
improvement was observed. Other kinetic bases (LDA, KHMDS or LiHMDS) did 
not modify the standard result (entries 5, 8 and 9). On the other hand when 
dimethylformamide was used as a co-solvent (entry 4) syn chlorohydrins were 
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isolated as major products reversely to the result obtained when using 
tetrahydrofuran as a single solvent of the reaction. 
When sodium tert-butoxide was used as a base (entry 7), the syn / anti ratio 
of chlorohydrins changed dramatically (17:8:42:33) compared to kinetic lithium 
bases. If the reaction is carried out using sodium tert-butoxide at room temperature 
(entry 6) a complex mixture of unidentifiable products was observed for 
degradation trough the epoxide. Finally when using sodium tert-butoxide in 
dimethylformamide at 0 oC, a 1.7/1 mixture of cis (4.29 + 4.30)/trans ( 4.27 + 
4.28)was observed (entry 10). 
  
2.3.1.1. Epoxidation  
The epoxidation reaction was the next step, represented in scheme 34. The 
first assays for the conversion of chlorohydrins into epoxides were carried out 
using chlorohydrin 4.23. These conditions are summarized in next table 16. In all 
cases the reaction was performed using one equivalent of the base since it was 
observed some degradation of the reaction mixture when using more than one 
equivalent. 
 
Scheme 34. Epoxidation of chlorohydrin 4.23 
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Table 16. General epoxidation conditions 
Entry Base Conditions Observations 
1 NaH THF, 0oC, 30min retro + 4.25 
2 NaOH DCM, 0oC, 30min degradation 
3 Et3N DCM, 0oC, 30min 4.23 
4 K2CO3 MeOH, 0oC, 1h 4.27 + 4.23 
5 K2CO3 THF, 0oC, 1h 4.27 + 4.25 
6 K2CO3 DMF, 0oC, 1h 4.27 + retro 
7 t-BuOK THF, 0oC, 1h 4.27 + retro 
8 t-BuONa DCM, 0oC, 30h 4.27 
retro = retoDarzens identified by presence of aldehyde and chloromethyl sulfone 
 
If triethylamine is used (entry 3) then starting material 4.23 was recovered. 
When sodium hydroxide (entry 2) was used then degradation was observed 
(aldehyde and and other byproducts), similar result was observed when potassium 
or lithium hydroxide were used.  
If the reaction is carried out using sodium hydride then aldehyde, 
chloromethyl sulfone and chlorohydrin 4.25 were obtained, denoting retroDarzens 
and epimerization pathways. When potassium carbonate was used in methanol 
desired epoxide 4.27 was detected by NMR as a minor product although the main 
compound present in the reaction mixture was starting material 4.23. Increasing 
reaction time and equivalents did not increase the conversion. Potassium carbonate 
in tetrahydrofuran gave rise to desired epoxide as a minor product and 
chlorohydrin 4.25 (entry 5). Dimethylformamide as a solvent gave rise to 
retroDarzens products and epoxide in a little amount (entry 6). Potassium tert-
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butoxide in tetrahydrofuran afforded a significant amount of epoxide but the 
retroDarzens products were the main reaction products (entry 7). 
Finally, sodium tert-butoxide in dichloromethane cold with an ice-bath 
afforded the desired epoxysulfone 4.27 as the single reaction product (entry 8). 
According to the coupling constants it was a trans epoxide (J = 1.4 Hz), confirming 
the anti-configuration of starting chlorohydrin 4.23.  
Same experimental conditions were applied to the other three 
chlorohydrins.  Chlorohydrin 4.24 afforded trans-epoxide 4.28 as a single reaction 
product and chlorohydrins 4.25 and 4.26 afforded desired cis-epoxides 4.29 and 
4.30 respectively, but also other byproducts were observed in the NMR of the 
crude mixture. Then for the preparation of cis-epoxides, initial reaction conditions 
were slightly changed by adding tert-butanol as a co-solvent. All transformations 
are summarized in scheme 35.  
 
Scheme 35. Epoxides preparation 
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  cis-Epoxides resulted to be quite unstable compounds (degradation was 
starting to be observed after a few hours standing on the bench). trans-Epoxides 
are less unstable than cis isomers (degradation is observed after a few days).  
 
2.3.1.2. Stereochemistry confirmation 
The stereochemistry of the chlorohydrins at the hydroxylated stereocenter 
was assigned by conversion into corresponding oxazolidinone after amine 
deprotection. In the other hand, configuration of the chlorinated stereocenter was 
assigned from the stereochemistry of the epoxide to be cis or trans (scheme 36).  
 
 
Scheme 36. Assignment chlorohydrin 4.23 
 
When chlorohydrin 4.23 was deprotected using trifluoroacetic acid and the 
resulting ammonium salt was directly submitted to reaction with triphosgene 
without any purification then undesired trifluoroacetamide was obtained. If 
ammonium salt resulting from deprotection was treated with triethylamine 
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previous to reaction with triphosgene, then a 1/1 mixture of E/Z chlorovinyl 
sulfones as trifluoroacetamides were obtained. Then it was decided to obtain the 
oxazolidinone without Boc deprotection. The chlorohydrin was directly treated 
with triphosgene, but starting material was recovered. On the other hand, when 
the N-protected chlorohydrin is treated with triethylamine and triphosgene then 
corresponding chlorovinyl sulfone 4.36 are formed. 
 
Scheme 38. Transformations during preparation of 4.32 
Finally it was decided to carry out an aqueous work up by extracting the 
amine resulting from Boc deprotection step with a phosphate buffer at pH 9. The 
resulting neutral amine was submitted to cyclization with triphosgene affording 
the desired oxazolidinone 4.32 and the structure can by assigned by NOE shown in 
scheme 39 and scheme 40.  
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 Scheme 39. Transformations for chlorohydrin 4.23 
 
 
Scheme 40. NOE for oxazolidinone 4.32 
Stereochemistry of other three oxazolidinones from corresponding 
chlorohydrins was also assigned by NOE and summarized in scheme 41. 
CH3H-5
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Scheme 41. NOE for oxazolidinones 4.33-4.35 
The conversion of chlorohydrin 4.23 into chlorohydrin 4.25 would result 
from epimerization of chlorinated stereocenter. In the same way chlorohydrin 4.24 
is converted to chlorohydrin 4.26 through epimerization under basic conditions, 
shown in scheme 42, it afforded to a useful information about stereochemical 
relationship of chlorohydrins. 
 
 
Scheme 42. Epimerization transformations for chlorohydrins 4.23-4.24 
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Some similarities are observed in the 1H-NMR spectra of the anti-
chlorohydrins 4.23 and 4.24, and it also happens between syn-compounds 4.25 and 
4.26.  The CH-CH3 signal in the anti-isomers is located around 4.15 ppm and in the 
case of syn-isomers appears at 3.85 ppm. The CH-OH signal for the anti-isomers is 
between 3.95 ppm - 4.25 ppm and for the syn-isomers is between 4.40 ppm - 4.55 
ppm. Also for the coupling constants between CH-Cl and CH-OH some similarities 
are observed: for the anti-isomers 4.23 and 4.24 is 9.0 and 9.6 Hz, respectively; and 
for the syn-isomers 4.25 and 4.26 are 0 Hz for both cases. 
 
 
Scheme 43. NMR similarities for chlorohydrins 4.23-4.26 
Once the preparation of the epoxysulfones derived from L-alanine was 
accomplished then their conversion into a modified dipeptide inhibitor was 
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assayed. All the deprotection assays were not successful. This transformation are 
currently undergoing in our group. 
 
 
Scheme 44. Transformation to dipeptide structure 
 
2.3.2. Vinyl sulfone epoxidation route 
 
On the other hand, the preparation of epoxysulfones through epoxidation 
of vinylsulfones was also studied. It had been reported121 that when carrying out a 
nucleophilic epoxidation over a vinyl sulfone then allyl sulfones are formed (t-
BuOOH/n-BuLi). Some new reaction conditions were studied to carry out the 
desired epoxidation without the isomerization into allyl sulfones. 
 
 
 
Scheme 45. Isomerization of vinyl to allyl sulfones 
 
The reaction, scheme 46, was carried out with different bases and using 
different oxidants as summarized in table 36. 
 
                                                          
121 Götz, M.G.; Caffrey, C.R.; Hansell E.; McKerrow J.H.; Powers, J.C. Bioorg. Med .Chem. 2004, 12, 5203–5211 
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Scheme 46. Epoxidation of vinyl sulfone 
Table 17. Epoxidation reaction 
Entry Oxidant Base Conditions Results 
1 m-CPBA - DCM, r.t., 2days 4.37 
2 t-BuOOH Triton B MeOH, 0oC, 2h 4.37 
3 t-BuOOH NaOH MeOH, 0oC, 1h 4.39a 
4 H2O2 NaOH MeOH, 0oC, 2h 4.38a 
5 Cum-OOH NaOH MeOH, 0oC, 1h 4.40a 
a about 1:1 mixture of isomers 
Peracid epoxidation did not work (entry 1). Same result was obtained when 
a combination of tert-butyl hydroperoxide and Triton B was used. But when a 
hydroperoxide (t-BuOOH, H2O2, Cum-OOH) and sodium hydroxide in methanol 
was used, a complete consumption of alkene was detected although the reaction 
product was the corresponding peroxyether 4.38-4.40 as a 1/1 mixture of non-
isolable isomers. 
Epoxysulfones can be obtained by treatment of the mixture of peroxides 
4.38-4.40 with sodium tert-butoxide in dichloromethane at 0 oC, affording the 
formation of the same four epoxides 4.27-4.30 prepared by the above explained 
Darzens reactions. 
The transformation of vinylsulfones into epoxysulfones could be 
accomplished in one-pot as illustrated in scheme 47. 
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Scheme 47. Epoxidation of vinyl sulfone in one-pot 
 
 
2.3.3. Chloroketone sulfones as inhibitors 
In order to transform chlorohydrins into other inhibitors besides 
epoxysulfones, oxidation of the hydroxyl group into the corresponding ketone was 
considered. It is known halomethylketones to be good inhibitors of cysteine 
protease122 so the presence of a sulfone could increase de activity (scheme 48). 
 
Scheme 48. Cysteine thiol attacks to chloroketones 
Chlorohydrin 4.23 was treated with meta-chloroperbenzoic acid in 
dichloromethane for 1h cold with an ice-bath. The reaction afforded a 1/1 mixture 
of isomeric sulfonyl chloroketones in high chemical yield (89%), as indicated in 
scheme 49. 
 
                                                          
122
 Rasnick, D. Anal. Biochem. 1985, 149, 461-465 
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Scheme 49. Preparation of chloroketones 4.41 from chlorohydrin 4.23 
 
Another synthetic pathway to the ketone 4.41 was explored through 
addition of chloromethylsulfone anion to methyl ester. The chlorosulfone was 
ionized using n-buthyl lithium at -78oC in tetrahydrofuran and after a few minutes 
ester was added in tetrahydrofuran. After stirring overnight at room temperature, 
chloroketones were obtained as 1/1 mixture of isomeric (chemical yield = 68%), 
illustrated in scheme 50. 
 
Scheme 50. Preparation of chloroketones 4.41 from ester 
 
 
2.3.4. Related compounds 
Chlorohydrin 4.23 derived from alanine has been also transformed into 
dipeptidyl chlorohydrin 4.42, in scheme 51. Chlorohydrin was deprotected with 
trifluoroacetic acid and coupled with carbobenzyloxy-L-fenilalanine to afford the 
desired product in good chemical yield (85%). 
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Scheme 51. Preparation of chloroketones 4.42  
 
Dipeptidyl compound 4.42 was oxidized with Dess-Martin periodinane to 
α-chloro β-keto sulfone 4.43 (chemical yield = 75%) as a 1/1 diastereoisomeric 
mixture represented in scheme 52. 
 
 
Scheme 52. Preparation of chloroketones 4.43 from ester 
 
Dipeptidyl chlorohydrin 4.42 it was submitted as last chance to obtain 
dipeptidyl epoxysulfones, applying same conditions used before, but only 
epimerization and retroDarzens compounds could be detected by NMR and MS 
spectra. 
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2.3.5. Inhibition testing 
These assays were carried out during my research stay at Leiden University 
under supervision of Prof. Dr. Herman S. Overkleeft and Dr. Bogdan I. Florea. 
Compounds 4.27 and 4.41 were investigated for their ability to inhibit 
cathepsins by using a competitive activity-based protein profiling (ABPP) assay 
against the known cysteine protease cathepsin activity-based probe DCG04-
BodipyFL.  Cathepsins from mouse liver lysates were treated with compounds 4.27 
and 4.41, and the residual cathepsin activity was captured by the DCG04-BodipyFL 
probe. After SDS-PAGE separation and in-gel fluorescence imaging, a typical band 
pattern was seen, which was compared with reported activity-based cathepsin 
profiling gels.  By comparison of the molecular weights of the individual bands 
seen, we have assigned the nature of the individual cathepsins labeled by DCG04-
BodipyFL. Competition for most of the bands was observed upon cotreatment with 
DCG04-BodipyFL, a result that underscores the annotation of the bands as being 
DCG04-BodipyFL sensitive cathepsins. Compound 4.27 is a more selective 
inhibitor than DCG04-BodipyFL, as it inhibits one to three cathepsins, while 
compound 4.41 inhibits four cathepsins at the 1 μM concentration used in this 
assay. Compounds 4.27 and 4.41 are able to outcompete the DCG04-BodipyFL 
inhibitor, and we can conclude that they bind in a covalent and irreversible 
fashion to the cathepsins, inhibiting their activity. 
 
Scheme 53. Structure of tested inhibitors 
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Scheme 54. ABPP for compounds 4.27 and 4.41 
 
These results demonstrate epoxysulfones and sulfonyl chloroketones to be 
promising electrophilic traps for cathepsins inhibitors. In both cases, they was good 
inhibitor a relative low concentrations. It could be increased modifying the amino 
acid structure to increase the affinity in the active site.  
On the other hand, an interesting selectivity in both cases with the 
different cathepsins should be mentioned. Cathepsins H, S and C was selectively 
inhibited in presence of cathepsins B and V, for this reason the development of this 
new traps are interesting.    
 
DCG     00.1        1       0.1       1
4.27 4.41
Cathepsins
μM
B
V
H
S
C
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2.4. Chlorovinyl sulfones as new inhibitors 
In the previously mentioned scheme 38, we isolate the chlorovinyl sulfone 
4.36 during the attempt to prepare the oxazolidinones.  We decided to take 
advantage of this result and prepare chlorovinyl sulfones as new inhibitors of 
cysteine proteases because they are very similar to the already known vinyl 
sulfones. 
 
 
Scheme 55. Vinyl sulfone and chlorovinyl sulfone inhibitors  
 
The retrosynthetic route was based on the chlorohydrins as previously 
explained for Darzens methodology, scheme 56. 
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Scheme 56. Retrosynthesis  of chlorovinyl sulfones 
 
The synthesis started with a mixture chlorohydrin derived from leucine 
and alanine. It were submitted to a elimination using mesyl chloride and a catalytic 
amount of triethylamine in dichloromethane at 0oC for 2h (scheme 54), isolating 
by column as about 1/1 (E/Z) isomers in excellent yields 4.46 (45%), 4.47 (41%), 
4.48 (37%) and 4.49 (32%). 
 
Scheme 57. Preparation of chlorovinyl sulfones 
 
A deprotection of Boc group with trifluoroacetic acid in dichloromethane 
and a coupling with desired amino acid in dichloromethane for overnight afforded 
to the desired dipeptidyl compound 4.50 (81%) and 4.51 (85%) in scheme 58 or 
tripeptidyl compound 4.52 (72%) and 4.53 (65%) in scheme 59. 
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Scheme 58. Preparation of dipeptidyl chlorovinyl sulfones 
 
Scheme 59. Preparation of tripeptidyl chlorovinyl sulfones 
 
2.4.1. Inhibition testing 
In vitro testing against cysteine proteases are currently carried out and the related 
publication is in progress. 
Biological test in Hela cell lysate 
The standard protocol was carried out with 1h of incubation, 1h labelling 
of residual activity with LWA-300 (green bodipy-epoxomicin) and resolve on 12.5 
SDS-PAGE. 
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Scheme 60. Inhibition results for compounds 4.52-4.53 
 
The presence of a Cl in the α-position of the sulfone is decreasing the 
inhibition activity. This change is probably explained by the big steric hindrance 
caused by the chlorine atom close to the reactive carbon in β-position. This 
difficulty to attack is decreasing the inhibition up to 1000 μM of inhibitor 
concentration. 
cinh (μM) 0 1 3 10 30 100 300 1000
cinh (μM) 0 1 3 10 30 100 300 1000
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2.5. New sulfonyl-aziridines as inhibitors  
 
This work was done in my research stay at University of Leiden, in the 
Institute of Chemistry under Pr. Dr. Hermen Overkleeft supervision. The goal of 
this project was developed a methodology to afford to new sulfonylaziridines to 
check the activity against cathepsins based on the aziridines studies of Schirmeister 
et al.123 
 
Scheme 61. Sulfonyl aziridine proposed  
Retrosynthesis of this inhibitor was based upon an aza-Darzens reaction as 
a key step: 
                                                          
123
 Schirmeister, T. J. Med. Chem. 1999, 42, 560 
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Scheme 62. Retrosynthetic route to aziridines 
 
The first step of the synthesis was obtaining the imine derivative from the 
desired amino acid.  
The limiting factor was the nature of the substituent due to the imine 
formed should be reactive for the nucleophilic attack of the chloromethylphenyl 
sulfone. In this case it was tried with phenylsulfonamide in different experimental 
conditions. 
 
Scheme 63. Preparation of imine intermediate  
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Table 37. Imine preparation 
Entry PG Amine, R1 Reagent Solvent T/t Result 
1 Boc SO2Ph MgSO4 DCM 0 / 4h SM 
2 Boc SO2Ph MgSO4 DCM 0 / 2days SM 
3 Boc SO2Ph Et3N DCM 0 / 4h byP+ SM 
4 Boc SO2Ph BF3 DCM 25 / o.n. byP 
5 Boc SO2Ph MgSO4 THF 0 / 4h SM 
6 Boc SO2Ph Ti(Oi-Pr)4 DCM 0 / 4h byP + SM 
7 Boc S(O)SO2Pha - DCM 0 / 2h SM 
8 Boc S(O)SO2Pha MgSO4 DCM 0 / 24h byP + SM 
9 Boc2 SO2Ph MgSO4 DCM 0 / 4h SM 
10 Boc2 SO2Ph Et3N DCM 0 / 4h byP + SM 
11 Boc2 SO2Ph BF3 DCM 25 / o.n. byP 
12 Boc2 SO2Ph Ti(OiPr)4 DCM rt / o.n. byP 
SM = starting material were recovered 
byP = unidentified by products were detected 
a = prepared refluxing  phenhylsulfonamide with thionyl chloride  
 
 
Phenyl sulfonamide was not enough nucleophile to attack the aldehyde 
generated, and then activation was required. In basic conditions (entry 3) starting 
material were recovered and the presence of unknown minor byproducts were 
detected. Activation with magnesium sulfate in dichloromethane or 
tetrahydrofuran (entries 1-2) only starting materials were isolated in perfect 
conditions. When boron trifluoride was used, dirtier crude spectra was detected 
and the presence of starting materials amounts was observed. Finally activation 
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using titanium tetra iso-propoxide did not afford to the desired product. Only 
starting material and unknown products were detected in the crude reaction.  
 
Same results were obtained when phenylsulfonamide derivative (readily 
obtained by treatment of phenylsulfonamide with thionylchloride) was used 
(entries 7-8), only starting materials and byproducts were detected. 
 
Finally the results when the aldehyde was diprotected with two Boc 
groups, the results are the same as for the analogous one having one Boc group 
(entries 9-12). For this reason it was decided to change to a more nucleophilic 
amine such as benzylamine. 
 
The imine was formed in good chemical yield (80% as calculated by NMR) 
using magnesium sulfate as a catalyst in dichloromethane cold with an ice bath for 
4h, based on Palomo’s work.124 According to the NMR, imine 5.54 is an isomeric 
mixture in 92:8 ratio (scheme 64). The imine reaction crude was very pure and 
used in the next step without any further purification. 
 
Scheme 64. Preparation imines 4.54  
 
                                                          
124 Palomo C., Cossio F.P., Cuevas C., Lecea B., Mielgo A., Roman P., Luque A., Martinez-Ripoli M. J. Am. Chem. 
Soc., 1992, 114 , 9360–9369 
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The aza-Darzens addition of chloromethylphenyl sulfone to this imine 4.54 was 
carried out represented in scheme 62. 
 
Scheme 62. Preparation aziridines 4.56  
Table 38. Preparation aziridine 4.56 
Entry Base Solvent T/t Result 
1 n-BuLi THF -78oC / 4h 4.55 + 4.56 
2 n-BuLi THF -78oC to 0 oC / 6h 4.55 + 4.56 
3 n-BuLi THF -78oC to r.t. / o.n. 4.55 + 4.56 
4 LHMDS THF -78oC  / 4h 4.55 + 4.56 
5 t-BuOK DCM 0 oC / 4h 4.55 + 4.56 
The experimental procedure started with deprotonation of chloromethyl 
phenyl sulfone using a base and then the imine was added in the corresponding 
solvent. In all cases a mixture of aziridine and chloro-amine was detected by 
HPLC-MS of the crude mixture. NMR experiments of the crude mixture did not 
allow characterization of aziridine nor chloro. No isolated product was obtained 
after chromatography. More experiments to optimize this reaction need to be 
done. It will be tested and publish in an organic or medicinal journal.
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2.6. Dipeptidyl carbonyl acetylenic inhibitors 
In order to explore new warheads for cysteine proteases inhibitors and 
encouraged by the high inhibition results of dipeptidyl enones reported recently 
by our group,125 new acetylenic inhibitors were designed:  
 
Scheme 63. Designed acetylenes  
 
 
 
 
                                                          
125 Royo, S.; Rodriguez, S.; Schirmeister, T.; Kesselring, J.; Kaiser, M.; Gonzalez, F. Chem. Med. Chem 2015, 10, 
1484 –1487 
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 The retrosynthetic analysis for these inhibitors is described below 
 
Scheme 64. Retrosynthesis of acetylenic inhibitors 
 
The ethinyl p-tolyl sulfone was prepared from p-toluensulfonyl chloride in 
two step in good yield. 
 
Scheme 65. Preparation ethinyl p-tolyl sulfone 
 
Commercial ethylpropiolate and ethinyl p-tolyl sulfone were treated with 
n-butyl lithium in tetrahydrofuran at -78 oC for 20 minutes and then ester was 
added in tetrahydrofuran and then 2h at -10 oC. It was isolated acetylene 4.58 after 
column in moderated yield (26%) but no evidence sulfone derivate was detected. 
Several reaction conditions was tested but no product was formed. 
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Scheme 66. Preparation acetylenic inhibitors 
 
Then deprotection of the carbamate group of 4.59 was carried out using 
trifluoroacetic acid in dichloromethane. Subsequent coupling with Cbz-Phe in 
dichloromethane afforded the desired dipeptidyl compound in excellent chemical 
yield (94%). 
 
Scheme 67. Preparation acetylenic inhibitor 4.59 
 
In vitro testing for this compound is currently being carried out and it will be 
publish in a medicinal journal. 
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3.  Experimental information 
 Competitive Activity-Based Profiling of Cathepsins in Mouse Liver Lysates 
Mouse liver was obtained from a Balb/c mouse (in conformity with the 
Leiden University animal experimentation protocol 13191u), cut into ca. 100 mg 
pieces, and frozen in liquid N2. For lysate production, the liver segment was taken 
up in 3× volumes of ice-cold lysis buffer (50 mM MES, pH 5.0, 250 mM sucrose, 
0.025% digitonin) for 30 min on ice and disrupted 10 times with 15 s sonication 
pulses interrupted by 5 s breaks on ice. The insoluble fraction was pelleted by 
centrifugation at 14 000 rpm in a cooled Eppendorf centrifuge, the supernatant was 
collected, and the protein concentration was determined with the Bradford 
(BioRad) colorimetric method using a BSA calibration curve. For competitive 
activity-based profiling, some 20 μg of total protein in 8 μL of lysis buffer at pH 5.0 
was first incubated by addition of 1 μL of 10× solution of the indicated inhibitor 
concentration for 30 min at 37 °C, followed by addition of 1 μL of a 5 μM solution 
of the broad-spectrum cathepsin activity-based probe (ABP) DCG04-BodipyFL to 
label the residual cathepsin activity for 30 min at 37 °C. Nonfluorescent DCG04 
cathepsin inhibitor at a final concentration of 1 μM was used as a positive control. 
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To assess the total labeling pattern of the DCG04-BodipyFL ABP, the lysate was 
first incubated with 1 μL of DMSO, and then samples were boiled with 6 μL of 4× 
Laemmli’s sample buffer under reducing conditions and resolved for 2 h on a 
12.5% SDS-PAGE gel. After rinsing with water, gel slabs were imaged with a 
Typhoon 2000 imager (GE Healthcare) using the fluorescein setting (λex = 490 nm, 
λem = 510 nm). Gel images were acquired with ImageQuant and colored with 
ImageJ. 
 
3.1. General Experimental Methods 
 
All of the solvents used in reactions were freshly distilled from appropriate 
drying agents before use. 1H and 13C NMR spectra were measured in CDCl3 (1H, 
7.24 ppm; 13C, 77.0 ppm) at 30 °C on a 300 or 500 MHz NMR spectrometer. IR 
spectra were recorded on oil films, KBr discs, or NaCl pellets on an FT-IR 
spectrometer. Mass spectra were measured in a QTOF I (quadrupole–hexapole 
TOF) mass spectrometer with an orthogonal Z-spray-electrospray interface. EM 
Science silica gel 60 was used for column chromatography, while TLC was 
performed with precoated plates (Kieselgel 60, F254, 0.25 mm). Unless otherwise 
specified, all of the reactions were carried out under an argon atmosphere with 
magnetic stirring. 
General Experimental Procedure for the Preparation of Amino Aldehydes 
 
To a cold (−78 °C) solution of tert-butoxycarbonyl alanine methyl ester 
(406 mg, 2 mmol) in DCM (20 mL) was added dropwise diisobutylaluminum 
hydride (1 M in hexane, 4 mL, 4 mmol). The resulting mixture was stirred for 30 
min. Then Rochelle salt saturated aqueous solution (50 mL) was added, and the 
Design, synthesis and evaluation of new inhibitors of cysteine proteases and proteasome  
 
227 
resulting mixture was stirred at room temperature until two phases were separated. 
After extraction with dichloromethane (3 × 15 mL), the organic layers were 
washed with brine, dried (Na2SO4), and concentrated. The crude material was 
purified by chromatography (silica gel, hexanes/ethyl acetate (7:3)) to afford the 
desired compound (288 mg, 83%). 
 
General experimental procedure for preparation of aldehyde from Weinreb amide 
To ice bath cold solution of ester (1mmol) in diethyl ether (20mL) was 
added lithium aluminum hydride (2mmol) dropwise. The mixture stirred for 30 
minutes and then it was quenched adding water (5mL) and then extracted with 
diethyl ether (3 × 15 mL). The organic layers were washed with 1 M hydrochloric 
acid (15 mL), sodium bicarbonate saturated aqueous solution (15 mL), and brine, 
dried (Na2SO4), and concentrated. Aldehyde can be used without further 
purification. 
 
 
1H NMR (300 MHz, cdcl3) δ 9.38 (s, 1H), 5.44 (t, J = 10.3 Hz, 1H), 4.22 – 3.77 (m, 
1H), 1.38 (s, 18H), 1.16 (d, J =  1.4 Hz, 3H). 
13C NMR (75 MHz, cdcl3) δ 200.19, 155.36, 79.68, 55.30, 28.10, 14.37. 
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General experimental procedure for preparation of nitroaldols 
To an ice bath solution of aminoaldehyde (1mmol) in dichloromethane 
(1mL) was added nitroalkane (6mmol) and triethylamine (0.3mmol). The mixture 
stirred for 8h, and then it was quenched adding ammonium chloride saturated 
aqueous solution (25mL) and then extracted with dichloromethane (3 × 15 mL). 
The organic layers were washed with 1 M hydrochloric acid (15 mL), sodium 
bicarbonate saturated aqueous solution (15 mL), and brine, dried (Na2SO4), and 
concentrated. Nitroaldols can be used without further purification. 
 
General experimental procedure for preparation of dipeptidyl nitroaldols 
To an ice bath solution of nitroaldol (1mmol) in dichloromethane (1mL) 
was added trifluoroacetic acid (1.5mL) in dichloromethane (1.5mL). The mixture 
stirred for 30 minutes, and then it was directly concentrated. The resulting salt was 
dissolved in dichloromethane (10mL) or dimethylformamide (10mL) and stirred in 
ice bath. Then desired aminoacid was added (1.1mmol) followed by hydroxo 
benzotriazole (1.1mmol), diisopropylamine (4 mmol) and EDC (1.1mmol). It 
stirred for 8h and then it was quenched adding ammonium chloride saturated 
aqueous solution (25mL) and then extracted with dichloromethane (3 × 15 mL). 
The organic layers were washed with 1 M hydrochloric acid (15 mL), sodium 
bicarbonate saturated aqueous solution (15 mL), and brine, dried (Na2SO4), and 
concentrated. Dipeptidylnitroaldols can be used without further purification. 
 
General experimental procedure for preparation of nitroalkenes 
To an ice bath solution of nitroaldol (1mmol) in dichloromethane (10mL) 
was added mesylchloride (2mmol) and slowly diisopropylamine (4mmol). The 
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mixture stirred for 2h and then it was quenched adding ammonium chloride 
saturated aqueous solution (25mL) and then extracted with dichloromethane (3 × 
15 mL). The organic layers were washed with 1 M hydrochloric acid (15 mL), 
sodium bicarbonate saturated aqueous solution (15 mL), and brine, dried (Na2SO4), 
and concentrated. The crude material was purified by chromatography (silica gel, 
hexanes/ethyl acetate (9:1 to 7:3)) to afford the desired compound. 
 
 
1H NMR (500 MHz, cdcl3) δ 7.41 – 7.23 (m, 8H), 7.16 (d, J = 6.6 Hz, 2H), 6.87 (dd, J 
= 13.4, 5.6 Hz, 1H), 6.66 (d, J = 13.3 Hz, 1H), 5.68 (s, 1H), 5.06 (s, 2H), 4.40 (s, 1H), 
3.05 (ddd, J = 21.9, 13.4, 7.5 Hz, 2H), 1.17 (d, J = 7.1 Hz, 3H). 
 
13C NMR (126 MHz, cdcl3) δ 170.58, 156.14, 141.55, 139.54, 135.96, 129.22, 129.22, 
128.84, 128.84, 128.59, 128.59, 128.34, 127.91, 127.47, 77.30, 77.30, 77.05, 77.05, 
76.79, 76.79, 67.25, 56.64, 43.13, 38.71, 19.46. 
 
 
1H NMR (500 MHz, cdcl3) δ 7.42 – 7.25 (m, 4H), 7.11 (ddd, J = 18.9, 5.7, 3.4 Hz, 
1H), 5.90 – 5.74 (m, 1H), 5.18 – 4.98 (m, 2H), 4.80 – 4.61 (m, 1H), 4.32 – 4.10 (m, 
1H), 1.73 – 1.49 (m, 3H), 1.36 – 1.29 (m, 1H), 1.25 – 1.18 (m, 2H), 0.96 – 0.75 (m, 
6H). 
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13C NMR (126 MHz, cdcl3) δ 172.35, 156.61, 142.29, 142.22, 139.69, 139.62, 136.04, 
135.97, 128.55, 128.27, 127.94, 127.86, 77.35, 77.09, 76.84, 67.24, 53.61, 43.35, 
41.14, 24.71, 22.81, 21.84, 19.37. 
 
 
1H NMR (500 MHz, cdcl3) δ 7.41 – 7.00 (m, 71H), 6.85 (dd, J = 13.4, 6.1 Hz, 5H), 
6.69 (d, J = 13.4 Hz, 5H), 6.11 (s, 7H), 5.52 (d, J = 6.3 Hz, 7H), 5.16 – 5.03 (m, 14H), 
4.73 – 4.58 (m, 8H), 4.41 (dt, J = 14.3, 7.2 Hz, 8H), 3.20 – 2.94 (m, 16H), 1.52 (dt, J 
= 13.3, 6.6 Hz, 6H), 1.44 – 1.19 (m, 18H), 0.98 – 0.66 (m, 43H). 
 
13C NMR (126 MHz, cdcl3) δ 170.60, 156.08, 141.01, 139.90, 139.75, 135.93, 129.21, 
128.87, 128.84, 128.61, 128.36, 128.06, 127.98, 127.49, 127.25, 77.29, 77.03, 76.78, 
67.28, 56.66, 45.78, 42.76, 38.44, 24.59, 22.50, 21.91. 
 
 
1H NMR (500 MHz, cdcl3) δ 7.42 – 7.23 (m, 35H), 7.17 – 7.03 (m, 13H), 6.80 (s, 
8H), 5.72 – 5.47 (m, 9H), 5.21 – 4.99 (m, 16H), 4.79 – 4.60 (m, 9H), 4.19 (s, 10H), 
1.74 – 1.59 (m, 21H), 1.59 – 1.50 (m, 10H), 1.50 – 1.36 (m, 15H), 1.06 – 0.71 (m, 
89H). 
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13C NMR (126 MHz, cdcl3) δ 172.13, 156.53, 141.64, 139.84, 128.58, 128.56, 128.32, 
127.98, 127.91, 127.89, 127.89, 127.88, 77.32, 77.06, 76.81, 67.24, 53.68, 45.94, 
42.75, 40.73, 24.74, 22.65, 22.53, 21.93. 
 
 
1H NMR (500 MHz, cdcl3) δ 7.42 – 7.24 (m, 11H), 7.17 (dd, J = 18.8, 6.6 Hz, 2H), 
6.99 – 6.92 (m, 1H), 6.00 – 5.82 (m, 1H), 5.21 (s, 1H), 5.15 – 5.05 (m, 2H), 4.92 (dd, 
J = 14.1, 7.0 Hz, 1H), 4.37 – 4.25 (m, 1H), 3.15 – 2.92 (m, 2H), 2.89 – 2.65 (m, 2H). 
13C NMR (75 MHz, cdcl3) δ 170.54, 156.11, 140.39, 140.15, 135.98, 134.74, 129.25, 
129.16, 128.94, 128.61, 128.40, 128.17, 128.09, 127.52, 127.44, 77.43, 77.01, 76.58, 
67.45, 56.65, 52.37, 48.37, 48.28, 39.79, 37.89. 
 
 
1H NMR (500 MHz, cdcl3) δ 7.40 – 6.86 (m, 21H), 5.81 – 5.68 (m, 1H), 5.64 – 5.50 
(m, 1H), 5.18 – 4.88 (m, 5H), 4.26 – 4.17 (m, 1H), 4.08 (ddd, J = 8.9, 7.0, 4.4 Hz, 
1H), 2.95 – 2.80 (m, 3H), 1.68 – 1.52 (m, 2H), 1.53 – 1.40 (m, 2H), 1.40 – 1.24 (m, 
2H), 0.98 – 0.86 (m, 6H), 0.83 (t, J = 9.1 Hz, 4H). 
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13C NMR (126 MHz, cdcl3) δ 172.23, 156.49, 140.67, 140.16, 135.98, 135.46, 129.13, 
129.08, 128.81, 128.60, 128.34, 128.28, 127.97, 127.31, 77.39, 77.13, 76.88, 67.27, 
53.83, 48.77, 40.68, 40.05, 39.83, 24.69, 22.78, 21.93. 
 
 
1H NMR (500 MHz, cdcl3) δ 7.41 – 7.13 (m, 40H), 7.06 (d, J = 6.5 Hz, 6H), 6.92 – 
6.58 (m, 6H), 6.21 (s, 4H), 5.50 (s, 4H), 5.08 (s, 7H), 4.59 (s, 4H), 4.41 (s, 4H), 3.22 – 
2.92 (m, 8H), 2.62 – 2.39 (m, 7H), 1.92 – 1.64 (m, 8H). 
13C NMR (75 MHz, cdcl3) δ 170.78, 156.21, 140.87, 140.56, 140.17, 139.97, 136.09, 
135.97, 135.85, 129.24, 128.87, 128.69, 128.60, 128.35, 128.29, 128.03, 127.93, 
127.52, 127.37, 126.48, 77.50, 77.07, 76.65, 67.30, 56.76, 47.14, 38.48, 35.27, 35.16, 
31.74, 31.66. 
 
 
1H NMR (500 MHz, cdcl3) δ 7.37 – 7.21 (m, 45H), 7.20 – 6.97 (m, 24H), 6.63 – 6.49 
(m, 6H), 5.38 – 5.23 (m, 4H), 5.23 – 5.06 (m, 16H), 4.77 – 4.54 (m, 8H), 4.29 – 3.96 
(m, 9H), 2.80 – 2.45 (m, 15H), 2.11 – 1.75 (m, 18H), 1.75 – 1.61 (m, 13H), 1.60 – 
1.41 (m, 8H), 1.05 – 0.87 (m, 36H). 
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13C NMR (126 MHz, cdcl3) δ 171.91, 156.60, 140.97, 140.19, 140.15, 140.08, 135.87, 
128.76, 128.75, 128.59, 128.29, 128.11, 128.08, 126.56, 67.50, 53.69, 47.34, 40.49, 
35.39, 31.85, 24.76, 22.86. 
 
 
General experimental procedure for preparation of methylated nitroalkenes 
To an ice bath solution of nitroaldol (1mmol) in dichloromethane (10mL) 
was added mesylchloride (2mmol) and slowly di-isopropylamine (4mmol). The 
mixture stirred for 2h and then it was quenched adding ammonium chloride 
saturated aqueous solution (25mL) and then extracted with dichloromethane (3 × 
15 mL). The organic layers were washed with 1 M hydrochloric acid (15 mL), 
sodium bicarbonate saturated aqueous solution (15 mL), and brine, dried (Na2SO4), 
and concentrated. The crude material was dissolved in dichloromethane (10mL) 
was added mesylchloride (2mmol) and slowly di-isopropylamine (4mmol). The 
mixture stirred for 2h and then it was quenched adding ammonium chloride 
saturated aqueous solution (25mL) and then extracted with dichloromethane (3 × 
15 mL). The organic layers were washed with 1 M hydrochloric acid (15 mL), 
sodium bicarbonate saturated aqueous solution (15 mL), and brine, dried (Na2SO4), 
and concentrated. The crude material was purified by chromatography (silica gel, 
hexanes/ethyl acetate (9:1 to 7:3)) to afford the desired compound. 
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1H NMR (500 MHz, cdcl3) δ 7.49 – 7.20 (m, 7H), 7.18 – 7.06 (m, 2H), 6.51 (dd, J = 
9.7, 1.0 Hz, 1H), 6.28 (s, 1H), 5.63 (d, J = 5.9 Hz, 1H), 5.13 – 5.01 (m, 2H), 4.61 (dp, 
J = 9.5, 6.9 Hz, 1H), 4.38 (d, J = 6.6 Hz, 1H), 3.11 – 2.90 (m, 2H), 2.23 (dd, J = 7.1, 
1.0 Hz, 2H), 1.12 (dd, J = 19.1, 7.0 Hz, 2H). 
13C NMR (126 MHz, cdcl3) δ 170.46, 156.06, 148.41, 136.05, 134.82, 129.27, 129.24, 
128.70, 128.63, 128.57, 128.28, 127.90, 127.28, 67.15, 56.43, 43.14, 38.94, 19.79, 
12.78. 
 
 
1H NMR (300 MHz, cdcl3) δ 7.40 – 7.29 (m, 8H), 6.91 – 6.74 (m, 2H), 6.74 – 6.53 
(m, 2H), 5.41 – 5.21 (m, 2H), 5.22 – 4.99 (m, 4H), 4.68 (ddd, J = 14.2, 7.1, 2.8 Hz, 
2H), 4.26 – 4.00 (m, 2H), 2.32 – 2.14 (m, 5H), 1.74 – 1.40 (m, 6H), 1.40 – 1.11 (m, 
7H), 1.03 – 0.81 (m, 13H). 
13C NMR (75 MHz, cdcl3) δ 171.94, 156.44, 148.61, 135.99, 135.04, 128.56, 128.30, 
127.97, 67.24, 53.48, 43.31, 41.08, 40.90, 24.67, 22.88, 21.82, 19.98, 12.79. 
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General experimental procedure for preparation of cyclopropanes 
To an ice bath solution of dimethyl sulfoxide (1 mL), potassium tert-
butoxide was added (1.05mmol) and stirred for 10 minutes. Alkene (1mmol) was 
added slowly in dimethyl sulfoxide (1mL) and it stirred for 48h. It was poured onto 
ice and extracted with diethyl ether. Organic layer was washed with water and 
brine, dried (Na2SO4), and concentrated. The crude material was purified by 
chromatography (silica gel, hexanes/ethyl acetate (9:1 to 7:3)) to afford the desired 
compound.  
 
General experimental procedure for preparation of nitroepoxides  
To cold (−78 °C) solution of nitroalkene (1mmol) in methanol (8mL), 
hydrogen peroxide (50%, 2 mmol) followed by a solution of sodium hydroxide 2M 
(3mL) and stirred for 1h. It was poured onto ice and extracted with diethyl ether. 
Organic layer was washed with water and brine, dried (Na2SO4), and concentrated. 
The crude cannot be isolated by silica gel chromatography. 
 
General experimental procedure for the preparation of chlorohydrins 
 
To a stirred solution of chloromethyl phenyl sulfone (2.5 mmol) in 
tetrahydrofuran (5 mL) at −78 °C was added slowly n-buthyl lithium (1.6 M in 
hexanes, 1.56 mL, 2.5 mmol). The mixture was stirred for 15 min, and then a 
solution of aldehyde (173 mg, 1 mmol) in tetrahydrofuran (5 mL) was added 
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slowly. The mixture was stirred for 1.5 h, and the reaction was monitorized by 
TLC. The reaction was quenched with ammonium chloride saturated aqueous 
solution (25 mL), and the reaction mixture was allowed to warm to room 
temperature and then extracted with ethyl ether (3 × 15 mL). The organic layers 
were washed with 1 M hydrochloric acid (15 mL), sodium bicarbonate saturated 
aqueous solution (15 mL), and brine, dried (Na2SO4), and concentrated. The crude 
material was purified by chromatography (silica gel, hexanes/ethyl acetate (9:1 to 
7:3)) to afford the desired compound. 
 
General experimental procedure for the protection of amines 
To an ice-bath cooled solution of the amine (1 mmol) in an aqueous 
solution of 2 M sodium hydroxide (1 mL, 2 mmol) was added the corresponding 
alkyl chloroformate (1 mmol). The resulting mixture, cooled with the ice-bath, 
was stirred for 1 h and then was stirred at room temperature for 45 min. The 
reaction mixture was carefully neutralized using 1 M hydrochloric acid solution 
and extracted with dichloromethane (3 × 30 mL). The organic layers were washed 
(brine), dried (Na2SO4), and concentrated. The crude oil was submitted to the next 
step without any further purification. 
 
General experimental procedure for addition of Grignard reagents to carbamates 
To an ice-bath cooled solution of the carbamate (1 mmol) in 
tetrahydrofuran (6 mL) was added the corresponding Grignard reagent (6 mmol). 
The resulting mixture was stirred while being cooled with an ice-bath for 10 min 
and then stirred at room temperature for 24 h. The reaction was quenched with 
saturated ammonium chloride solution (10 mL) and extracted with ethyl acetate 
(3 × 30 mL). The organic layers were washed (brine), dried (Na2SO4), and 
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concentrated. The crude oil was purified by silica gel chromatography, eluted with 
hexanes/ ethyl acetate (7:3), (6:4) and ethyl acetate to afford the corresponding 
amide. 
 
General experimental procedure for one-pot transformation of amines into amides 
To an ice-bath cooled solution of the amine (1 mmol) in tetrahydrofuran 
(6 mL) was added triethylamine (3 mmol) and then the corresponding alkyl 
chloroformate (1 mmol). The resulting mixture was stirred while being cooled by 
an ice-bath for 1 h and then stirred at room temperature for 45 min. The reaction 
mixture was cooled with an ice-bath and the corresponding Grignard reagent 
(6 mmol) was added. The resulting mixture was stirred while being cooled with 
the ice-bath for 10 min and then stirred at room temperature for 24 h. The 
reaction was cautiously quenched with saturated ammonium chloride solution 
(10 mL) and extracted with ethyl acetate (3 × 30 mL). The organic layers were 
washed (brine), dried (Na2SO4), and concentrated. The crude oil was purified by 
silica gel chromatography, eluted with hexanes/ ethyl acetate (7:3), (6:4) and 
ethyl acetate to afford the corresponding amide. 
 
General experimental procedure for preparation of chlorhydrins 
To cold (−78 °C) stirred solution chloromethylphenyl sulfone (2.5mmol) in 
tetrahydrofuran (5mL), n-buthyl lithium  (1.6M in hexanes) (2.5mmol) It stirred 
for 15 minutes and then a solution of aldehyde (1mmol) in tetrahydrofuran (5mL) 
was added slowly and stirred for 1.5 hours. It was quenched with ammonium 
chloride saturated aqueous solution (25mL) and the reaction allowed to warm up 
to room temperature. Then it was extracted with diethyl ether (3 x 15mL) and the 
organic layer was washed with hydrochloric acid, sodium bicarbonate saturated 
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aqueous solution and brine, dried (Na2SO4), and concentrated. The crude oil was 
purified by silica gel chromatography, eluted with hexanes/ethyl acetate (9:1 to 
6:4) to isolate a first fraction and other purification of this fraction was carried out 
by silica gel chromatography, eluted with dichloromethane/ ethyl acetate (10:0 to 
8:2) 
 
 
 
White solid, mp 84–87 °C. Yield 91 mg, 25%. [α]D20 +18.0 (c = 1, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 7.5 Hz, 1H), 7.67 (t, J = 7.5 Hz, 1H), 7.55 
(t, J = 7.8 Hz, 1H), 5.01 (d, J = 9.8 Hz, 1H), 4.68 (d, J = 9.0 Hz, 1H), 4.12 (m, 1H), 
3.97 (d, J = 9.3 Hz, 1H), 1.36 (s, 9H), 1.20 (d, J = 6.8 Hz, 2H) ppm.  
13C NMR (125 MHz, CDCl3) δ 155.4, 135.3, 134.6, 129.6, 129.2, 79.6, 73.5, 73.4, 
47.2, 28.2, 18.4 ppm. 
HRMS (ESI) calcd for C15H22ClNNaO5S ([M + Na]+) 386.0805, found 386.0800. 
 IR (NaCl) ν 3390, 3020, 2980, 2930, 1711, 1498, 1449, 1393, 1368, 1345, 1322, 
1311, 1152, 1100, 1081, 1060, 1018, 998, 822, 699, 686, 578, 553, 543, 456, 432, 418 
cm–1. 
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White solid, mp 87–91 °C. Yield 73 mg, 20%. [α]D20 −10.0 (c = 1, CHCl3). 
1H NMR (500 MHz, CDCl3) δ 7.99 (d, J = 7.6 Hz, 1H), 7.76 (d, J = 7.3 Hz, 1H), 7.64 
(t, J = 7.7 Hz, 1H), 5.04 (s, 1H), 4.52 (d, J = 9.6 Hz, 1H), 4.24 (d, J = 9.5 Hz, 1H), 4.16 
(m, 1H), 4.05 (s, 1H), 1.45 (s, 9H), 1.14 (d, J = 6.6 Hz, 2H) ppm. 
 13C NMR (125 MHz, CDCl3) δ 155.1, 135.0, 134.6, 130.2, 129.3, 79.6, 73.3, 71.4, 
47.6, 28.2, 13.0 ppm. 
HRMS (ESI) calcd for C15H22ClNNaO5S ([M + Na]+) 386.0805, found 386.0805.  
IR (NaCl) ν 3444, 3019, 2980, 2360, 2342, 1707, 1500, 1449, 1393, 1368, 1348, 1312, 
1220, 1153, 1136, 1099, 1058, 1024, 997, 818, 686, 577, 558, 532, 487, 461, 430, 418 
cm–1. 
 
 
White solid, mp 85–90 °C. Yield 65 mg, 18%. [α]D20 −14.0 (c = 1, CHCl3). 
1H NMR (300 MHz, CDCl3) δ 7.96 (d, J = 8.0 Hz, 1H), 7.68 (t, J = 7.0 Hz, 1H), 7.57 
(t, J = 7.6 Hz, 1H), 4.85 (s, 1H), 4.79 (d, J = 8.4 Hz, 1H), 4.51 (s, 1H), 3.92 (m, 1H), 
3.34 (m, 1H), 1.40 (s, 9H), 1.25 (d, J = 6.8 Hz, 2H) ppm.  
13C NMR (75 MHz, CDCl3) δ 156.8, 136.0, 135.2, 130.7, 129.5, 80.7, 76.9, 71.3, 50.8, 
28.9, 18.5 ppm.  
HRMS (ESI) calcd for C15H22ClNNaO5S ([M + Na]+) 386.0805, found 386.0811.  
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IR (NaCl) ν 3444, 3019, 2980, 2934, 1703, 1504, 1449, 1393, 1368, 1345, 1322, 1311, 
1156, 1101, 1083, 1055, 1026, 998, 686, 576, 559, 540, 503, 472, 429, 418 cm–1. 
 
 
White solid, mp 85–89 °C. Yield 44 mg, 12%. [α]D20 +20.0 (c = 1, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.97 (d, J = 7.3 Hz, 1H), 7.72 (t, J = 7.5 Hz, 1H), 7.60 
(t, J = 7.8 Hz, 1H), 4.95 (s, 1H), 4.58 (d, J = 7.7 Hz, 1H), 4.45 (d, J = 7.6 Hz, 1H), 3.84 
(s, 1H), 3.16 (s, 1H), 1.42 (s, 9H), 1.30 (d,J = 6.7 Hz, 2H) ppm.  
13C NMR (125 MHz, CDCl3) δ 155.6, 135.5, 134.8, 130.0, 129.2, 80.1, 74.7, 71.5, 
49.0, 28.3, 17.5 ppm.  
HRMS (ESI) calcd for C15H22ClNNaO5S ([M + Na]+) 386.0805, found 386.0804.  
IR (NaCl) ν 3378, 3019, 2980, 1707, 1504, 1449, 1393, 1368, 1324, 1312, 1154, 1083, 
1049, 1028, 686, 587, 576, 540 cm–1. 
 
General Experimental Procedure for the Preparation of Epoxysulfones from 
Chlorohydrins 
 
To an ice-bath-cold solution of chlorohydrin (1 mmol) in 
dichloromethane/tert-butanol (1:1) (3 mL) was added slowly sodium tert-butoxide 
(0.95 mmol) in one portion. The mixture was stirred for 30 min, and then the 
reaction was quenched with ammonium chloride saturated aqueous solution (25 
mL). The resulting mixture was extracted with dichloromethane (3 × 15 mL), and 
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then the organic layers were washed with 1 M hydrochloric acid (15 mL), sodium 
bicarbonate saturated aqueous solution (15 mL), and brine, dried (Na2SO4), and 
concentrated. The crude material was purified by chromatography (silica gel, 
hexanes/ethyl acetate (7:3)) to afford the desired compound. 
 
 
Colorless oil. Yield 275 mg, 84%. [α]D20 +2.0 (c = 1, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 8.3 Hz, 1H), 7.71 (t, J = 6.9 Hz, 1H), 7.60 
(t, J = 7.6 Hz, 1H), 4.37 (br s, 1H), 4.17–4.08 (m, 1H), 4.00 (t, J = 1.4 Hz, 1H), 3.69 
(d, J = 1.3 Hz, 1H), 1.42 (s, 9H), 1.26 (d, J = 7.0 Hz, 3H) ppm.  
13C NMR (125 MHz, CDCl3) δ 154.8, 136.0, 134.5, 129.4, 128.8, 80.1, 66.3, 59.9, 
44.3, 28.3, 18.4 ppm.  
HRMS (ESI) calcd for C15H21NNaO5S ([M + Na]+) 350.1038, found 350.1032.  
IR (NaCl) ν 3020, 2981, 1712, 1498, 1449, 1393, 1368, 1327, 1265, 1083, 1058, 686, 
580, 555 cm–1. 
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Colorless oil. Yield 258 mg, 79%. [α]D20 +6.0 (c = 1, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.94 (d, J = 7.9 Hz, 1H), 7.71 (t, J = 7.2 Hz, 1H), 7.60 
(t, J = 7.9 Hz, 1H), 4.54 (m, 1H), 4.23 (m, 1H), 3.68 (m, 1H), 3.57 (dd, J = 6.1, 1.0 
Hz, 1H), 1.44 (s, 9H), 1.23 (d, J = 6.9 Hz, 3H) ppm.  
13C NMR (125 MHz, CDCl3) δ 154.9, 137.1, 134.5, 129.4, 128.8, 80.2, 67.6, 59.5, 
46.4, 28.2, 17.0 ppm.  
HRMS (ESI) calcd for C15H21NNaO5S ([M + Na]+) 350.1038, found 350.1039.  
IR (NaCl) ν 3019, 2980, 1748, 1733, 1699, 1684, 1498, 1473, 1457, 1329, 1157, 1087, 
686, 418 cm–1. 
 
 
Colorless oil. Yield 229 mg, 70%. [α]D20 −2.0 (c = 1, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 7.3 Hz, 1H), 7.73 (t, J = 7.5 Hz, 1H), 7.61 
(t, J = 7.8 Hz, 1H), 4.55 (s, 1H), 4.15 (m, 1H), 3.87 (m, 1H), 3.70 (m, 1H), 1.43 (s, 
9H), 1.28 (d, J = 6.9 Hz, 3H) ppm.  
13C NMR (125 MHz, CDCl3) δ 154.6, 136.9, 134.5, 129.5, 128.8, 80.1, 67.5, 59.9, 
44.4, 28.3, 18.2 ppm.  
HRMS (ESI) calcd for C15H21NNaO5S ([M + Na]+) 350.1038, found 350.1034.  
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IR (NaCl) ν 3020, 2981, 1710, 1499, 1456, 1449, 1369, 1329, 1311, 1233, 1017, 583 
cm–1. 
 
 
Colorless oil. Yield 209 mg, 64%. [α]D20 −4.0 (c = 1, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 7.3 Hz, 1H), 7.71 (t, J = 7.5 Hz, 1H), 7.60 
(t, J = 7.8 Hz, 1H), 4.55 (s, 1H), 4.25 (m, 1H), 3.68 (m, 1H), 3.57 (dd, J = 6.1, 1.5 Hz, 
1H), 1.44 (s, 9H), 1.23 (d, J = 6.9 Hz, 3H) ppm.  
13C NMR (125 MHz, CDCl3) δ 154.9, 137.1, 134.4, 129.4, 128.8, 80.2, 67.5, 59.5, 
46.4, 28.3, 17.0 ppm.  
HRMS (ESI) calcd for C15H21NNaO5S ([M + Na]+) 350.1038, found 350.1044.  
IR (NaCl) ν 3019, 1714, 1497, 1456, 1448, 1369, 1330, 1312, 1157, 1087, 687, 584 
cm–1. 
 
General Experimental Procedure for the Preparation of Chloroketone 4.41 from 
Chlorohydrin 4.23 
 
To an ice-bath-cold solution of chlorohydrin 4.1 (363.5 mg, 1 mmol) in 
dichloromethane (5 mL) was added slowly Dess–Martin periodinane (424.1 mg, 1 
mmol) in one portion. The reaction mixture was stirred for 2 h, and then the 
reaction was quenched with sodium thiosulfate (10%)/sodium carbonate saturated 
aqueous solution (1:1) (25 mL). The mixture was stirred for 30 min and then 
extracted with dichloromethane (3 × 15 mL), and the organic layers were washed 
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with brine, dried (Na2SO4), and concentrated. The crude material was purified by 
chromatography (silica gel, hexanes/ethyl acetate (7:3)) to afford the desired 
compound (yield 321 mg, 89%). 
 
General Experimental Procedure for the Preparation of Chloroketones from Esters 
 
To a stirred solution of chloromethyl phenyl sulfone (3 mmol) in 
tetrahydrofuran (10 mL) at −78 °C was added slowly n-butyl lithium (1.6 M in 
hexanes, 3 mmol), and the mixture was stirred for 30 min. The amino ester (1 
mmol) in tetrahydrofuran (5 mL) was added, and the resulting mixture was 
gradually warmed to room temperature and stirred overnight. The reaction was 
quenched with ammonium chloride saturated solution (25 mL). The resulting 
mixture was extracted with ethyl ether (3 × 15 mL), and then the organic layers 
were washed with brine, dried (Na2SO4), and concentrated. The crude material was 
purified by chromatography (silica gel, hexanes/ethyl acetate (7:3)) to afford the 
desired compound (yield 217 mg, 60%). 
 
 
White solid, mp 103–106 °C. [α]D20 −8.0 (c = 1, CHCl3).  
1H NMR (300 MHz, CDCl3) δ 7.91 (d, J = 7.7 Hz, 4H), 7.74 (t, J = 7.5 Hz, 2H), 7.60 
(t, J = 7.5 Hz, 4H), 5.87 (s, 1H), 5.75 (s, 1H), 5.29 (s, 1H), 4.99 (s, 1H), 4.71 (s, 2H), 
1.48 (s, 9H), 1.43 (s, 15H) ppm.  
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13C NMR (75 MHz, CDCl3) δ 196.7, 155.0, 135.3, 135.2, 134.3, 130.6, 130.4, 129.1, 
81.0, 80.7, 73.3, 71.9, 55.5, 54.7, 28.3, 28.2, 17.2, 16.1 ppm.  
HRMS (ESI) calcd for C15H20ClNNaO5S ([M + Na]+) 384.0648, found 384.0642. 
IR (NaCl) ν 3019, 2981, 2930, 1771, 1540, 1498, 1449, 1394, 1369, 1331, 1313, 1158, 
1082, 1072, 1032, 1007, 686, 570, 553, 533, 525, 514, 418 cm–1. 
 
General Experimental Procedure for the Preparation of Oxazolidinones 
 
To an ice-bath-cold solution of chlorohydrin (1 mmol) in dichloromethane 
(3 mL) was added slowly trifluoroacetic acid/ dichloromethane (1:1) (3 mL). The 
mixture was stirred for 30 min and directly concentrated. Dichloromethane (5 mL) 
and then phosphate buffer (pH 9) were added, and the mixture was stirred for 15 
min and then extracted with dichloromethane. If the aqueous phase still contained 
free amine as determined by TLC, it was treated with phosphate buffer and 1 M 
potassium hydroxide. Then the organic layers were washed with brine, dried 
(Na2SO4), and concentrated. The crude mixture was dissolved in dichloromethane 
(6 mL) and cooled with an ice bath. Then a solution of triphosgene (1.2 mmol) in 
dichloromethane (5 mL) was added dropwise. The resulting mixture was stirred 
overnight at room temperature. The reaction was quenched with ammonium 
chloride saturated aqueous solution (25 mL). The resulting mixture was extracted 
with dichloromethane (3 × 15 mL), and then the organic layers were washed with 
brine, dried (Na2SO4), and concentrated. The crude material was purified by 
chromatography (silica gel, hexanes/ethyl acetate (1:1)) to afford the desired 
compound. 
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White solid, mp 129–132 °C. Yield 194 mg, 67%. [α]D20 +8.0 (c = 1, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 7.6 Hz, 2H), 7.78 (t, J = 7.4 Hz, 1H), 7.65 
(t, J = 7.9 Hz, 2H), 5.90 (br s, 1H), 5.05 (d, J = 3.1 Hz, 1H), 5.01 (d, J = 2.4 Hz, 1H), 
4.35–4.27 (m, 1H), 1.49 (d, J = 6.1 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3) δ 157.1, 135.6, 135.3, 129.7, 129.5, 79.1, 73.9, 49.4, 
21.6 ppm.  
HRMS (ESI) calcd for C11H12ClNNaO4S ([M + Na]+) 312.0073, found 312.0074.  
IR (NaCl) ν 3019, 2965, 2929, 1698, 1685, 1519, 1508, 1448, 1367, 1328, 1311, 1156, 
1085, 686, 590, 571, 418 cm–1. 
 
 
White solid, mp 127–129 °C. Yield 188 mg, 65%. [α]D20 +4.0 (c = 1, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 8.05 (d, J = 8.5 Hz, 2H), 7.76 (t, J = 6.6 Hz, 1H), 7.64 
(t, J = 7.9 Hz, 2H), 5.43 (br s, 1H), 4.85 (d, J = 9.9 Hz, 1H), 4.76 (dd, J = 6.6, 9.95 Hz, 
1H), 4.01 (m, 1H), 1.32 (d, J = 6.4 Hz, 1H) ppm.  
13C NMR (125 MHz, CDCl3) δ 157.1, 135.4, 135.3, 130.4, 129.5, 79.6, 70.2, 51.3, 
15.8 ppm.  
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HRMS (ESI) calcd for C11H12ClNNaO4S ([M + Na]+) 312.0073, found 312.0068.  
IR (NaCl) ν 3019, 2960, 2928, 2855, 1698, 1684, 1520, 1448, 1386, 1367, 1328, 1311, 
1260, 1156, 1127, 1085, 1051, 1035, 1017, 686, 612, 591, 571, 418 cm–1. 
 
 
White solid, mp 127–131 °C. Yield 199 mg, 69%. [α]D20 +4.0 (c = 1, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 8.03 (d, J = 7.7 Hz, 2H), 7.76 (t, J = 7.4 Hz, 1H), 7.63 
(t, J = 7.6 Hz, 2H), 5.45 (br s, 1H), 4.95 (t, J = 3.4 Hz 1H), 4.77 (d, J = 2.9 Hz, 1H), 
4.04 (m, 1H), 1.44 (d, J = 6.2 Hz, 2H) ppm. 
13C NMR (125 MHz, CDCl3) δ 156.7, 140.9, 135.2, 135.0, 130.6, 129.1, 79.6, 74.7, 
51.2, 21.3 ppm.  
HRMS (ESI) calcd for C11H12ClNNaO4S ([M + Na]+) 312.0073, found 312.0077.  
IR (NaCl) ν 3019, 2963, 2927, 2871, 1715, 1698, 1540, 1508, 1448, 1386, 1366, 1328, 
1311, 1156, 1127, 1085, 1017, 686, 612, 590, 571, 418 cm–1. 
 
 
White solid, mp 126–129 °C. Yield 211 mg, 73%. [α]D20 +4.0 (c = 1, CHCl3).  
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1H NMR (500 MHz, CDCl3) δ 8.00 (d, J = 6.9 Hz, 3.1, 1.5 Hz, 2H), 7.77 (tt, J = 7.6, 
0.4 Hz, 1H), 7.63 (t, J = 8.3 Hz, 2H), 5.43 (dd, J = 8.3, 3.2 Hz, 1H), 5.27 (br s, 1H), 
4.82 (d, J = 3.2 Hz, 1H), 4.33 (dq, J = 13.4, 6.8 Hz, 1H), 1.43 (d, J = 6.6 Hz, 1H) 
ppm.  
13C NMR (75 MHz, CDCl3) δ 157.0, 135.3, 134.5, 130.6, 129.2, 74.6, 72.9, 50.9, 15.3 
ppm.  
HRMS (ESI) calcd for C11H12ClNNaO4S ([M + Na]+) 312.0073, found 312.0074.  
IR (NaCl) ν 3020, 2956, 2927, 1734, 1457, 1448, 1396, 1378, 1328, 1322, 1312, 1156, 
1082, 1056, 1035, 699, 686, 585, 573, 552, 459, 435, 418 cm–1. 
 
 
Yellow oil. Yield 153 mg, 45%. [α]D20 −46.0 (c = 1, CHCl3).  
1H NMR (300 MHz, CDCl3) δ 8.08 (d,J = 7.3 Hz, 2H), 7.91 (d, J = 7.5 Hz, 2H), 7.69 
(m, 3H), 7.59 (m, 3H), 7.18 (d, J = 8.1 Hz, 1H), 6.92 (br s, 1H), 6.78 (br s, 1H), 6.32 
(d, J = 9.2 Hz, 1H), 5.82 (dq, J = 9.2, 7.2 Hz, 1H), 4.85 (dq,J = 8.1, 6.9 Hz, 1H), 1.53 
(d, J = 6.9 Hz, 3H), 1.42 (d, J = 6.9 Hz, 3H) ppm.  
13C NMR (75 MHz, CDCl3) δ 157.0 (q, J = 37.7 Hz), 142.0, 138.1, 136.3, 134.7, 
134.6, 132.4, 129.5, 129.4, 129.0, 115.6 (d, J = 289.6 Hz), 45.4, 45.0, 20.5, 18.8 ppm.  
HRMS (ESI) calcd for C12H11ClF3NNaO3S ([M + Na]+) 363.9998, found 363.9994.  
IR (NaCl) ν 3428, 3020, 1728, 1540, 1508, 1448, 1331, 1312, 1288, 1124, 1087, 922, 
882, 856, 684, 586, 570, 553, 524, 517, 503, 489, 473, 418 cm–1. 
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General experimental procedure for preparation of chlorovinylsulfones 
To an ice bath solution of vinylsulfones mixture (1mmol) in 
dichloromethane (1mL) was added trifluoroacetic acid (1.5mL) in dichloromethane 
(1.5mL). The mixture stirred for 30 minutes, and then it was directly concentrated. 
The resulting salt was dissolved in dichloromethane (10mL) or dimethylformamide 
(10mL) and stirred in ice bath. Then desired aminoacid was added (1.1mmol) 
followed by hydroxo benzotriazole (1.1mmol), diisopropylamine (4 mmol) and 
EDC (1.1mmol). It stirred for 8h and then it was quenched adding ammonium 
chloride saturated aqueous solution (25mL) and then extracted with 
dichloromethane (3 × 15 mL). The organic layers were washed with 1 M 
hydrochloric acid (15 mL), sodium bicarbonate saturated aqueous solution (15 mL), 
and brine, dried (Na2SO4), and concentrated. The crude material was purified by 
chromatography (silica gel, hexanes/ethyl acetate (1:1)) to afford the desired 
compound. 
 
 
1H NMR (500 MHz, cdcl3) δ 8.01 – 7.89 (m, 3H), 7.73 – 7.64 (m, 2H), 7.63 – 7.47 
(m, 3H), 7.20 – 7.01 (m, 2H), 4.92 – 4.73 (m, 2H), 4.63 – 4.39 (m, 2H), 1.57 – 1.32 
(m, 15H), 1.32 – 1.22 (m, 7H). 
13C NMR (126 MHz, cdcl3) δ 154.79, 141.85, 137.03, 134.14, 132.23, 129.20, 128.87, 
127.84, 80.02, 45.92, 28.24, 18.95. 
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1H NMR (500 MHz, cdcl3) δ 8.26 – 8.01 (m, 9H), 7.71 – 7.63 (m, 5H), 7.61 – 7.51 
(m, 9H), 6.41 – 6.24 (m, 5H), 5.63 – 5.43 (m, 5H), 4.79 – 4.59 (m, 6H), 1.44 (s, 32H), 
1.41 (d, J = 6.9 Hz, 12H). 
13C NMR (126 MHz, cdcl3) δ 154.84, 146.01, 137.92, 134.21, 129.29, 129.09, 128.86, 
128.43, 79.91, 45.20, 28.35, 21.15. 
 
 
1H NMR (500 MHz, cdcl3) δ 7.98 – 7.89 (m, 2H), 7.75 – 7.64 (m, 1H), 7.62 – 7.53 
(m, 2H), 7.44 – 7.23 (m, 8H), 7.22 – 7.12 (m, 2H), 6.98 – 6.82 (m, 1H), 6.28 – 6.13 
(m, 1H), 5.58 – 5.46 (m, 1H), 5.19 – 5.02 (m, 2H), 4.77 – 4.60 (m, 1H), 4.46 – 4.28 
(m, 1H), 3.17 – 2.93 (m, 2H), 1.21 – 1.10 (m, 3H). 
13C NMR (126 MHz, cdcl3) δ 170.49, 140.45, 136.84, 136.18, 136.05, 134.24, 132.81, 
129.46, 129.28, 129.02, 128.88, 128.57, 128.25, 127.94, 127.28, 77.32, 77.06, 76.81, 
67.14, 56.33, 44.65, 41.97, 38.90, 27.00, 24.98, 18.62. 
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1H NMR (500 MHz, cdcl3) δ 8.25 – 8.11 (m, 10H), 7.75 – 7.67 (m, 5H), 7.66 – 7.56 
(m, 10H), 7.41 – 7.30 (m, 23H), 7.26 – 7.19 (m, 14H), 7.17 – 7.06 (m, 10H), 6.01 – 
5.87 (m, 5H), 5.88 – 5.78 (m, 6H), 5.75 – 5.62 (m, 6H), 5.58 – 5.40 (m, 6H), 5.18 – 
4.99 (m, 11H), 4.44 – 4.28 (m, 6H), 3.19 – 2.91 (m, 12H), 1.33 – 1.16 (m, 19H). 
13C NMR (126 MHz, cdcl3) δ 169.57, 139.53, 135.93, 135.26, 135.14, 133.33, 131.89, 
128.55, 128.36, 128.11, 127.97, 127.66, 127.34, 127.03, 126.37, 76.40, 76.15, 76.15, 
75.89, 66.22, 55.41, 43.73, 41.05, 37.99, 26.09, 24.06, 17.71. 
 
 
1H NMR (500 MHz, cdcl3) δ 7.94 – 7.79 (m, 2H), 7.69 – 7.59 (m, 1H), 7.58 – 7.44 
(m, 3H), 7.38 – 7.25 (m, 4H), 7.17 (t, J = 11.7 Hz, 1H), 6.24 (dd, J = 34.5, 6.9 Hz, 
1H), 5.19 – 4.99 (m, 2H), 4.92 – 4.77 (m, 1H), 4.50 (d, J = 7.4 Hz, 1H), 4.43 – 4.30 
(m, 1H), 1.79 – 1.66 (m, 1H), 1.66 – 1.40 (m, 6H), 1.40 – 1.24 (m, 1H), 0.96 – 0.69 
(m, 14H). 
13C NMR (75 MHz, cdcl3) δ 172.65, 171.31, 156.39, 140.13, 136.94, 136.41, 134.15, 
132.90, 129.19, 128.82, 128.45, 127.99, 127.67, 66.78, 53.51, 51.99, 46.68, 42.31, 
41.43, 40.65, 24.82, 24.63, 24.57, 22.96, 22.74, 22.62, 22.45, 22.26, 21.95. 
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1H NMR (500 MHz, cdcl3) δ 8.20 – 8.08 (m, 5H), 7.72 – 7.63 (m, 3H), 7.63 – 7.52 
(m, 6H), 7.46 – 7.31 (m, 13H), 6.70 – 6.58 (m, 3H), 6.41 – 6.24 (m, 6H), 5.84 – 5.62 
(m, 4H), 5.19 – 4.99 (m, 9H), 4.47 – 4.32 (m, 4H), 4.21 – 4.04 (m, 4H), 1.88 – 1.76 
(m, 3H), 1.74 – 1.61 (m, 16H), 1.61 – 1.44 (m, 12H), 1.05 – 0.72 (m, 54H). 
13C NMR (75 MHz, cdcl3) δ 172.81, 171.48, 156.56, 140.30, 137.10, 136.57, 134.32, 
133.06, 129.36, 128.99, 128.62, 128.16, 127.99, 127.84, 66.94, 53.68, 52.15, 46.84, 
42.48, 41.59, 40.82, 24.99, 24.79, 24.74, 23.13, 22.91, 22.79, 22.61, 22.42, 22.12. 
 
General experimental procedure for preparation of imines 
To an ice bath solution of amino aldehyde (1mmol) in dichloromethane, 
benzyilamine was slowly added (2mmol). After stirring 1 hour it was quenched by 
adding ammonium chloride aqueous saturated solution. It was extracted with 
dichloromethane (3 x 15mL) washed with brine dried (MgSO4) and concentrated. 
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1H NMR (400 MHz, CDCl3) δ 7.82 – 7.68 (m, 5H), 7.39 – 7.29 (m, 12H), 7.29 – 7.18 
(m, 16H), 5.55 (d, J = 6.2 Hz, 4H), 4.70 – 4.54 (m, 10H), 4.35 (s, 4H), 1.78 (td, J = 
13.3, 6.6 Hz, 5H), 1.66 – 1.54 (m, 6H), 1.48 (d, J = 19.2 Hz, 54H), 0.94 (dt, J = 12.6, 
6.0 Hz, 34H). 
13C NMR (101 MHz, CDCl3) δ 164.79, 155.69, 138.98, 130.80, 128.72, 128.46, 
127.79, 126.95, 79.02, 64.07, 52.08, 42.12, 28.39, 23.13. 
 
 
General experimental procedure for preparation of acetylene 
To a cold (-78 oC) solution of acetylene (2.5mmol) in tetrahydrofuran 
(5mL), n-butyllithium (1.6M in hexanes, 2.5mmol) was slowly added. After stirred 
30 minutes, ester of aminoacid (1mmol) was added in tetrahydrofuran (5mL). It 
stirred for overnight and quenched adding ammonium chloride aqueous saturated 
solution. It was extracted with diethyl ether (3 x 15mL), washed with brine dried 
(MgSO4) and concentrated. 
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1H NMR (500 MHz, cdcl3) δ 7.43 – 7.06 (m, 33H), 6.75 – 6.61 (m, 3H), 5.67 – 5.49 
(m, 4H), 5.15 – 4.96 (m, 7H), 4.60 – 4.41 (m, 7H), 4.24 – 4.06 (m, 8H), 3.15 – 2.97 
(m, 7H), 1.35 (dd, J = 25.1, 7.2 Hz, 9H), 1.29 – 1.15 (m, 13H). 
13C NMR (126 MHz, cdcl3) δ 172.41, 170.59, 155.96, 136.38, 136.24, 129.36, 128.53, 
128.00, 127.90, 126.95, 66.96, 61.44, 56.02, 48.22, 38.60, 18.23, 14.12. 
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English version: 
In this thesis, according to the initial objectives, several conclusions can be 
accomplished:  
Cysteine protease inhibitors 
 New families of inhibitors have been published against proteasome and 
parasitic enzymes. 
 Epoxysulfones and chloroketones proved to be very good inhibitors of 
cathepsins H, S and C according to ABPP. 
 Nitroalkenes are a new class of cysteine protease reversible inhibitors and a 
source of new families of inhibitors. 
 New families of inhibitors were developed and are waiting to be tested and 
published. 
 A lot of inhibitors have been tested against proteasome, as a part of my 
formation and opening a new target of inhibition using ABPP. 
 
Synthesis studies 
 
 New route to obtain amides was developed using carbamates as 
intermediates in a single one pot reaction. 
 A new 1,4 sulfur – oxygen interaction was confirmed in a naphtoquinones 
structures and controlling the high tendency of diastereoisomeric excess 
when the interaction is present. Furthermore, the understanding of the 
role of this interaction in the biochemical vitamin K process in the blood 
coagulation has been achieved. 
 A complete study of stereoselectivity of nucleophilic epoxidation of MBH 
adducts was done, been the syn isomer the major in all cases. 
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 The mechanism of dehydrosulfenylation of 2-aryl esters for furnishing 
enoates has been determined to be a homolytic process. This mechanism 
was confirmed by ESI tandem MS radical intermediate monitorization and 
trapping the radical with tempo. 
 
Future work 
 
 Continue developing the big families of nitrocompounds with all the 
derivatizations initiated. 
 Synthetize new epoxysulfones and chloroketones with the correct 
structures to be tested against proteasome and other enzymes 
 Finish the new aziridines sulfones to check the inhibition power for this 
warhead. 
 Look for new S-O interactions and their effect on new developed 
compounds. 
 Apply the BHM adducts and their epoxidation to develop new compounds 
and studies. 
 Improve the radical intermediates detection to develop new utilities such 
as mechanism routes and other useful information. 
 Complete and evaluate the new interesting families of cysteine proteases 
synthetized and publish the results. 
 Finish the studies of asymmetric synthesis initiated and publish the results. 
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Versión Española: 
En esta tesis, atendiendo a los objetivos iniciales, se pueden extraer diversas 
conclusiones: 
Inhibidores de cisteína protease: 
 Nuevas familias de inhibidores han sido publicadas contra proteasoma y 
otras enzimas. 
 Epoxisulfonas y clorocetonas derivadas de la alanina and demostrado ser 
buenos inhibidores contra cathepsinas H, S y C a tenor de los resultados de 
ABPP. 
 Nitroalquenos han sido desarrollados como nuevos inhibidores reversibles 
de cisteína proteasa y como una fuente de desarrollo de nuevas familias 
gracias  a sus posibles derivatizaciones.  
 Nuevas familias de inhibidores y compuestos han sido desarrolladas 
durante esta tesis y están pendientes de ser testadas y publicadas 
 Muchos compuestos han sido testados contra proteasoma, como parte de la 
formación de esta tesis doctoral abriendo la puerta a nuevos objetivos de 
inhibición usando la metodología ABPP. 
 
Estudios de síntesis: 
 
 Una nueva ruta para la obtención de amidas a través de carbamatos ha sido 
desarrollada utilizando un simple proceso de un paso. 
 Una nueva interacción 1,4 azufre-oxígeno en unas naftoquinonas ha sido 
detectada además de estudiarse la alta tendencia en el exceso 
diastereoisomérico cuando esta interacción está presente. Esta interacción 
ayudará a entender mejor su papel en el proceso bioquímico de la vitamina 
K en la coagulación de la sangre. 
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 Un completo estudio de la estereoselectividad de la epoxidación 
nucleófilica de aductos de MBH se llevó a cabo, resultando en todos los 
casos el isómero syn como mayoritario. 
 El determinó el mecanismo de deshidrosulfenilación de los 2-aril ésteres 
como homolítico. Esto se confirmó detectando el radical intermedio con la 
técnica de ESI tándem MS y atrapando el radical con el tempo. 
 
Trabajo futuro: 
 
 Continuar el desarrollo de las familias de nitro compuestos con todas las 
derivatizaciones posibles que hay iniciadas. 
 Sintetizar nuevas epoxisulfonas y clorocetonas con la correcta estructura 
para ser testadas de nuevo contra proteasoma y otras enzymas y poder saber 
todo su potencial. 
 Acabar al síntesis de las sulfonil aziridinas para comprobar su potencial y 
poder saber el futuro de este nuevo tipo de inhibidor.  
 Buscar nuevas interacciones S-O y averiguar su efecto sobre posibles 
reacciones. 
 Aplicar la metodología de síntesis y epoxidación de aductos MBH para 
generar nuevas familias de compuestos y explorar su utilidad. 
 Mejorar y ampliar la detección de radicales intermedios de reacción y 
desarrollar su utilidad para saber rutas, mecanismo u otra información de 
utilidad. 
 Acabar y evaluar los prometedores nuevos inhibidores de cisteína proteasas 
sintetizados y publicar los resultados. 
 Acabar los estudios empezados de síntesis asimétrica y publicar los 
resultados. 
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Crystallographic data 
Table 1 Crystal data and structure refinement for syn-2.2 
Identification code STR1168M 
Empirical formula C18H16O3S 
Formula weight 312.37 
Temperature/K 298(2) 
Crystal system triclinic 
Space group P-1 
a/Å 7.7667(5) 
b/Å 10.1556(6) 
c/Å 10.4484(6) 
α/° 77.2900(10) 
β/° 71.4970(10) 
γ/° 80.5300(10) 
Volume/Å3 758.37(8) 
Z 2 
ρcalcmg/mm3 1.368 
m/mm-1 0.223 
F(000) 328.0 
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Crystal size/mm3 0.24 × 0.22 × 0.16 
2Θ range for data collection 4.14 to 54.98° 
Index ranges -10 ≤ h ≤ 10, -13 ≤ k ≤ 13, -13 ≤ l ≤ 13 
Reflections collected 8857 
Independent reflections 3482[R(int) = 0.0164] 
Data/restraints/parameters 3482/0/263 
Goodness-of-fit on F2 1.027 
Final R indexes [I>=2σ (I)] R1 = 0.0374, wR2 = 0.1030 
Final R indexes [all data] R1 = 0.0458, wR2 = 0.1110 
Largest diff. peak/hole / e Å-3 0.27/-0.18 
 
 
  
Table 2 Fractional Atomic Coordinates (×104) and Equivalent Isotropic 
Displacement Parameters (Å2×103) for STR1168M. Ueq is defined as 1/3 of of the 
trace of the orthogonalised UIJ tensor. 
Atom x y z U(eq) 
S1 654.0(6) 2628.1(4) 9242.9(4) 55.90(15) 
C1 834.5(19) 3369.1(14) 7417.0(15) 45.5(3) 
O1 -1738.3(15) 3088.2(13) 6771.5(14) 64.0(3) 
O2 4923.6(15) 1140.8(13) 6980.0(17) 76.4(4) 
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C2 2877.7(19) 3090.4(15) 6623.8(17) 48.8(3) 
C3 171(3) 4869.6(17) 7261(2) 61.6(4) 
O3 3927.2(18) 3727.0(14) 7141.4(16) 68.8(4) 
C4 3230(3) 3618(2) 5083(2) 64.0(5) 
C5 -303.7(17) 2578.0(14) 6974.6(14) 43.4(3) 
C6 3454.2(18) 1568.8(15) 6800.6(17) 49.2(3) 
C7 2215.8(17) 674.4(14) 6693.5(15) 42.9(3) 
C8 2855(2) -644.6(16) 6497.7(18) 54.1(4) 
C9 1687(3) -1497.6(18) 6451.5(19) 59.7(4) 
C10 -129(3) -1042.6(18) 6608.5(17) 58.8(4) 
C11 -783(2) 271.0(17) 6780.7(16) 51.1(4) 
C12 382.9(17) 1151.3(14) 6814.4(13) 41.0(3) 
C13 -1746(2) 2683.1(16) 10000.3(15) 51.7(4) 
C14 -2687(3) 3776.9(18) 10611.0(17) 58.1(4) 
C15 -4542(3) 3826(2) 11224.3(19) 70.4(5) 
C16 -5478(3) 2811(2) 11214(2) 78.8(6) 
C17 -4573(3) 1719(3) 10633(2) 82.3(6) 
C18 -2700(3) 1630(2) 10039.7(19) 68.5(5) 
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Table 3 Anisotropic Displacement Parameters (Å2×103) for syn-2.2. The 
Anisotropic displacement factor exponent takes the form: -
2π2[h2a*2U11+...+2hka×b×U12] 
Atom U11 U22 U33 U23 U13 U12 
S1 58.7(3) 58.0(2) 54.4(2) -6.35(17) -26.36(18) -0.97(18) 
C1 42.3(7) 41.2(7) 53.3(8) -1.8(6) -19.0(6) -3.9(5) 
O1 42.9(6) 66.8(7) 86.3(8) -6.1(6) -34.0(6) 3.8(5) 
O2 38.6(6) 62.1(7) 133.8(12) -6.4(7) -40.3(7) -4.4(5) 
C2 37.5(7) 43.6(7) 66.7(9) -2.7(6) -18.6(6) -11.3(6) 
C3 67.0(11) 41.9(8) 75.5(12) -4.3(8) -27.6(10) 0.7(7) 
O3 54.0(7) 56.7(7) 108.3(11) -13.2(7) -36.0(7) -18.1(6) 
C4 52.9(9) 59(1) 68.0(11) 6.3(8) -8.7(8) -14.1(8) 
C5 33.3(6) 49.7(7) 45.0(7) -0.2(6) -13.6(5) -4.7(5) 
C6 31.4(6) 48.4(8) 66.7(9) -2.7(7) -16.6(6) -7.2(5) 
C7 34.9(6) 43.6(7) 49.0(7) -2.1(6) -13.3(5) -6.8(5) 
C8 48.0(8) 47.4(8) 63.8(9) -6.3(7) -15.2(7) -3.4(6) 
C9 70.7(11) 45.9(8) 62.2(10) -8.5(7) -16.3(8) -13.4(8) 
C10 65.6(10) 61.9(10) 54.1(9) -7.7(7) -14.9(7) -29.8(8) 
C11 40.3(7) 66.7(10) 49.0(8) -5.5(7) -14.6(6) -16.7(7) 
C12 33.7(6) 49.0(7) 40.7(7) -2.3(5) -12.7(5) -9.1(5) 
C13 64.1(9) 49.5(8) 41.5(7) -4.9(6) -15.7(7) -10.0(7) 
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C14 73.4(11) 51.5(9) 50.5(9) -8.6(7) -19.0(8) -8.6(8) 
C15 77.2(12) 65.0(11) 56.5(10) -8.8(8) -7.4(9) -0.2(9) 
C16 71.8(12) 86.9(14) 64.6(12) -7.1(10) -1.7(10) -16.7(11) 
C17 90.4(15) 85.7(15) 66.7(12) -11.3(10) -0.8(10) -45.1(12) 
C18 87.0(13) 57.2(10) 55.1(10) -14.5(8) -1.1(9) -23.8(9) 
  
Table 4 Bond Lengths for syn-2.2 
Atom Atom Length/Å  Atom Atom Length/Å 
S1 C1 1.8597(15)  C7 C8 1.386(2) 
S1 C13 1.7753(17)  C7 C12 1.4011(18) 
C1 C2 1.551(2)  C8 C9 1.372(2) 
C1 C3 1.516(2)  C9 C10 1.379(3) 
C1 C5 1.516(2)  C10 C11 1.376(2) 
O1 C5 1.2110(16)  C11 C12 1.386(2) 
O2 C6 1.2096(17)  C13 C14 1.387(2) 
C2 O3 1.4078(18)  C13 C18 1.385(2) 
C2 C4 1.531(2)  C14 C15 1.376(3) 
C2 C6 1.524(2)  C15 C16 1.359(3) 
C5 C12 1.486(2)  C16 C17 1.364(3) 
C6 C7 1.4708(19)  C17 C18 1.385(3) 
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Table 5 Bond Angles for syn-2.2 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
C13 S1 C1 102.01(7)  C8 C7 C6 119.98(13) 
C2 C1 S1 105.37(9)  C8 C7 C12 120.15(13) 
C3 C1 S1 110.66(12)  C12 C7 C6 119.86(13) 
C3 C1 C2 112.65(13)  C9 C8 C7 120.10(15) 
C5 C1 S1 106.50(9)  C8 C9 C10 119.87(16) 
C5 C1 C2 109.53(12)  C11 C10 C9 120.84(15) 
C5 C1 C3 111.76(13)  C10 C11 C12 120.06(14) 
O3 C2 C1 108.69(13)  C7 C12 C5 120.66(12) 
O3 C2 C4 109.95(14)  C11 C12 C5 120.41(12) 
O3 C2 C6 109.80(12)  C11 C12 C7 118.94(14) 
C4 C2 C1 111.33(13)  C14 C13 S1 119.78(13) 
C6 C2 C1 110.20(11)  C18 C13 S1 121.34(14) 
C6 C2 C4 106.86(14)  C18 C13 C14 118.84(17) 
O1 C5 C1 121.04(13)  C15 C14 C13 120.62(18) 
O1 C5 C12 120.99(13)  C16 C15 C14 120.10(19) 
C12 C5 C1 117.96(11)  C15 C16 C17 120.1(2) 
O2 C6 C2 119.49(13)  C16 C17 C18 120.8(2) 
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O2 C6 C7 122.28(14)  C13 C18 C17 119.41(19) 
C7 C6 C2 118.19(11)      
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Elimination reactions of sulfoxides and sulfones are well-known reactions in 
synthetic organic chemistry.(1) In particular, the transformation of 2-arylsulfinyl 
esters to afford unsaturated carbonyl compounds by elimination is a common 
synthetic transformation.(2-5) The elimination reaction of sulfoxides follows an Ei 
(elimination internal) mechanism, as demonstrated by the seminal work by Cram 
and Kingsbury,(6) who also suggested the existence of a competing homolytic 
mechanism for some sulfoxides having a group to stabilize a radical intermediate. 
Although extensive work has been reported for the elimination of sulfoxides 
through an Ei mechanism,(7, 8) no convincing evidence has appeared for a radical 
mechanism involving any sulfinyl substrate. 
In the context of our investigations with sulfoxides,(9, 10) we became interested in 
determining the nature of the mechanism during the elimination reaction of 2-
arylsulfinyl esters. We considered two plausible mechanistic routes for the 
elimination of a 2-arylsulfinyl ester to afford the corresponding enoate (Scheme 1): 
(a) the concerted elimination reaction (Ei) or (b) a radical process involving the 
homolytic scission of the C–S bond to furnish free radical 4 and aryl sulfinyl 
radical 3. 
 
Scheme 1. Possible Mechanistic Routes 
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We undertook the study of the elimination reaction of 2-arylsulfinyl esters with a 
range of R alkyl groups and Ar aryl groups attached to the sulfur atom. 2-
Arylsulfinyl esters 2a–f were prepared from the corresponding 2-bromo esters by 
treatment with the corresponding sodium thiophenolates, which furnished the 
expected thioethers 1a–f. Upon oxidation of the thioethers, sulfoxides 2a–f were 
obtained as a mixture of stereoisomers (Scheme 2).(11) Then compounds2a–f were 
submitted to elimination by heating to reflux in toluene for 5 h, affording the 
corresponding E-enoates.(12) 2-Arylsulfinyl esters 2a–c gave rise to ethyl 
acrylate 5 and compounds 2d, 2e, and 2f afforded enoates 6, 7, and 8, respectively, 
as dominant products.(13) 
 
Scheme 2. Preparation and Elimination of 2-Arylsulfinyl Esters 2a–f 
Careful isolation of all the products obtained during the elimination reaction of 
compound 2agave the phenylthiosulfonate 9 (that partly converts to diphenyl 
disulfide and sulfonic acid, see below) and rearranged sulfoxide 10 as a minor 
product (15%) (Scheme 3).(14) 
 
Scheme 3. Elimination Reaction of Compound 2a 
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It is also noteworthy that the unprecedented rearrangement of 2-arylsulfinyl 
ester 2a to yield 10provided an alternative synthetic entry to 3-arylsulfinyl ester. 
To determine whether the formation of minor compound 10 was an inter- or an 
intramolecular process, we conducted a crossover experiment between 2b and 
compound 2f (see Scheme 4). 
 
Scheme 4. Crossover Experiment between 2b and 2f 
After heating of both sulfoxides 2b and 2f, the 1H NMR or 13C NMR spectra were 
highly crowded due to the presence of numerous species, making it difficult to 
identify the newly formed species. However, after removal of volatile acrylates and 
chromatographic separation of the fraction containing the 3-arylsulfinyl esters and 
the thiolsulfonate esters, electrospray ionization mass spectrometry (ESI–MS) 
analysis, operated in positive ion mode (ESI(+)), unravelled a rapid and direct 
snapshot of the formed species in the reaction mixture (see Figures S1 and 
S2,Supporting Information) and demonstrated that the rearrangement was an 
intermolecular rather than an intramolecular process.(15) A similar result was 
observed when sulfoxides 2b and 2ewere heated at 80 °C for 2 h as judged by ESI–
MS analysis. 
The corresponding 2-arylsulfonyl esters were also prepared. When 2-arylsulfonyl 
esters or 2-arylthioethers (1a–f) underwent the same experimental conditions for 
elimination as the sulfoxides, only starting material was recovered, thus illustrating 
that eliminations are a characteristic feature of only the sulfoxides. 
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Since the photolytic homolysis of C–S bonds has been described,(16) the 
elimination reactions were also performed in the absence of light. When 2-
arylsulfinyl esters 2a–f were submitted to elimination by heating in the absence of 
light the products were the same as in the presence of light, thus ruling out a 
photolytic homolysis. 
The interception of the radical intermediates would provide evidence for presence 
of a single-electron transfer mechanism in the elimination reaction. A nitroxyl 
radical (2,2,6,6-tetramethyl-1-piperidinyloxy) (Tempo) succeeded in intercepting 
the radical intermediates derived from 2-arylsulfinyl esters 2b, 2d, and 2e. The 
reactions were investigated by electrospray ionization mass spectrometry (ESI–
MS).(17) Compounds 2b, 2d, and 2e afforded adducts 11 and 15, 12and 14, 
and 13 and 14, respectively. In case of the reaction using 2e as starting material, 
both resulting reaction compounds 13 and 14 were isolated and fully characterized 
(see theSupporting Information) (Scheme 5).(18) 
 
Scheme 5. Trapping of the Radical Intermediates Using Tempo 
These results denote the occurrence of a radical process during the elimination of 
2-arylsulfinyl esters into enoates. A possible mechanism is proposed in Scheme 6. 
Sulfoxide 2 would give rise to radical 4 and aryl sulfinyl radical 3. Sulfinyl radicals 
combine to give vicinal disulfoxides (vic-disulfoxides) which isomerize to give 
phenyl thiosulfonate 9. Thiosulfonate 9 partly converts into the corresponding 
diaryl sulfide 16 and sulfonic acid as it is known.(19) Radical 4 would furnish the 
 Publications  
 
417 
enoate. The formation of the subproduct 10 can be explained by addition of in situ 
formed phenyl sulfenic acid to the enoate. The addition of sulfenic acids to 
unsaturated esters have been demonstrated previously.(20-
22) Compound 10 would be formed in a low yield due to the high tendency of 
sulfinyl radicals (or sulfenic acids) to afford thiosulphonates, although final 
reaction yields would depend on the subtle interplay between kinetics and 
thermodynamics of each elementary step depicted in Scheme 6. 
 
Scheme 6. Radical Mechanism in the Elimination of 2-Arylsulfinyl Esters 
In studies to determine the reaction mechanism of a multistep reaction, the 
identification of the intermediates is an essential process.(23) In this context, ESI–
MS is a useful technique for analyzing chemical intermediates or products in 
diverse chemical and biochemical processes,(24-26) as illustrated above for the 
identification of the products formed in the crossover experiment. Although the 
detection of free radicals is sometimes difficult, ESI–-MS has been recently 
employed for observing radical intermediates in some processes.(27-32) For a 
better understanding of the mechanism of the arylsulfinyl esters elimination 
depicted in Scheme 6, attempts to intercept and characterize the formed species 
were carried out on the basis of online ESI mass spectrometry and ESI tandem mass 
spectrometry. Closely related thermally driven homolytic reactions have been 
successfully investigated by Metzgeŕs group by means of ESI mass spectrometry 
using modified ESI sources.(28) To investigate the elimination reaction, toluene 
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solutions of 2a were heated to 100 °C and at different time intervals, aliquots were 
extracted, immediately diluted with hot acetonitrile, and analyzed by ESI(+) mass 
spectrometry. The obtained ESI mass spectra recorded at different intervals were 
nearly identical (Figure 1), with the most significant difference being the 
appearance of new signals corresponding to the PhSSO2Ph product as evidenced 
for the peaks assigned to [PhSSO2Ph + Na]+ (m/z = 273) and [PhSSO2Ph + K]+ 
(m/z = 289). Negative ESI mass spectrum revealed the presence of sulfonic acid as 
[M – H]− adduct. Diphenyl disulfide was not observed in the ESI mass spectrum 
because it is not readily ionized upon ESI conditions. 
 
Figure 1. ESI(+) mass spectra of toluene/acetonitrile solutions of compound 2a. 
Samples of the initial solution of 2a (upper panel) and of compound 2a after heating 
for 60 min (lower panel). Note that species at m/z 227, 249, and 265 in the lower 
panel correspond to 2a and its rearranged isomer 10. 
The transient radical cations PhSO• and CH3CH·CO2CH2CH3 (not as H+, Na+, or 
K+ adducts) could not be identified in the ESI mass spectrum directly. However, 
monitoring the advance of the 2a conversion to methylacrylate and the rearranged 
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product 10 was possible by ESI–MS, provided that both 2a and 10 isomers at m/z = 
249 displayed distinctive unimolecular dissociation upon collision-induced 
dissociation (CID) conditions. CID spectra of the sodium adducts of 2a and 10 are 
shown in Figure 2 which allowed us to monitor the temporal evolution of the 
species. 
 
Figure 2. CID spectra of mass-selected species at (a) m/z = 249 [2a + Na]+ and 
(b) m/z = 249 [10 + Na]+ (Elaboratory = 15 eV).  
Also helpful is the use of the MS/MS technique, where the fragment spectrum 
gives direct information about structural aspects of the investigated ion and can 
provide efficient information about mechanistic properties. It is remarkable that 
species [2a + Na]+ (m/z = 249) dissociated predominantly via homolytic C–S bond 
cleavage affording the radical species [CH3CH·CO2CH2CH3 + Na]+ (m/z = 124) 
whereas species [10 + Na]+ (m/z = 249) dissociated via formation of the closed-shell 
[CH2CH·CO2CH2CH3 + Na]+ (m/z = 123) product ion. Moreover, at identical 
collision energies, it is clear that species [2a + Na]+ is significantly easier to 
dissociate than [10 + Na]+ as evidenced by the relative intensity of the formed 
product ions. The gas-phase behavior of 2a is reminiscent of that observed for 
heated solutions for which this compound is more prone to homolytically 
dissociate via S–C bond cleavage. 
The same conditions were also used for monitoring the evolution of the reaction of 
2-arylsulfinyl esters 2b–f. It is remarkable that species [2a–f + Na]+ unvariably 
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dissociated predominantly via homolytic C–S bond cleavage affording the 
respective radical species [RCH2CH·CO2X + Na]+respectively, as illustrated in 
Figure 3 for 2b–f. Fragmentation studies were also performed for the 2-arylsulfide 
esters and 2-arylsulfonyl esters but no radical intermediates were detected in their 
respective CID spectra. It is known that sulfides and sulfones do not eliminate as 
easily as sulfoxides.(33) 
 
Figure 3. CID spectra of mass-selected species [2b–f + Na]+ using a collision energy 
(Elaboratory) = 15 eV. Radical species detected are m/z = 124 for 2b and2c, m/z = 
138 for 2d, m/z = 152 for 2e and m/z = 186 for 2f. 
The formation of rearrangement products during the elimination of a 2-
arylsulfinyl ester was also observed during the synthesis of the natural 
product 18 starting from sulfoxide 17.(9) In this case, 3-arylsulfonyl lactone 19 was 
obtained as a minor product along with the expected α-methylene γ-
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butyrolactone 18 (Scheme 7) when the reaction was performed in open air. 
Sulfone19 was formed in a highly stereoselective fashion as judged by single-
crystal X-ray diffraction methods (see Figure S4, Supporting Information).(34) In 
this case, sulfone 19 was formed instead of the expected sulfoxide, following the 
well-known tendency of γ-hydroxy sulfides to be oxidized to sulfones instead of 
sulfoxides under photooxidation conditions.(35) 
 
Scheme 7. Synthesis of Compounds 18 and 19 
In summary, the mechanism of the dehydrosulfenylation of 2-arylsulfinyl esters 
for furnishing enoates has been determined to be a homolytic process. The 
interception of the radical intermediate using a nitroxyl radical and ESI–-MS and 
ESI tandem MS techniques were useful for drawing a comprehensive picture of the 
intermediates involved in the dehydrosulfenylation of 2-arylsulfinyl esters and 
suggest that a radical-mediated process is operative. An unprecedented 
transformation of 2-arylsulfinyl esters to 3-arylsulfinyl esters is also observed as a 
side reaction whose intimate mechanism is proposed. 
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In 1981, Silverman investigated the mechanism of vitamin K epoxide-reductase 
using 2,3-dimethyl-1,4-naphthoquinone 2,3-epoxide as a model for vitamin K 2,3-
epoxide.1 and 2 This study advanced our understanding of the mechanism of vitamin 
K epoxide-reductase during the catalytic conversion of vitamin K 2,3-epoxide into 
vitamin K, which is essential for blood coagulation. This author reported 
that anti α-hydroxy-β-ethylsulfenyl-α,β-dimethyl naphthoquinone (anti-1) 
isomerized into an 8:2 mixture of syn/anti isomers when treated with sodium 
ethylthiolate ( Scheme 1) through a retro-aldol/aldol mechanism. A similar result 
was observed for α-hydroxy-β-phenylsulfenyl-α,β-dimethyl naphthoquinone 2. 2 
 
Scheme 1. Isomerization of naphthoquinone derivatives. 
 
We have recently reported that syn–anti-β-hydroxy-α-sulfenyl-γ-butyrolactones 
isomerized into syn–syn-β-hydroxy-α-sulfenyl-γ-butyrolactones ( Scheme 2). 3 We 
proposed that nonbonded sulfur–oxygen interactions could control the 
stereoselectivity of the reaction. When we determined the crystal structures 
of syn–syn lactones, we observed that the sulfur–oxygen distances were less than 
the sum of the Van der Waals radii (3.3 Å), with the angle formed by the hydroxyl 
oxygen, sulfur, and quaternary aromatic carbon being approximately 180°. In 
addition, the carbonylic oxygen–sulfur was directed <40° from the perpendicular to 
the C–S–C. Then two concomitant, attractive 1,4 intramolecular interactions of 
divalent sulfur with both the carbonyl and the hydroxyl oxygens served as the 
driving force to establish the stereochemical preference. 
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Scheme 2. Isomerization of β-hydroxy-α-sulfenyl-γ-butyrolactones. 
 
Weak nonbonding interactions between sulfur and oxygen atoms have been 
invoked to explain the biological activities as well as their physical properties in a 
large number of organosulfur compounds.4 
Herein, we show that for α-hydroxy-β-sulfenyl-α,β-dimethyl naphthoquinones, 
the intramolecular interaction of divalent sulfur with the hydroxyl oxygen also 
control the stereochemical preference. The crystal structure of syn α-hydroxy-β-
sulfenyl-α,β-dimethyl naphthoquinone has been determined. Also α-hydroxy-β-
alkoxy-α,β-dimethyl naphthoquinones have been prepared for comparison. The 
isomerization of these oxygenated analogs under the same conditions as the 
sulfurated ones gave either the anti isomer or an equal mixture of syn/anti isomers. 
α-Hydroxy-β-sulfenyl-α,β-dimethyl naphthoquinones anti-1 and anti-2 were 
prepared starting from the epoxide 5 using the corresponding thiol in the presence 
of triethylamine.2 Having already reported compounds 1 and 2, we went on to 
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prepare compound syn3resulting from the opening of the epoxide with sodium 
methyl thiolate and further isomerization. 6 This reaction furnished a mixture of 
isomers with the syn isomer predominating. 
For the preparation of the oxygenated derivatives, acidic conditions were required. 
The epoxide was opened with the corresponding alcohol7 using boron trifluoride as 
a catalyst using conditions we had previously reported.8 These reactions resulted to 
be very slow (see Experimental section). During the coagulation 
cascade,9 accordingly vitamin-K-epoxide is selectively opened by a cysteine residue 
of vitamin-K-epoxide reductase, but it is not opened by the coagulation factors, 
which are serine proteases (Scheme 3). 
 
 
Scheme 3. Preparation of substrates. 
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Compounds 1–5 were submitted to the isomerization reaction using sodium 
ethylthiolate or sodium phenylthiolate. Compounds 1 and 2 gave the same results 
as previously reported, giving rise to the syn isomer as the major form.2 Similar 
results were also obtained for methyl sulfenyl derivative 3. syn-isomers 1–3 (or 
anti isomers 1–3 or any mixture of both) invariably isomerized into a mixture of 
syn/anti lactones, with the syn isomer being the major one in all cases (entries 1–
9, Table 1). As already reported,2 and 10the elimination product was also obtained in 
some cases (Table 1). In contrast to β-hydroxy-α-sulfenyl-γ-
butyrolactones,3 compounds 1–3 did not isomerize in the presence of bases, such as 
triethylamine or N-methylmorpholine. 
 
Table 1.Ratio of syn/anti isomers resulting from isomerization 
Entry Substrate Base anti/syn 
1 syn1 NaSEt 14/65a 
2 anti1 NaSEt 14/71a 
3 syn1 NaSPh 5/83a 
4 syn2 NaSEt 17/83 
5 syn2 NaSPh 13/61a 
6 anti2 NaSEt 27/68a 
7 anti2 NaSPh 28/69a 
8 syn3 NaSEt 8/82a 
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Entry Substrate Base anti/syn 
9 syn3 NaSPh 20/80 
10 anti4 NaSEt 70/30 
11 anti4 NaSPh >95/5 
12 anti5 NaSEt 58/42 
13 anti5 NaSPh 38/62 
a Elimination product was already obtained. 
 
When oxygenated substrates 4–5 were submitted to the same reaction conditions 
as their sulfurated counterparts, they underwent an isomerization that furnished a 
mixture of isomers (entries 10–13, Table 1). Compound 4 was treated with sodium 
ethylthiolate and sodium phenylthiolate giving rise to a mixture of isomers, with 
the main product being the anti isomer (entries 10 and 11). This result is opposite 
to the one observed starting from sulfurated compound 1, which furnished the syn 
isomer under the same conditions (compare 1–3 with 10–11 entries). Similarly 
compound 5 gave an equal mixture of syn/anti isomers whilst 3 gave the syn 
isomer as the main product (compare 8–9 with 12–13 entries). No elimination 
products were observed for compounds 4–5, as expected. Silverman had previously 
suggested an elimination mechanism through the formation of disulfide for 
compound 4.2 
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The crystal structure of compound syn2 has been determined ( Fig. 1). 11 The 
distance between the hydroxyl oxygen and sulfur was 2.97 Å. The azimuthal angle 
was φ=113.7° and polar angle was θ=99.4° for the sulfur–hydroxyl oxygen contact. 
These geometric features are similar to the ones depicted for β-hydroxy-α-
sulfenyl-γ-butyrolactones. 3 For them, the azimuthal angles and polar angles for 
sulfur–hydroxyl oxygen contacts were 107° and 93°, respectively. 
 
 
Fig. 1. X-ray structure of compound syn-2 
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The short atomic distance observed is interpreted as a nonbonded interaction 
between oxygen and sulfur atoms, an interaction that would stabilize the syn 
isomer. 
The linear alignment of the C–S covalent bond and the coordinating hydroxyl 
oxygen should allows an effective orbital interaction between the oxygen lone 
electron pair and the σ* orbital of the S–C bond, which may elongate the S–C bond 
(1.77 Å for syn2, 1.75 Å for the diphenyl disulfide). The phenyl ring attached to 
the sulfur atom is oriented away from the hydroxyl, permitting the interaction to 
take place. Sulfur–oxygen interactions type I have nucleophilic oxygen tending to 
approach along the extension of the covalent bonds to sulfur. 12 
The distance between the carbonyl oxygen and sulfur was 3.55 Å. For this contact, 
the azimuthal angle was 94.9° and the polar angle was 97.9°. These parameters 
cannot be attributed to a sulfur–oxygen interaction. The planar structure of the 
naphthoquinone imposes rigidity that does not permit the sulfur atom to contact 
the carbonyl oxygen. This orientation might be at the origin of the lower 
selectivity observed during isomerization of compounds 1–3 as compared to the β-
hydroxy-α-sulfenyl-γ-butyrolactones. 
 
In summary, an attractive 1,4 intramolecular interaction of divalent sulfur with 
hydroxyl oxygen has been observed in the X-ray structure of syn α-hydroxy-β-
phenylsulfenyl-α,β-dimethyl naphthoquinone. This sulfur–oxygen interaction can 
be invoked to account for the tendency of α-hydroxy-β-sulfenyl-α,β-dimethyl 
naphthoquinones to assume the syn configuration. This study should contribute to 
the understanding of the role played by this subtle noncovalent interaction in 
determining the biochemical processing of vitamin-K-epoxide during blood 
coagulation.
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Stereoselective synthesis of α,β-epoxyesters is of considerable synthetic interest 
because a number of compounds can be obtained by the opening of the oxirane 
ring.1, 2,3, 4, 5, 6, 7, 8 and 9 A convenient method for the preparation of α,β-
epoxyesters is via nucleophilic epoxidation of chiral α,β-unsaturated esters.2 We 
previously reported that the nucleophilic epoxidation of γ-hydroxy-α,β-
unsaturated esters8 (Scheme 1) is a diastereoselective reaction that favor 
the syn isomer. We have also reported that the stereoselectivity depends highly on 
the substitution of the double bond and that high synstereoselectivity (dr >19:1) is 
observed for the α-methyl-substituted enoates 9 ( Scheme 1). Free hydroxyl group 
resulted to be key for the control of the stereoselectivity. The nucleophilic 
epoxidation of methyl 2-methylene-3-tert-butyldimethylsilyloxycarboxylate esters 
has been recently reported by A. Myers to get the anti diastereomer with high 
selectivity 12 ( Scheme 1). The epoxidation of Morita–Baylis–Hillman adducts is an 
interesting transformation because the resulting epoxides can be used in the total 
synthesis of interesting natural products. 10, 11 and 12 We now report a study of the 
stereoselectivity of the nucleophilic epoxidation of β-hydroxy-α-methylene esters. 
 
Scheme 1. Stereoselective nucleophilic epoxidations of unsaturated esters. 
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We wanted to study the selectivity of epoxidation of 3-hydroxy-methylene 
carboxylate esters with a range of R alkyl and aryl groups (Scheme 2). For the 
preparation of the substrates, a comparison of different experimental procedures 
was performed as shown in Table 1. Most of the substrates were prepared in good 
yield using DABCO as a base and a (1:1) mixture of dioxane/water as 
reported.13 We obtained higher yields when the reaction was performed at higher 
concentrations (10 M) than reported (see Experimental section). 
Compounds 1i and j were obtained in best yields under solvent-free conditions and 
longer period of time, and compounds 1m and n were prepared using 
dimethylsulfoxide as a solvent. 
 
Scheme 2.  Preparation of substrates. 
 
 
Table 1.Preparation of esters 1 
Entry Substrate Conditions Yield 
1 1a DABCO, dioxane/H2O (1:1), 10 M, 48 h, rt 99 
2 1b DABCO, dioxane/H2O (1:1), 10 M, 48 h, rt 70 
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Entry Substrate Conditions Yield 
3 1c DABCO, dioxane/H2O (1:1), 10 M, 48 h, rt 99 
4 1d DABCO, dioxane/H2O (1:1), 10 M, 48 h, rt 85 
5 1e DABCO, dioxane/H2O (1:1), 10 M, 48 h, rt 81 
6 1f DABCO, dioxane/H2O (1:1), 10 M, 48 h, rt 99 
7 1g DABCO, dioxane/H2O (1:1), 10 M, 48 h, rt 99 
8 1h DABCO, dioxane/H2O (1:1), 12 M, 48 h, rt 99 
9 1i DABCO, solvent-free 4 days, rt 82 
10 1j DABCO, solvent-free 5 weeks, rt 77 
11 1k DABCO, dioxane/H2O (1:1), 10 M, 36 h, rt 99 
12 1l DABCO, solvent-free 5 days, rt 94 
13 1m DABCO, DMSO 7 M, 4 days, rt 99 
14 1n DABCO, DMSO 7 M, 4 days, rt 99 
15 1o DABCO, dioxane/H2O (1:1), 10 M, 36 h, rt 89 
16 1p DABCO, dioxane/H2O (1:1), 10 M, 16 h, rt 95 
17 1q DABCO, dioxane/H2O (1:1), 10 M, 16 h, rt 87 
18 1r DABCO, dioxane/H2O (1:1), 10 M, 3 h, rt 83 
19 1s DABCO, dioxane/H2O (1:1), 10 M, 20 h, rt 85 
 
 
Esters 1 were epoxidized using lithium tert-butylperoxide (2 equiv) as the 
oxidizing reagent in THF as solvent at −20 °C. 2, 8 and 9 Table 2 shows that 
the 2syn isomer was the major product in all cases. For the aliphatic series 
(compounds 1a–f), the higher steric volume of the R pendant alkyl group the 
higher stereoselectivity is observed (entries 1–6). When the R is an alkenyl group 
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then the epoxidation reaction is not stereoselective (entry 7). Compounds 1h–
s having an aromatic group gave the corresponding synisomer 2 in very good 
selectivity. 
 
Table 2.Epoxidation of compounds 1 
Entry Substrate 2/3 Yielda 
1 Me 67/33 72 
2 Et 76/24 70 
3 n-Pr 81/19 79 
4 i-Bu 81/19 71 
5 Chx 92/8 85 
6 PhCH2CH2 77/23 59 
7 PhCH CH 53/47 47 
8 Ph 93/7 68 
9 p-Tol 89/11 82 
10 p-MeOPh 92/8 73 
11 p-FPh 90/10 65 
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Entry Substrate 2/3 Yielda 
12 p-ClPh 84/16 52 
13 m-ClPh 92/8 38 
14 o-ClPh 92/8 52 
15 p-BrPh 90/10 68 
16 o-NO2Ph 83/17 43 
17 m-NO2Ph 80/20 60 
18 p-NO2Ph 91/9 65 
19 Furfuryl 93/7 69 
a Isolated yield of products corresponds to mixtures 
of syn and anti diastereomers. 
We also epoxidized compound 1h by using oxidants other than lithium tert-
butylperoxide ( Table 3). If the reaction was carried out using tert-butyl 
hydrogenperoxide in the presence of substoichiometric amount of base (entry 1), 
then a slightly lower selectivity was observed compared to the reaction carried out 
using a stoichiometric amount of oxidant (entry 8, Table 2). Lithium 
cumylperoxide gave similar result to lithium tert-butylperoxide (entry 2). On the 
other hand, in the alkaline peroxides series, potassium gave poorer stereoselectivity 
than either lithium or sodium (entries 1 and 6–8). The yield of the epoxidation 
using m-CPBA (entry 3) was low at rt but it increased at higher temperature (entry 
4), affording the syn isomer as the major one. When m-CPBA was used in the 
presence of potassium carbonate 14 (entry 5), only starting material was recovered. 
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Table 3. Epoxidation of compound 1h 
Entry Conditionsa 2h/3h Yield (%)b 
1 TBPLi 88/12 66 
2 CMPLi 91/9 72 
3 m-CPBA 90/10 28 
4 m-CPBA 88/12 80 
5 m-CPBA — NR 
6 TBPNa 85/15 41 
7 TBPNa 87/13 62 
8 TBPK 83/17 61 
a For entry 1: 1.5 equiv of TBHP, 0.8 equiv of MeLi, THF, −20 °C, 20 h. For 
entry 2: 1.5 equiv of CMHP, 1.1 equiv of MeLi, THF, −20 °C, 20 h. For 
entry 3: 2.1 equiv of m-CPBA, DCM, rt, 96 h. For entry 4: 2.1 equiv of m-
CPBA, 70 °C (sealed tube), 96 h. For entry 5: 2.5 equiv of m-CPBA, 
1.3 equiv of K2CO3, DCM, rt, 96 h. For entry 6: 2.0 equiv of TBHP, 
1.0 equiv of t-BuONa, THF, 0 °C, 3 h. For entry 7: 2.0 equiv of TBHP, 
0.25 equiv of t-BuONa, THF, 0 °C, 3 h. For entry 8: 2.0 equiv of TBHP, 
0.25 equiv of t-BuOK, THF, 0 °C, 3 h. 
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b Isolated yield of products corresponds to mixtures 
of syn and anti diastereomers. 
 
The stereochemistry of epoxides 2b and h was confirmed by comparison with 
already reported data.12 and 15 The epoxyesters 2d, 3d, 2e, and 3e were transformed 
into cyclic carbonates through a one-pot sequence: treatment with thiophenol in 
the presence of a base, which resulted in the opening of the oxirane ring and then 
addition of triphosgene to give carbonates 4, 5, 6, and 7, respectively (Scheme 3). 
The stereochemical assignment of the carbonates was performed by NOE 
experiments (Scheme 3). Carbonates 4 and 6gave NOE between H-5 and methyl 
ester whilst 5 and 7 gave NOE between H-5 and methylene from the 
(phenylthio)methyl group. 
 
Scheme 3. Cyclic carbonates 4–7 
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In summary, the diastereoselectivity of the nucleophilic epoxidation of 3-hydroxy-
2-methylene esters has been studied. The syn isomer was the major one in all 
cases. The resulting 3-hydroxy 2-epoxyesters were treated with thiophenol for 
transformation into 2,3-dihydroxy-2-((phenylthio)methyl), which upon treatment 
with triphosgene afforded the corresponding cyclic carbonates. 
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Carbamates and amides are widely used protecting groups for amines.1 While some 
recent reports have described the conversion of carbamates into amides,2 more 
general and convenient methods to accomplish this transformation are desirable. 
During the course to the attempted preparation of diphenyl-L-prolinol, we 
reacted N-CBZ-L-proline methyl ester 3 with phenyl magnesium bromide. 
Unexpectedly, we obtained N-benzoyl-L-prolinol 1 as the main product ( Scheme 
1). 
 
 
Scheme 1.  Treatment of N-CBZ-L-proline methyl ester with phenyl magnesium 
bromide. 
 
This result prompted us to examine the reactivity of carbamates with Grignard 
reagents. When carbamates of secondary amines are treated with Grignard 
reagents or organolithium compounds, the corresponding amine and ketone are 
obtained (Scheme 2).4 Interestingly the reaction between carbamates of primary 
amines and Grignard reagents has been reported before as an undesired 
process.5 We are pleased to report herein that carbamates of primary amines when 
treated with Grignard reagents gave rise to amides in high yield and that primary 
amines can be converted into amides in a one-pot reaction through carbamate 
protection and Grignard addition (Scheme 2). 
 
  
446 
 
Scheme 2. Treatment of carbamates of secondary and primary amines 
 
N-Alkyl carbamates (benzyl, methyl, and terc-butyl) of primary amines 
(benzylamine, allylamine, and 3-phenylpropylamine) were prepared according to 
standard procedures.1 The resulting carbamates were reacted with Grignard 
reagents in THF at room temperature for 24 h ( Table 1). 
 
 
Entry R R′ Grignard (R′′MgX) Yield (%) 
1 Bn Bn MeMgBr 66 
2 Bn Bn EtMgBr 70 
3 Bn Bn PhMgBr 73 
4 Bn Bn t-BuMgCl 74 
5 Bn PhCH2CH2CH2 MeMgBr 77 
6 Bn PhCH2CH2CH2 EtMgBr 72 
7 Bn PhCH2CH2CH2 t-BuMgCl 89 
8 Bn PhCH2CH2CH2 i-PrMgCl 62 
9 Bn CH2 CHCH2 MeMgBr 43 
10 Bn CH2 CHCH2 EtMgBr 43 
11 Bn CH2 CHCH2 t-BuMgCl 69 
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Entry R R′ Grignard (R′′MgX) Yield (%) 
12 Bn CH2 CHCH2 i-PrMgCl 99 
13 Me PhCH2CH2CH2 MeMgBr 95 
14 Me PhCH2CH2CH2 EtMgBr 71 
15 Me PhCH2CH2CH2 t-BuMgCl 79 
16 Me PhCH2CH2CH2 i-PrMgCl 83 
17 t-Bu PhCH2CH2CH2 EtMgBr 85 
 
Table 1. Treatment of carbamates with Grignard reagents 
 
In all cases, starting carbamates were transformed into the corresponding 
amides6 in good to high yield. The broad availability of Grignard reagents 
permitted the preparation of a wide variety of amides, which is an advantage over 
similar procedures in the literature.2 
We are also glad to report a new one-pot procedure for the conversion of amines 
into amides. When a primary amine was treated with an alkoxy carbonyl chloride 
in the presence of triethyl amine, followed by addition of a Grignard reagent, the 
corresponding amide was obtained in good to high yield (Table 2). 
 
 
Entry R R′ R′′ Yield (%) 
1 PhCH2CH2CH2 Me Et 87 
2 PhCH2CH2CH2 Bn Et 92 
3 PhCH2CH2CH2 Bn Me 66 
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Entry R R′ R′′ Yield (%) 
4 CH2 CHCH2 Bn Me 70 
5 CH2 CHCH2 Bn t-Bu 47 
6 CH2 CHCH2 Bn i-Pr 58 
7 CH2 CHCH2 Bn Et 36 
8 CH2 CHCH2 Me Et 41 
9 CH2 CHCH2 Me Me 83 
10 PhCH2CH2CH2 t-Bu Et 90 
Table 2. One-pot conversion of amines into amides 
 
This one-pot process represents a new approach to synthesizing amides from 
amines. 
When carbamates of secondary amines are treated with Grignard reagents, the 
corresponding amines and ketones are obtained.3 However, carbamates of primary 
amines give amides. Carbamates of primary amines probably react with Grignard 
reagents through an N,O-magnesium chelate 2 ( Fig. 1) whilst carbamates of 
secondary amines cannot form this intermediate. The unexpected formation of the 
amide of diphenyl-L-prolinol from N-CBZ-L-proline methyl ester could be 
explained by formation of chelate 3 (Fig. 1). 
 
Figure 1. Chelation intermediates. 
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In summary, we have shown that carbamates of primary amines give rise to amides 
when treated with Grignard reagents. Primary amines can then be transformed 
into amides through protection as a carbamate followed by Grignard treatment in a 
one-pot procedure. 
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Lysosomal cysteine proteases (cathepsins) have been identified as therapeutic 
targets in the search for new drugs against a number of human pathologies, 
including cancer,(1) Alzheimer’s disease,(2) and osteoporosis.(3) The design of new 
cathepsin inhibitors is intimately based on the discovery of new chemical moieties 
that react effectively and selectively with the cysteine thiol nucleophile present in 
the enzyme active site. Thiol-reactive groups present in cathepsin inhibitors 
include Michael acceptors, such as the vinyl sulfone K1777,(4) nitriles,(5) and 
azanitriles,(6) as well as electrophiles reactive toward SN2 substitution. The most 
representative examples of the latter group are the epoxysuccinates,(7) as present 
for instance in the natural product E-64 and its derivatives,(8, 9) halomethyl 
ketones(10) and acyloxymethyl ketones(11-13) (Figure 1). The here-studied 
epoxysulfone moiety is designed to combine structural features of two cysteine 
protease-reactive electrophiles: vinyl sulfones and epoxysuccinates. 
 
Figure 1. Known cysteine protease inhibitors. 
In the context of our investigations of the preparation of new epoxide-based 
cathepsin inhibitors,(14) we became interested in the synthesis of epoxysulfones. 
The preparation of epoxysulfones derived from amino acids as new warheads of 
cysteine proteases was previously attempted through nucleophilic epoxidation of 
vinyl sulfones,(15) but it was reported that when vinyl sulfones were treated with 
lithium tert-butyl peroxide, allyl sulfones were formed instead of the desired 
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epoxysulfones. We report herein the synthesis of epoxysulfones derived from 
amino acids through a Darzens reaction using amino aldehydes derived from the 
corresponding amino acids and chloromethyl phenyl sulfone. 
In a first attempt, the Darzens reaction between tert-butoxycarbonyl alaninal (1 
equiv) and chloromethyl phenyl sulfone (1 equiv) using 1 equiv of n-butyllithium 
in tetrahydrofuran as a solvent at low temperature (−78 °C) proved abortive in that 
the starting materials were recovered. After carrying out a set of experiments using 
increasing amounts of sulfone and base, we found that optimal results were 
obtained when 2.5 equiv of chloromethyl phenyl sulfone and 2.5 equiv of n-
butyllithium were employed (Table 1, entry 1). In this case, a mixture of all four 
possible isomeric chlorohydrins 1–4 were obtained in good chemical yield. No 
significant changes were observed upon increasing the reaction time (entry 2) or 
performing the reaction at lower temperature (entry 3). This also held true when 
lithium diisopropylamide or lithium bis(trimethylsilyl)amide was used as the base 
instead of n-butyllithium (entries 4 and 5). In contrast, when dimethylformamide 
was added to the reaction mixture as a cosolvent, the synisomer 3 was formed as 
the main reaction product (entry 6). On the other hand, when potassium tert-
butoxide was used as the base under the same conditions as above, 
the synisomers 3 and 4 were the main products isolated (entry 7). When the same 
reaction was performed at room temperature, a complex mixture of nonidentifiable 
products resulted, as observed by NMR spectroscopy of the crude reaction mixture. 
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Entry Base Conditions 1:2:3:4 Yield (%) 
1 n-BuLi THF, −78 °C, 30 min 33:27:24:16 75 
2 n-BuLi THF, −78 °C, 5 h 35:26:25:14 77 
3 n-BuLi THF, −90 °C, 2 h 33:24:24:19 71 
4 LDA THF, −78 °C, 30 min 36:29:21:13 70 
5 LiHMDS THF, −78 °C, 30 min 35:25:25:15 67 
6 n-BuLi THF/DMF, −78 °C, 30 min 27:15:46:12 66 
7 t-BuOK THF, −78 °C, 30 min 17:8:42:33 55 
 
Similar J3,4 coupling constants were observed for anti chlorohydrins 1 and 2 and 
also for synchlorohydrins 3 and 4. For anti chlorohydrins 1 and 2, J3,4 was equal to 
9.0 and 9.6 Hz respectively, while for syn chlorohydrins 3 and 4, J3,4 was equal to 0 
Hz. 
The mixture of four chlorohydrins 1–4 derived from the Darzens reaction was 
separated by silica gel chromatography. In order to establish the stereochemistries 
of the obtained chlorohydrins, they were transformed into oxazolidinones 6–9. 
This transformation was attempted by initial deprotection the tert-butoxycarbonyl 
group followed by treatment with triphosgene (Scheme 1). When compound 1 was 
reacted with trifluoroacetic acid and the resulting ammonium salt was directly 
  
456 
treated with triphosgene in the presence of triethylamine, unexpectedly 
chlorovinyl sulfone 5 was isolated as the single reaction product. 
Compound 5 results from N-deprotection and trifluoroacetamide formation 
followed by elimination of water. In order to avoid the formation of such 
undesired compounds, the ammonium salt resulting from deprotection was 
transformed into the free amine with a phosphate buffer (pH 9.0), and then the 
free amine was converted into oxazolidinone 6 by reaction with triphosgene 
(Scheme 1). The same synthetic sequence was followed to prepare 
oxazolidinones 7, 8, and 9 starting from chlorohydrins 2, 3, and 4, respectively. 
The configurations of the asymmetric carbon atoms in oxazolidinones 6–9 were 
established by NMR experiments (Scheme 1). Both 
oxazolidinones 6 and 8 exhibited NOEs between H-5 and the methyl protons, 
while oxazolidinones 7 and 9 exhibited NOEs between H-5 and H-4. 
 
Scheme 1. Transformation of Chlorohydrins into Oxazolidinones 
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An extensive experimental investigation was then carried out to convert 
chlorohydrins into epoxysulfones by base treatment. First, chlorohydrin 1 was 
treated with sodium hydride, but NMR spectra of the crude mixture showed 
starting material, isomer 3 resulting from epimerization, and, as major products, 
alaninal and chloromethyl sulfone resulting from a retro-Darzens reaction. When 
chlorohydrin 2 was treated with sodium hydride, conversion into the isomeric 
compound 4 and retro-Darzens products was also observed. Triethylamine did not 
afford the desired compounds. Potassium carbonate in different solvents was next 
attempted. When methanol was used, the epoxide was detected as a minor 
product, and mainly starting material was recovered. When tetrahydrofuran was 
used as the solvent, traces of epoxide were detected, but epimerization to give 
compound 3 was also observed. Potassium carbonate in dimethylformamide gave 
the desired epoxide, but the retro-Darzens reaction also took place. Potassium tert-
butoxide was then tried. When it was used in tetrahydrofuran as the solvent, the 
retro-Darzens reaction took place. Finally, sodium tert-butoxide gave trans-
epoxysulfone 10 as the only reaction product when dichloromethane was applied 
as the solvent. In the case of cis-epoxysulfones, a mixture of dichloromethane 
and tert-butanol was used as a solvent. Under these reaction conditions, trans-
epoxide 11 and cis-epoxides 12 and 13 were obtained from compounds 2, 3, 
and 4 respectively (Scheme 2). 
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Scheme 2. Transformation of Chlorohydrins into Epoxysulfones 
 
Chlorohydrin 1 was transformed into chloroketone 14 through oxidation. 
Compound 14 was also prepared by addition of chloromethyl phenyl sulfone to N-
protected methyl L-alaninate (Scheme3). Chloroketone 14 was obtained in both 
cases as an equimolar mixture of epimers. 
 
Scheme 3. Preparation of Chloroketone 14 
 
Compounds 10 and 14 were investigated for their ability to inhibit cathepsins by 
using a competitive activity-based protein profiling (ABPP) assay against the 
known cysteine protease cathepsin activity-based probe DCG04-
BodipyFL.(16) Proteins from mouse liver lysates at pH 5.0 were treated with 
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compounds 10 and 14 for 1 h at 37 °C, and the residual cathepsin activity was 
captured by the DCG04-BodipyFL probe. After SDS-PAGE separation and in-gel 
fluorescence imaging, a typical band pattern was seen, which was compared with 
reported activity-based cathepsin profiling gels.(17) By comparison of the 
molecular weights of the individual bands seen, we have assigned the nature of the 
individual cathepsins labeled by DCG04-BodipyFL as indicated in Figure 2. 
Competition for most of the bands was observed upon cotreatment with DCG04-
BodipyFL, a result that underscores the annotation of the bands as being DCG04-
BodipyFL-sensitive cathepsins. Compound 10 is a more selective inhibitor than 
DCG04-BodipyFL, as it inhibits one to three cathepsins, while 
compound 14 inhibits four cathepsins at the 1 μM concentration used in this assay. 
Compounds 10 and 14 are able to outcompete the DCG04-BodipyFL inhibitor, and 
we can conclude that they bind in a covalent and irreversible fashion to the 
cathepsins, inhibiting their activity. 
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Figure 2. Competitive activity-based protein profiling (ABPP) assay of 
compounds 10 and 14 against the DCG04-Bodipy-FL probe in mouse liver lysate at 
pH 5.0. The inhibitors were used at 0.1 and 1 μM concentration, and the cathepsin 
probe was used at 0.5 μM. DMSO (1 μL) was used as negative control (0). 
 
In summary, the Darzens reaction between tert-butoxycarbonyl alaninal and 
chloromethyl phenyl sulfone afforded chlorohydrins, which were converted into 
epoxysulfones by reaction with sodium tert-butoxide. Epoxysulfone 10 and 
chloroketone 14 derived from chlorohydrins by oxidation proved to be inhibitors 
of cathepsins H, S, and C, as determined by competitive activity-based protein 
profiling. The introduction of epoxysulfone warheads, including those obtained 
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from further amino acid-derived amino aldehydes, into more elaborate peptidic 
sequences may result in more specific and/or more active cysteine protease 
inhibitors, whereas introduction of a reporter molecule (as in DCG-04) may yield a 
new class of activity-based cysteine protease probes. 
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